<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life - Rutjes, AWS - 2018 | Cochrane Library</title> <meta content="Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life - Rutjes, AWS - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011906.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life - Rutjes, AWS - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011906.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011906.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life" name="citation_title"/> <meta content="Anne WS Rutjes" name="citation_author"/> <meta content="David A Denton" name="citation_author"/> <meta content="Sussex Partnership NHS Foundation Trust" name="citation_author_institution"/> <meta content="Marcello Di Nisio" name="citation_author"/> <meta content="University &quot;G. D'Annunzio&quot; of Chieti‐Pescara" name="citation_author_institution"/> <meta content="Lee‐Yee Chong" name="citation_author"/> <meta content="UK Cochrane Centre" name="citation_author_institution"/> <meta content="Rajesh P Abraham" name="citation_author"/> <meta content="Surrey and Borders Partnership NHS Foundation Trust" name="citation_author_institution"/> <meta content="Aalya S Al‐Assaf" name="citation_author"/> <meta content="Newcastle University" name="citation_author_institution"/> <meta content="John L Anderson" name="citation_author"/> <meta content="Brighton and Sussex Medical School, University of Brighton" name="citation_author_institution"/> <meta content="Muzaffar A Malik" name="citation_author"/> <meta content="Brighton and Sussex Medical School, University of Brighton" name="citation_author_institution"/> <meta content="Robin WM Vernooij" name="citation_author"/> <meta content="Iberoamerican Cochrane Centre" name="citation_author_institution"/> <meta content="Gabriel Martínez" name="citation_author"/> <meta content="Universidad de Antofagasta" name="citation_author_institution"/> <meta content="Naji Tabet" name="citation_author"/> <meta content="Brighton and Sussex Medical School" name="citation_author_institution"/> <meta content="n.tabet@bsms.ac.uk" name="citation_author_email"/> <meta content="Jenny McCleery" name="citation_author"/> <meta content="Oxford Health NHS Foundation Trust" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD011906.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/12/17" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011906.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011906.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011906.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antioxidants [administration &amp; dosage]; Ascorbic Acid [administration &amp; dosage]; beta Carotene [administration &amp; dosage]; Calcium [administration &amp; dosage]; Cholecalciferol [administration &amp; dosage]; Cognition [*drug effects, physiology]; Cognitive Dysfunction [*prevention &amp; control]; Copper [administration &amp; dosage]; Dementia [prevention &amp; control]; *Dietary Supplements; Folic Acid [administration &amp; dosage]; Minerals [*administration &amp; dosage]; Randomized Controlled Trials as Topic; Selenium [administration &amp; dosage]; Vitamin A [administration &amp; dosage]; Vitamin B 12 [administration &amp; dosage]; Vitamin B 6 [administration &amp; dosage]; Vitamin E [administration &amp; dosage]; Vitamins [*administration &amp; dosage]; Zinc [administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011906.pub2&amp;doi=10.1002/14651858.CD011906.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="9nGOjNGw";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011906\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011906\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","ru","ms","ja","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011906.pub2",title:"Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life",firstPublishedDate:"Dec 17, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Dementia and Cognitive Improvement Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9nGOjNGw&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011906.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011906.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011906.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011906.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011906.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011906.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011906.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011906.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011906.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011906.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>21501 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011906.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-sec-0181"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-sec-0032"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-sec-0033"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-sec-0057"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-sec-0164"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/appendices#CD011906-sec-0186"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/table_n/CD011906StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/table_n/CD011906StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information#CD011906-cr-0002">Anne WS Rutjes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information#CD011906-cr-0003">David A Denton</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information#CD011906-cr-0004">Marcello Di Nisio</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information#CD011906-cr-0005">Lee‐Yee Chong</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information#CD011906-cr-0006">Rajesh P Abraham</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information#CD011906-cr-0007">Aalya S Al‐Assaf</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information#CD011906-cr-0008">John L Anderson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information#CD011906-cr-0009">Muzaffar A Malik</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information#CD011906-cr-0010">Robin WM Vernooij</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information#CD011906-cr-0011">Gabriel Martínez</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information#CD011906-cr-0012"><i class="icon corresponding-author fa fa-envelope"></i>Naji Tabet</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information#CD011906-cr-0013">Jenny McCleery</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information/en#CD011906-sec-0193">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 17 December 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011906.pub2">https://doi.org/10.1002/14651858.CD011906.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011906-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011906-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011906-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011906-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011906-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011906-abs-0001" lang="en"> <section id="CD011906-sec-0001"> <h3 class="title" id="CD011906-sec-0001">Background</h3> <p>Vitamins and minerals play multiple functions within the central nervous system which may help to maintain brain health and optimal cognitive functioning. Supplementation of the diet with various vitamins and minerals has been suggested as a means of maintaining cognitive function, or even of preventing dementia, in later life. </p> </section> <section id="CD011906-sec-0002"> <h3 class="title" id="CD011906-sec-0002">Objectives</h3> <p>To evaluate the effects of vitamin and mineral supplementation on cognitive function in cognitively healthy people aged 40 years or more. </p> </section> <section id="CD011906-sec-0003"> <h3 class="title" id="CD011906-sec-0003">Search methods</h3> <p>We searched ALOIS, the Cochrane Dementia and Cognitive Improvement Group’s (CDCIG) specialised register, as well as MEDLINE, Embase, PsycINFO, CINAHL, ClinicalTrials.gov and the WHO Portal/ICTRP from inception to 26th January 2018. </p> </section> <section id="CD011906-sec-0004"> <h3 class="title" id="CD011906-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials that evaluated the cognitive effects on people aged 40 years or more of any vitamin or mineral supplements taken by mouth for at least three months. </p> </section> <section id="CD011906-sec-0005"> <h3 class="title" id="CD011906-sec-0005">Data collection and analysis</h3> <p>Study selection, data extraction, and quality assessments were done in duplicate. Vitamins were considered broadly in the categories of B vitamins, antioxidant vitamins, and combinations of both. Minerals were considered separately, where possible. If interventions and outcomes were considered sufficiently similar, then data were pooled. In order to separate short‐term cognitive effects from possible longer‐term effects on the trajectory of cognitive decline, data were pooled for various treatment durations from 3 months to 12 months and up to 10 years or more. </p> </section> <section id="CD011906-sec-0006"> <h3 class="title" id="CD011906-sec-0006">Main results</h3> <p>In total, we included 28 studies with more than 83,000 participants. There were some general limitations of the evidence. Most participants were enrolled in studies which were not designed primarily to assess cognition. These studies often had no baseline cognitive assessment and used only brief cognitive assessments at follow‐up. Very few studies assessed the incidence of dementia. Most study reports did not mention adverse events or made only very general statements about them. Only 10 studies had a mean follow‐up &gt; 5 years. Only two studies had participants whose mean age was &lt; 60 years at baseline. The risk of bias in the included studies was generally low, other than a risk of attrition bias for longer‐term outcomes. We considered the certainty of the evidence behind almost all results to be moderate or low. </p> <p>We included 14 studies with 27,882 participants which compared folic acid, vitamin B12, vitamin B6, or a combination of these to placebo. The majority of participants were aged over 60 years and had a history of cardio‐ or cerebrovascular disease. We found that giving B vitamin supplements to cognitively healthy adults, mainly in their 60s and 70s, probably has little or no effect on global cognitive function at any time point up to 5 years (SMD values from ‐0.03 to 0.06) and may also have no effect at 5‐10 years (SMD ‐0.01). There were very sparse data on adverse effects or on incidence of cognitive impairment or dementia. </p> <p>We included 8 studies with 47,840 participants in which the active intervention was one or more of the antioxidant vitamins: ß‐carotene, vitamin C or vitamin E. Results were mixed. For overall cognitive function, there was low‐certainty evidence of benefit associated with ß‐carotene after a mean of 18 years of treatment (MD 0.18 TICS points, 95% CI 0.01 to 0.35) and of vitamin C after 5 years to 10 years (MD 0.46 TICS points, 95% CI 0.14 to 0.78), but not at earlier time points. From two studies which reported on dementia incidence, there was low‐certainty evidence of no effect of an antioxidant vitamin combination or of vitamin E, either alone or combined with selenium. One of the included studies had been designed to look for effects on the incidence of prostate cancer; it found a statistically significant increase in prostate cancer diagnoses among men taking vitamin E. </p> <p>One trial with 4143 participants compared vitamin D3 (400 IU/day) and calcium supplements to placebo. We found low‐ to moderate‐certainty evidence of no effect of vitamin D3 and calcium supplements at any time‐point up to 10 years on overall cognitive function (MD after a mean of 7.8 years ‐0.1 MMSE points, 95% CI ‐0.81 to 0.61) or the incidence of dementia (HR 0.94, 95% CI 0.72 to 1.24). A pilot study with 60 participants used a higher dose of vitamin D3 (4000 IU on alternate days) and found preliminary evidence that this dose probably has no effect on cognitive function over six months. </p> <p>We included data from one trial of zinc and copper supplementation with 1072 participants. There was moderate‐certainty evidence of little or no effect on overall cognitive function (MD 0.6 MMSE points, 95% CI ‐0.19 to 1.39) or on the incidence of cognitive impairment after 5 years to 10 years. A second smaller trial provided no usable data, but reported no cognitive effects of six months of supplementation with zinc gluconate. </p> <p>From one study with 3711 participants, there was low‐certainty evidence of no effect of approximately five years of selenium supplementation on the incidence of dementia (HR 0.83, 95% CI 0.61 to 1.13). </p> <p>Finally, we included three trials of complex supplements (combinations of B vitamins, antioxidant vitamins, and minerals) with 6306 participants. From the one trial which assessed overall cognitive function, there was low‐certainty evidence of little or no effect on the TICS (MD after a mean of 8.5 years 0.12, 95% CI ‐0.14 to 0.38). </p> </section> <section id="CD011906-sec-0007"> <h3 class="title" id="CD011906-sec-0007">Authors' conclusions</h3> <p>We did not find evidence that any vitamin or mineral supplementation strategy for cognitively healthy adults in mid or late life has a meaningful effect on cognitive decline or dementia, although the evidence does not permit definitive conclusions. There were very few data on supplementation starting in midlife (&lt; 60 years); studies designed to assess cognitive outcomes tended to be too short to assess maintenance of cognitive function; longer studies often had other primary outcomes and used cognitive measures which may have lacked sensitivity. The only positive signals of effect came from studies of long‐term supplementation with antioxidant vitamins. These may be the most promising for further research. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011906-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011906-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011906-abs-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011906-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011906-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD011906-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011906-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011906-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011906-abs-0005">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011906-abs-0004" lang="en"> <h3>Vitamin and mineral supplementation for preventing cognitive deterioration in cognitively healthy people in mid and late life </h3> <p><b>Review question</b> </p> <p>This review aimed to find out whether people aged 40 years or older could maintain their mental abilities or reduce their risk of dementia by taking vitamin or mineral supplements. </p> <p><b>Background</b> </p> <p>There is great interest in anything people might do to keep themselves mentally healthy as they age and, especially, to reduce their risk of developing dementia. Various vitamin and mineral supplements have been suggested as ways to do this. Vitamins and minerals have many functions in the body and the ways they might affect brain health are not well understood. Therefore, we were interested in the effects of any vitamins or minerals, either alone or in combination. </p> <p><b>What we did</b> </p> <p>We searched up to January 2018 for all trials which had studied the effect on cognition (thinking and remembering) of any vitamin or mineral supplements in people aged 40 years or more who had no cognitive problems at the beginning of the study. The studies had to include a comparison group which had not taken the supplement being studied and, to be sure the comparison was fair, it should have been decided at random whether people got the supplement or not. </p> <p><b>What we found</b> </p> <p>We grouped the 28 included trials according to the kind of supplement they used and how it might work. </p> <p>Most of the trials were not originally designed to study cognition or dementia and used only simple measures of cognition. Very few studies investigated whether participants developed dementia. Long‐term studies are probably needed to find effects on the risk of dementia or cognitive decline but only 10 studies had an average length of follow‐up longer than five years. The studies were generally well‐conducted although the longer trials had difficulty following up all of the participants and this could have biased some of the longer‐term results. </p> <p>There were 14 trials of B vitamins (folic acid, vitamin B6, vitamin B12) with nearly 28,000 participants, mainly in their 60s and 70s. Most of these trials were quite short (less than two years). We found no evidence that B vitamins had any effect on cognition. </p> <p>There were 8 trials of antioxidant vitamins (beta‐carotene/vitamin A, vitamin C, vitamin E) with approximately 47,000 participants. These trials tended to be longer than the B vitamin trials so may have had more chance of detecting effects on dementia and cognitive decline. The results were mixed. We found low‐certainty evidence of better overall cognitive function after an average of 18 years taking beta‐carotene and after five years to 10 years taking vitamin C, but no effects after shorter periods of treatment. There were also small benefits of beta‐carotene, vitamin C, and antioxidant combinations on memory at some time points but not others. There was no evidence of any benefits from vitamin E alone. Two studies examined the risk of developing dementia. One found no effect of a combination of antioxidant vitamins and the other found no effect of vitamin E, either alone or combined with the mineral selenium. Most of the studies did not report any information about harmful effects. One included trial was designed to look for an effect on the risk of prostate cancer; it found a higher risk among the men taking vitamin E. </p> <p>There was a small trial of vitamin D supplements which found they probably had no effect on cognition over six months. There were longer trials of vitamin D with calcium (one trial), zinc and copper (one trial), and complex multivitamins (three trials). All lasted between five and 10 years, but none of them found any evidence of beneficial effects on cognition. One trial found no effect of selenium taken for approximately five years on the risk of developing dementia. </p> <p><b>Conclusions</b> </p> <p>We found no good evidence to suggest that middle‐aged or older people can preserve cognitive function or prevent dementia by taking vitamin or mineral supplements. There were a few positive results associated with long‐term use of antioxidant vitamins, particularly beta‐carotene and vitamin C, although the effects were small. Further research into the effects of these vitamins may be worthwhile. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011906-sec-0181" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011906-sec-0181"></div> <h3 class="title" id="CD011906-sec-0182">Implications for practice</h3> <section id="CD011906-sec-0182"> <p>We found no evidence to support recommending any vitamin or mineral supplement to middle‐aged or older adults who wish to maintain their cognitive function or prevent dementia. </p> </section> <h3 class="title" id="CD011906-sec-0183">Implications for research</h3> <section id="CD011906-sec-0183"> <p>All of the studies in this review differed in their population, interventions, and outcomes. Therefore, many questions about possible effects of different doses or treatment combinations on different participants remain unanswered. In particular, there are very few data on the long‐term effects of supplementation started in midlife. Identifying the most important questions is likely to depend on a better understanding of the pathophysiology of cognitive decline and dementia and of the mechanisms by which vitamins and minerals might modify these processes. Moving forward, there is a place both for investigating possible mechanisms in smaller trials, which can incorporate highly sensitive cognitive assessments and possibly biomarker outcomes, and for larger, longer, pragmatic trials in which it may be necessary to rely on simpler and less sensitive outcome measures. Considering the data in this review, the only real signals of effect were from long‐term studies of antioxidant vitamins (vitamin C and beta‐carotene) so these might be considered the most promising candidates for further research. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011906-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011906-sec-0022"></div> <div class="table" id="CD011906-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">B vitamins compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>B Vitamins compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> cognitively healthy people in mid and late life<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> B Vitamins (folic acid, vitamins B6 and vitamin B12, alone or in combination)<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with B Vitamins</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning 3 to 12 months of supplementation (final measurement data) </p> <p>assessed with: MMSE or TICSm</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>SMD 0<br/> (0.08 lower to 0.08 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2556<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning 3 to 12 months of supplementation (change from baseline data) </p> <p>assessed with: MMSE or TICSm</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.03 lower<br/> (0.26 lower to 0.19 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning &gt; 1 to 2 years of supplementation (final measurement data) </p> <p>assessed with: MMSE, TICS, or TICSm</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.15 higher<br/> (0.17 lower to 0.47 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6956<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning &gt; 1 to 2 years of supplementation (change from baseline data) </p> <p>assessed with MMSE</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.06 higher<br/> (0.2 lower to 0.31 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>241<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning &gt; 2 to 5 years of supplementation (final measurement data) </p> <p>assessed with MMSE, TICS, F‐TICSm or a composite score</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.01 lower<br/> (0.11 lower to 0.09 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3985<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning ‐ &gt; 5‐10 years of supplementation (final measurement data) </p> <p>assessed with MMSE, TICS or TICSm</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.01 lower<br/> (0.09 lower to 0.07 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10249<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incidence of MCI or dementia &gt; 2 to 5 years of supplementation<br/> assessed with: MMSE &lt; 24 on 2 or more occasions<br/> follow‐up: median 2.8 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.89<br/> (0.67 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1803<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>103 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>91 per 1.000<br/> (69 to 121) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded for indirectness due to restricted inclusion criteria for participants in included studies </p> <p><sup>2</sup> Downgraded for imprecision due to small sample size and wide confidence intervals </p> <p><sup>3</sup> Downgraded for study limitations due to missing data from 26% of participants in SEARCH 2010 </p> <p><sup>MMSE: Mini Mental State Examination</sup><br/> <sup>TICS: Telephone Interview for Cognitive Status</sup><br/> <sup>TICSm: modified Telephone Interview for Cognitive Status</sup><br/> <sup>F‐TICSm: modified Telephone Interveiw for Cognitive Status (French version)</sup> </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011906-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antioxidants compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Antioxidants compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> cognitively healthy people in mid and late life<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> antioxidant vitamins (vitamins C, E, and beta‐carotene, alone or in combination)<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Antioxidants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Vitamin E supplementation</b><br/> Overall cognitive functioning </p> <p>assessed with: MMSE<br/> Scale from: 0 to 30<br/> follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MMSE score was 26.6</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1.4 higher<br/> (1.18 higher to 1.62 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicates better cognitive function.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Vitamin E supplementation</b><br/> Overall cognitive functioning assessed with: TICS </p> <p>Scale from: 0 to 41<br/> follow‐up: range 6 years to 10 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Two studies found no evidence of an effect of vitamin E</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(2 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> LOW <sup>4 5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Range of follow‐up durations was approximate. Mean in one study was 9.6 years and in the other study was 8.9 years. There were 5226 participants in one study. The number in the other study was not reported for this time point (approximately 800). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Beta‐carotene supplementation</b> </p> <p>Overall cognitive functioning<br/> assessed with: TICS<br/> Scale from: 0 to 41<br/> follow‐up: mean 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TICS score was 34.29</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.14 lower<br/> (0.37 lower to 0.09 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1904<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicates better cognitive function.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Beta‐carotene supplementation</b> </p> <p>Overall cognitive functioning<br/> assessed with: TICS<br/> follow‐up: mean 8.9 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>MD 0.13 lower<br/> (0.46 lower to 0.19 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> LOW <sup>4 7</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference with 95% CI reported in paper. Absolute values in each treatment group not reported. Number in each treatment group at final follow‐up not reported. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Beta‐carotene supplementation</b> </p> <p>Overall cognitive functioning<br/> assessed with: TICS<br/> Scale from: 0 to 41<br/> follow‐up: mean 18 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean TICS score was 34.23</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>MD 0.18 higher<br/> (0.01 higher to 0.35 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4052<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> MODERATE <sup>6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Vitamin C supplementation</b> </p> <p>Overall cognitive functioning<br/> assessed with: TICS<br/> follow‐up: mean 8.9 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>MD 0.46 higher<br/> (0.14 higher to 0.78 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> LOW <sup>4 7</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference with 95% CI reported in paper. Absolute values in each group not reported. Number in each treatment group at final follow‐up not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplementation with beta‐carotene + vit C + vit E</b> </p> <p>Overall cognitive functioning<br/> assessed with: TICSm<br/> Scale from: 0 to 39<br/> follow‐up: mean 5 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TICSm score was 24.02</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.09 higher<br/> (0.05 lower to 0.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20536<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplementation with beta‐carotene + vit C + vit E</b> </p> <p>Overall cognitive functioning<br/> assessed with: 3MS (modified MMSE)<br/> Scale from: 0 to 100<br/> follow‐up: median 6.9 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean 3MS score was 92.1</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.6 higher<br/> (0.2 lower to 1.4 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1100<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicates better cognitive function.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incidence of all‐cause dementia<br/> follow‐up: mean approximately 5 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Two studies, one using a combination of beta‐carotene, vit C and vit E and one using vit E ± selenium, found no significant difference in the incidence of dementia. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 993<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>8 9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded for risk of bias due to lack of blinding (open‐label study) </p> <p><sup>2</sup> Downgraded for indirectness (diabetic participants only) </p> <p><sup>3</sup> Downgraded for imprecision due to small sample size </p> <p><sup>4</sup> Downgraded for risk of bias due to incomplete outcome data </p> <p><sup>5</sup> Downgraded for indirectness (both studies included only women and in one study all participants also had cardiovascular disease or 3 or more coronary risk factors) </p> <p><sup>6</sup> Downgraded for indirectness (included men only) </p> <p><sup>7</sup> Downgraded for indirectness (included only women with cardiovascular disease or ≥ 3 coronary risk factors) </p> <p><sup>8</sup> Downgraded for indirectness (all participants had high risk of coronary heart disease death over the next 5 years) </p> <p><sup>9</sup> Downgraded for imprecision due to wide confidence interval </p> <p><sup>MMSE: Mini Mental State Examination</sup><br/> <sup>TICS: Telephone Interview for Cognitive Status</sup><br/> <sup>TICSm: Modified Telephone Interview for Cognitive Status</sup><br/> <sup>3MS: The Modified Mini‐Mental State Examination</sup> </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011906-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Vitamin D3 compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vitamin D3 compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> cognitively healthy people in mid and late life<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> vitamin D3 +/‐ calcium carbonate<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Vitamin D3</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall cognitive functioning</p> <p>assessed with: MoCA change from baseline</p> <p>Scale from: 0 to 30</p> <p>follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>There was no significant difference between groups in the change in MoCA score (P=0.186).</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Experimental intervention was vitamin D3 4000 IU on alternate days.</p> <p>Data not fully reported (conference abstract only).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning<br/> assessed with: 3MS<br/> Scale from: 0 to 100<br/> follow‐up: mean 7.8 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean 3MS score was 96.6</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.1 lower<br/> (0.81 lower to 0.61 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>918<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Experimental intervention was vitamin D3 400 IU/day and calcium carbonate 1000 mg/day.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incidence of probable dementia or MCI<br/> follow‐up: mean 7.8 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No significant difference in incidence between treatment groups. In an intention‐to‐treat analysis, incidence was 62.2/10 000 person‐years in the vit D + Ca group and 65.9/10 000 person‐years in the placebo group (HR 0.94, 95% CI 0.72 to 1.24, P = 0.68). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4143<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Experimental intervention was vitamin D3 400 IU/day and calcium carbonate 1000 mg/day.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded for imprecision (small sample size) </p> <p><sup>2</sup> Downgraded for risk of bias due to incomplete outcome data </p> <p><sup>3</sup> Downgraded for indirectness (study included women only) </p> <p><sup>4</sup> Downgraded for imprecision due to wide confidence interval </p> <p><sup>MCI: Mild Cognitive Impairment<br/> MOCA: Montreal cognitive assessment<br/> 3MS: The Modified Mini‐Mental State Examination</sup> </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011906-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Zinc + copper compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Zinc + copper compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> cognitively healthy people in mid and late life<br/> <b>Setting:</b> Community<br/> <b>Intervention:</b> Zinc + copper oxides<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Zinc + copper</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning<br/> assessed with: 3MS<br/> Scale from: 0 to 100<br/> follow‐up: median 6.9 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean 3MS score was 92.1</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.6 higher<br/> (0.19 lower to 1.39 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1072<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incidence of dementia or MCI<br/> assessed with: 3MS score &lt; 80<br/> follow‐up: median 6.9 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>4.5% of participants met the authors' definition of cognitive impairment (3MS &lt; 80) and "there was no significant effect of treatment group on likelihood of having cognitive impairment." </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1072<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded for risk of bias due to unclear selective reporting and high risk of bias due to incomplete outcome data </p> <p><sup>2</sup> Downgraded for indirectness (Yaffe 2004 included participants with age‐related macular degeneration) </p> <p><sup>3</sup> Downgraded two levels for study limitations due to incomplete outcome data and selective reporting </p> <p><sup>3MS: The Modified Mini‐Mental State Examination</sup><br/> <sup>MCI: Mild cognitive impairment</sup> </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011906-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Complex multivitamin compared to control for maintaining cognitive function in cognitively healthy people in mid and late life</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Complex multivitamin compared to control for maintaining cognitive function in cognitively healthy people in mid and late life</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> cognitively healthy people in mid and late life<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> complex multivitamins (combinations of B vitamins and antioxidant vitamins +/‐ minerals)<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Complex multivitamin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning</p> <p>assessed with: TICS</p> <p>Scale from: 0 to 41</p> <p>follow‐up: mean 2.5 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TICS score was 34.3</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.04 higher<br/> (0.09 lower to 0.18 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5947<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Follow‐up ranged from 0.18 to 5.3 years.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning<br/> assessed with: TICS<br/> Scale from: 0 to 41<br/> follow‐up: mean 8.5 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TICS score was 33.1</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.12 higher<br/> (0.14 lower to 0.38 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2324<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Follow‐up ranged from 0.3 to 14.2 years.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incidence of MCI or all‐cause dementia ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded for study limitations due to incomplete outcome data and wide range of follow‐up durations </p> <p><sup>2</sup> Downgraded for indirectness (study included only men) </p> <p><sup>TICS: Telephone Interview for Cognitive Status<br/> MCI: mild cognitive impairment</sup> </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011906-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011906-sec-0023"></div> <section id="CD011906-sec-0024"> <h3 class="title" id="CD011906-sec-0024">Description of the condition</h3> <section id="CD011906-sec-0025"> <h4 class="title">Cognitive health, mild cognitive impairment, and dementia</h4> <p>There is no consensus definition of cognitive health or successful cognitive ageing, but it has been described as ‘‘not just the absence of cognitive impairment, but the development and preservation of the multidimensional cognitive structure that allows the older adult to maintain social connectedness, an ongoing sense of purpose, and the abilities to function independently, to permit functional recovery from illness and injury, and to cope with residual cognitive deficits” (<a href="./references#CD011906-bbs2-0098" title="DeppCA , HarmellA , VahiaIV . Successful cognitive aging. Current Topics in Behavioral Neurosciences2012;10:35‐50. [PUBMED: 22275006] ">Depp 2012</a>; <a href="./references#CD011906-bbs2-0105" title="HendrieHC , AlbertMS , ButtersMA , GaoS , KnopmanDS , LaunerLJ , et al. The NIH Cognitive and Emotional Health Project. Report of the critical evaluation study committee. Alzheimer's &amp; Dementia2006;2(1):12‐32. [PUBMED: 19595852] ">Hendrie 2006</a>). Successful cognitive ageing is distinct from mild cognitive impairment (MCI) and dementia. </p> <p>Dementia is a syndrome of cognitive and functional decline that is usually progressive. It affects multiple cognitive domains, among which memory is usually prominent, but orientation, executive function, language, perception, and social cognition are also often affected. In most cases, the onset of dementia is gradual. It is usually preceded by a stage of mild cognitive impairment when cognitive deficits beyond those of normal ageing are detectable, but function is not significantly impaired. The term dementia is used once the cognitive deficits begin to have a significant effect on daily activities. As the syndrome progresses, those affected become increasingly dependent on others for all activities of daily living. </p> </section> <section id="CD011906-sec-0026"> <h4 class="title">Types of MCI and dementia</h4> <p>Subtypes of dementia are distinguished by the underlying pathology. The four most common subtypes are Alzheimer's disease dementia (AD) (accounting for an estimated 60% to 70% of all dementia cases); vascular dementia (VaD); dementia with Lewy Bodies (DLB); and frontotemporal dementia (FTD). Accurate diagnosis of the subtypes may be difficult. Mixed pathology is common, with more than 80% of cases having some features of Alzheimer’s disease (<a href="./references#CD011906-bbs2-0110" title="JellingerKA . Clinicopathological analysis of dementia disorders in the elderly ‐ an update. Journal of Alzheimer's Disease2006;9(3 Suppl):61‐70. [PUBMED: 16914845] ">Jellinger 2006</a>; <a href="./references#CD011906-bbs2-0163" title="World Health Organization (WHO). Dementia: a Public Health Priority. Geneva, Switzerland: WHO, 2012. [ISBN 9789241564458] ">WHO 2012</a>). However, the proportion of dementia attributable to Alzheimer’s disease reduces with age (<a href="./references#CD011906-bbs2-0152" title="SavvaGM , WhartonSB , IncePG , ForsterG , MatthewsFE , BrayneC . Age, neuropathology, and dementia. New England Journal of Medicine2009;360(22):2302‐9. [PUBMED: 1947442] ">Savva 2009</a>). </p> <p>There are numerous different operational definitions of MCI, with different scope (e.g. memory or non‐memory impairments) (<a href="./references#CD011906-bbs2-0119" title="MatthewsFE , StephanBC , BondJ , McKeithI , BrayneC . Operationalization of mild cognitive impairment: a graphical approach. PLOS Medicine2007;4(10):1615‐9. [PUBMED: 17973571] ">Matthews 2007</a>), prevalence (<a href="./references#CD011906-bbs2-0158" title="StephanBC , MatthewsFE , McKeithIG , BondJ , BrayneC . Early cognitive change in the general population: how do different definitions work?. Journal of the American Geriatrics Society2007;55(10):1534‐40. [PUBMED: 17908056] ">Stephan 2007</a>), and risk of progression to dementia (<a href="./references#CD011906-bbs2-0120" title="MatthewsFE , StephanBC , McKeithIG , BondJ , BrayneC . Two‐year progression from mild cognitive impairment to dementia: to what extent do different definitions agree?. Journal of the American Geriatrics Society2008;56(8):1424‐33. ">Matthews 2008</a>). Currently, there is no single, universally accepted definition of MCI (<a href="./references#CD011906-bbs2-0159" title="StephanBCM , MinettT , PagettE , SiervoM , BrayneC , McKeithIG . Diagnosing mild cognitive impairment (MCI) in clinical trials: a systematic review. BMJ Open2013;3(2):e001909. [PUBMED: 23386579] ">Stephan 2013</a>), but adaptations of the criteria suggested by <a href="./references#CD011906-bbs2-0138" title="PetersenRC , SmithGE , WaringSC , IvnikRJ , TangalosEG , KokmenE . Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology1999;56(3):303‐8. [PUBMED: 10190820] ">Petersen 1999</a> are commonly used in clinical trials. Categorisation of MCI may also be based on the suspected underlying cause of the cognitive deficits, e.g. MCI due to Alzheimer's disease and MCI due to vascular disease (termed 'vascular cognitive impairment, no dementia': VCIND). </p> <p>It is increasingly recognised that some dementia syndromes, including AD, have a very long preclinical phase with pathological changes beginning years, or even decades, before the onset of symptoms (<a href="./references#CD011906-bbs2-0156" title="SperlingRA , AisenPS , BeckettLA , BennettDA , CraftS , FaganAM , et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimer's &amp; Dementia2011;7(3):280‐92. ">Sperling 2011</a>). Attempts have been made to develop criteria to capture preclinical states as early as possible. For example, the label 'pre‐MCI' has been applied to people with impaired executive function and language, elevated apathy scores, and reduced volumes of left brain areas of the hippocampus, an area involved in consolidation of information from short‐term memory to long‐term memory but also spatial memory, enabling orientation. (<a href="./references#CD011906-bbs2-0101" title="DuaraR , LoewensteinDA , GreigMT , PotterE , BarkerW , RajA , et al. Pre‐MCI and MCI: neuropsychological, clinical, and imaging features and progression rates. American Journal of Geriatric Psychiatry2011;19(11):951‐60. [PUBMED: 21422909] ">Duara 2011</a>). It is likely that biomarker tests, tests that measure some biological state, will be needed to identify people in the earliest stages of dementing illnesses. </p> </section> <section id="CD011906-sec-0027"> <h4 class="title">Prevalence of MCI and dementia</h4> <p>In the UK Medical Research Council's population‐based Cognitive Function and Ageing Study (CFAS), which mapped 18 different definitions of MCI, the range of prevalence estimates was found to be variable (0.1% to 42.0%), and conversion rates to dementia generally low (<a href="./references#CD011906-bbs2-0158" title="StephanBC , MatthewsFE , McKeithIG , BondJ , BrayneC . Early cognitive change in the general population: how do different definitions work?. Journal of the American Geriatrics Society2007;55(10):1534‐40. [PUBMED: 17908056] ">Stephan 2007</a>). Prevalence rates and rates of conversion to dementia have been reported to be higher in specialist settings than in population‐based studies (adjusted conversion rate from MCI to dementia 9.6% versus 4.9%) (<a href="./references#CD011906-bbs2-0128" title="MitchellAJ , Shiri‐FeshkiM . Rate of progression of mild cognitive impairment to dementia ‐ meta‐analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica2009;119(4):252‐65. [PUBMED: 19236314] ">Mitchell 2009</a>). </p> <p>The risk of dementia increases with age. According to a World Health Organization (WHO) report, only 2% to 10% of cases start before the age of 65 years (<a href="./references#CD011906-bbs2-0163" title="World Health Organization (WHO). Dementia: a Public Health Priority. Geneva, Switzerland: WHO, 2012. [ISBN 9789241564458] ">WHO 2012</a>). The same report estimated that there were 35.6 million people with dementia in the world in 2010, and that this figure would double every 20 years to reach 65.7 million in 2030 (<a href="./references#CD011906-bbs2-0163" title="World Health Organization (WHO). Dementia: a Public Health Priority. Geneva, Switzerland: WHO, 2012. [ISBN 9789241564458] ">WHO 2012</a>). However, there is a degree of uncertainty about the expected increase in prevalence of dementia. Recent research by <a href="./references#CD011906-bbs2-0121" title="MatthewsFE , ArthurA , BarnesLE , BondJ , JaggerC , RobinsonL , et al. A two‐decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet2013;382(9902):1405‐12. [PUBMED: 23871492] ">Matthews 2013</a> in the UK and by <a href="./references#CD011906-bbs2-0089" title="ChristensenK , ThinggaardM , OksuzyanA , SteenstrupT , Andersen‐RanbergK , JeuneB , et al. Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart. Lancet2013;382(9903):1507‐13. ">Christensen 2013</a> in Denmark indicates that age‐specific prevalence of dementia may be falling in developed countries, suggesting the possibility that dementia risk may be modifiable. Nevertheless, because of population ageing, the overall prevalence continues to rise. </p> </section> <section id="CD011906-sec-0028"> <h4 class="title">Risk factors</h4> <p>Generally, risk factors for dementia can be divided into modifiable and non‐modifiable categories. Non‐modifiable risk factors include age, genetic factors, and gender (females are at higher risk). At a population level, age is the most significant risk factor. In people older than 65 years, the risk of AD (the commonest cause of dementia) doubles every five years (<a href="./references#CD011906-bbs2-0116" title="LaunerLJ , AndersenK , DeweyME , LetenneurL , OttA , AmaducciLA , et al. EURODEM Incidence Research Group and Work Groups. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. Neurology1999;52(1):78‐84. ">Launer 1999</a>; <a href="./references#CD011906-bbs2-0125" title="McCullaghCD , CraigD , McIlroySP , PassmoreAP . Risk factors for dementia. Advances in Psychiatric Treatment2001;7(1):24‐31. ">McCullagh 2001</a>; <a href="./references#CD011906-bbs2-0160" title="Van denBergS , SplaineM . Policy brief risk factors for dementia. alz.co.uk/sites/default/files/policy‐brief‐risk‐factors‐for‐dementia.pdf (accessed 19 September 2014). ">Van den Berg 2012</a>; <a href="./references#CD011906-bbs2-0161" title="Van derFlierWM , ScheltensP . Epidemiology and risk factors of dementia. Journal of Neurology, Neurosurgery, and Psychiatry2005;76(Suppl 5):v2–v7. ">Van der Flier 2005</a>). A pooled analysis of four prospective studies in Europe found that the incidence of AD among people aged 90 years and over was 63.5/1000 person‐years (<a href="./references#CD011906-bbs2-0116" title="LaunerLJ , AndersenK , DeweyME , LetenneurL , OttA , AmaducciLA , et al. EURODEM Incidence Research Group and Work Groups. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. Neurology1999;52(1):78‐84. ">Launer 1999</a>). Genetics plays a major role in early onset AD, but a lesser role in the much commoner late onset disease. </p> <p>Many potentially modifiable risk factors are common to AD and vascular dementia. These include diabetes mellitus, midlife obesity, midlife hypertension, smoking,,and physical inactivity (<a href="./references#CD011906-bbs2-0142" title="PrinceM , AlbaneseE , GuerchetM , PrinaM . The World Alzheimer Report 2014. Dementia and Risk Reduction: An Analysis of Protective and Modifiable Factors. London, UK: Alzheimer’s Disease International (ADI), 2014. ">Prince 2014</a>; <a href="./references#CD011906-bbs2-0163" title="World Health Organization (WHO). Dementia: a Public Health Priority. Geneva, Switzerland: WHO, 2012. [ISBN 9789241564458] ">WHO 2012</a>). The fact that risk factors are active in midlife is consistent with what is known of the long preclinical phase of dementia and implies that there is a long period in which preventive efforts could be effective. </p> <p>At present, there is no cure for any subtype of dementia, but identifying and targeting modifiable risk factors might offer opportunities to modify its onset and course. Studies to test this hypothesis have investigated cognitive stimulation, exercise, diet, and other nutritional interventions, and the management of vascular risk factors, such as hypertension, diabetes, obesity, smoking, and physical inactivity (<a href="./references#CD011906-bbs2-0117" title="LindsayJ , LaurinD , VerreaultR , HebertR , HelliwellB , HillGB , et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. American Journal of Epidemiology2002;156(5):445‐53. [PUBMED: 12196314] ">Lindsay 2002</a>; <a href="./references#CD011906-bbs2-0118" title="LouridaI , SoniM , Thompson‐CoonJ , PurandareN , LangIA , UkoumunneOC , et al. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology2013;24(4):479‐89. [PUBMED: 23680940] ">Lourida 2013</a>; <a href="./references#CD011906-bbs2-0129" title="NortonS , MatthewsFE , BarnesDE , YaffeK , BrayneC . Potential for primary prevention of Alzheimer's disease: an analysis of population‐based data. Lancet Neurology2014;13(8):788‐94. [PUBMED: 25030513] ">Norton 2014</a>; <a href="./references#CD011906-bbs2-0164" title="WilsonRS , BennettDA , BieniasJL , AggarwalNT , Mendes De LeonCF , MorrisMC , et al. Cognitive activity and incident AD in a population‐based sample of older persons. Neurology2002;59(12):1910‐4. [PUBMED: 12499482] ">Wilson 2002</a>). </p> </section> </section> <section id="CD011906-sec-0029"> <h3 class="title" id="CD011906-sec-0029">Description of the intervention</h3> <p>This review focusses on the effect of vitamins or minerals (or both) on cognitive functioning. Vitamins are organic compounds that are essential for the normal physiological process in the body and play important roles in growth and development (<a href="./references#CD011906-bbs2-0113" title="KennedyDO , HaskellCF . Vitamins and cognition: what is the evidence?. Drugs2011;71(15):1957‐71. ">Kennedy 2011</a>). MInerals are inorganic elements and as nutrients are also needed by the body to grow and develop normally (<a href="./references#CD011906-bbs2-0088" title="Centers for Disease Control and Prevention. Vitamins and minerals. cdc.gov/nutrition/everyone/basics/vitamins/index.html (accessed before 15 June 2015). ">Centers for Disease Control and Prevention 2014</a>). Most of these essential nutrients are available naturally in the diet. Dietary supplements are any consumed products that aim to provide nutrients additional to those obtained in the regular diet. </p> </section> <section id="CD011906-sec-0030"> <h3 class="title" id="CD011906-sec-0030">How the intervention might work</h3> <p>Vitamins and minerals have numerous important roles in human physiology. Recognised biological roles of all those considered for this review are summarised briefly in <a href="./appendices#CD011906-sec-0187">Appendix 1</a>. </p> <p>The most commonly cited mechanisms by which vitamins and minerals may influence cognitive function are (1) via effects on specific plasma amino‐acids called homocysteine for B vitamins (folic acid, vitamin B6, and vitamin B12) and (2) via antioxidant effects, reducing the concentration of free radicals that may damage human cells, for vitamins C, E, and ß‐carotene, possibly vitamin D, and some minerals such as selenium. These hypotheses about possible mechanisms are based largely on preclinical studies and on observations of associations between elevated homocysteine levels or elevated markers of oxidative stress and cognitive decline or dementia (<a href="./references#CD011906-bbs2-0090" title="ClarkeR . Homocysteine, B vitamins, and the risk of dementia. American Journal of Clinical Nutrition2007;85(2):329‐30. ">Clarke 2007a</a>, <a href="./references#CD011906-bbs2-0082" title="BennettS , GrantMM , AldredS . Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. Journal of Alzheimer's Disease2009;17(2):245‐57. ">Bennett 2009</a>). Detailed understanding of mechanisms is, however, lacking. </p> </section> <section id="CD011906-sec-0031"> <h3 class="title" id="CD011906-sec-0031">Why it is important to do this review</h3> <p>The prevalence and high societal costs of dementia are such that even small reductions in its age‐specific incidence would have a large impact on healthcare costs and on the overall burden it causes to patients, their families, and communities. In order to decide where preventive efforts should be concentrated, robust assessments are needed of the effects of interventions and of the ‘dose’ and duration of intervention necessary to achieve an effect. </p> <p>For individuals, fear of cognitive decline and dementia may be powerful motivators to seek preventive interventions. Vitamin and mineral supplementation and cognitive activities (e.g. computerised ‘brain training’ games), in particular, are subject to promotion by those with commercial interests. It is important for people to know whether time, effort, and money they might invest to prevent cognitive decline is likely to be well spent. Information about adverse effects is also important. Although nutritional and behavioural interventions are often perceived to be ‘low risk’, they are not necessarily without the potential to cause harm. For example, trials have found high doses of vitamin E to be associated with higher rates of side effects than placebo (<a href="./references#CD011906-bbs2-0084" title="BjelakovicG , NikolovaD , GluudLL , SimonettiRG , GluudC . Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database of Systematic Reviews2012, Issue 3. [DOI: 10.1002/14651858.CD007176.pub2] ">Bjelakovic 2012</a>; <a href="./references#CD011906-bbs2-0086" title="Brigelius‐Flohe , R . Adverse effects of vitamin E by induction of drug metabolism. Genes &amp; Nutrition2007;2(3):249‐56. ">Brigelius‐Flohe 2007</a>; <a href="./references#CD011906-bbs2-0127" title="MillerER3rd , Pastor‐BarriusoR , DalalD , RiemersmaRA , AppelLJ , GuallarE . Meta‐analysis: high‐dosage vitamin E supplementation may increase all‐cause mortality. Annals of Internal Medicine2005;142(1):37‐46. ">Miller 2005</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011906-sec-0032" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011906-sec-0032"></div> <p>To evaluate the effects of vitamin and mineral supplementation on cognitive function in cognitively healthy people aged 40 years or more. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011906-sec-0033" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011906-sec-0033"></div> <section id="CD011906-sec-0034"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011906-sec-0035"> <h4 class="title">Types of studies</h4> <p>We included randomised or quasi‐randomised controlled trials, published or unpublished, reported in any language. We included trials with a duration of intervention of 12 weeks or more. Trials in cognitively healthy people with a duration as short as 12 weeks typically investigate cognitive enhancement rather than maintenance of cognitive function. We included these trials in order to give a full picture of the data, although it is recognised that the relationship between short‐term cognitive enhancement and maintenance of cognitive function over longer periods of time, or incidence of dementia, is unclear. </p> </section> <section id="CD011906-sec-0036"> <h4 class="title">Types of participants</h4> <p>We included trials in which the participants were cognitively healthy people from midlife onwards, i.e. participants aged 40 years and over without a dementia diagnosis or cognitive impairment at baseline ('midlife' was defined for the purposes of disease classification, in DSM‐IV 1994, as between 40 years and 65 years).The cognitive status of participants was determined by the trialists' own definitions of ‘cognitively healthy’. These definitions were recorded. We contacted trialists if further clarification was needed to determine health status. If trials included a cognitively mixed population, we required at least 80% of participants to be free of cognitive impairment (including subjective cognitive impairment) at baseline. </p> </section> <section id="CD011906-sec-0037"> <h4 class="title">Types of interventions</h4> <p>We included studies comparing the effect of orally‐administered vitamin or mineral supplements (or vitamin and mineral supplements) with control interventions which were not expected to have an effect on cognition (placebo or no intervention/usual care). Eligible vitamins and minerals are listed in <a href="./appendices#CD011906-sec-0187">Appendix 1</a>. These vitamins and minerals could be given singly or in combination and at any dose, for a minimum of 12 weeks. Trials of vitamins or minerals (or vitamins and minerals) given in combination with other nutrients (e.g. fatty acids, amino acids) or with drugs were excluded unless the design allowed the effects of vitamins or minerals to be isolated. For example, a trial comparing vitamin X to amino acid Y was ineligible, but a trial comparing vitamin X and amino acid Y to amino acid Y only was eligible. </p> </section> <section id="CD011906-sec-0038"> <h4 class="title">Types of outcome measures</h4> <section id="CD011906-sec-0039"> <h5 class="title">Primary outcomes</h5> <p>Mean overall cognitive functioning measured with any internationally accepted and validated measure: for example, Alzheimer's Disease Assessment Scale ‐ cognitive subscale (ADAS‐cog); Mini Mental State Examination (MMSE); Repeatable Battery for the Assessment of Neuropsychological Status (RBANS); Cambridge Cognition Examination (CAMCOG). </p> </section> <section id="CD011906-sec-0040"> <h5 class="title">Secondary outcomes</h5> <p>Any internationally accepted and validated measures of:</p> <p> <ul id="CD011906-list-0001"> <li> <p>specific cognitive functioning subdomain: episodic memory;</p> </li> <li> <p>specific cognitive functioning subdomain: executive functioning;</p> </li> <li> <p>specific cognitive functioning subdomain: speed of processing;</p> </li> <li> <p>incidence of MCI or all‐cause dementia;</p> </li> <li> <p>quality of life, either generic or disease‐specific;</p> </li> <li> <p>clinical global impression (a scale measuring a clinician's judgement on overall symptom severity); </p> </li> <li> <p>functional performance;</p> </li> <li> <p>number of participants experiencing one or more serious adverse events (SAE);</p> </li> <li> <p>mortality.</p> </li> </ul> </p> <p>If a trial provided data on more than one cognitive scale for a specific outcome, we applied a hierarchy of cognition‐related outcomes and used data on the cognitive scale that was highest on this hierarchy. For example, if a trial reported results on both the Mini Mental State Examination and the Clinical Dementia Rating scale (CDR), we used the outcome data from MMSE in our quantitative analyses. The rank of a scale in the hierarchy was determined by the frequency of its use in a large set of 79 trials, evaluating vitamin and mineral supplementation, dietary interventions, and physical exercise interventions. </p> </section> </section> </section> <section id="CD011906-sec-0041"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011906-sec-0042"> <h4 class="title">Electronic searches</h4> <p>We searched ALOIS (<a href="http://www.medicine.ox.ac.uk/alois" target="_blank">www.medicine.ox.ac.uk/alois</a>), the Cochrane Dementia and Cognitive Improvement Group’s (CDCIG) specialised register. </p> <p>ALOIS is maintained by the Information Specialist for the CDCIG, and contains studies that fall within the areas of dementia prevention, dementia treatment and management, and cognitive enhancement in healthy elderly populations. The studies are identified through: </p> <p> <ol id="CD011906-list-0002"> <li> <p>Monthly searches of a number of major healthcare databases: MEDLINE, Embase, CINAHL, PsycINFO and LILACS; </p> </li> <li> <p>Monthly searches of a number of trial registers: ISRCTN; UMIN (Japan's Trial Register); the WHO portal (which covers ClinicalTrials.gov; ISRCTN; the Chinese Clinical Trials Register; the German Clinical Trials Register; the Iranian Registry of Clinical Trials and the Netherlands National Trials Register, plus others); </p> </li> <li> <p>Quarterly search of <i>The Cochrane Library</i>’s Central Register of Controlled Trials (CENTRAL); </p> </li> <li> <p>Six‐monthly searches of a number of grey literature sources: ISI Web of Knowledge Conference Proceedings; Index to Theses; Australasian Digital Theses. </p> </li> </ol> </p> <p>To view a list of all sources searched for ALOIS see <a href="http://www.medicine.ox.ac.uk/alois/content/about-alois" target="_blank">About ALOIS</a> on the ALOIS website (www.medicine.ox.ac.uk/alois). </p> <p>Details of the search strategies run in healthcare bibliographic databases, used for the retrieval of reports of dementia, cognitive improvement, and cognitive enhancement trials, can be viewed in the ‘methods used in reviews’ section within the editorial information about the Cochrane <a href="http://mrw.interscience.wiley.com/cochrane/clabout/articles/DEMENTIA/frame.html" target="_blank">Dementia and Cognitive Improvement Group</a>. </p> <p>We ran additional searches in MEDLINE, Embase, PsycINFO, CINAHL, ClinicalTrials.gov and the WHO Portal/ICTRP to ensure that the searches for each suite of reviews was as comprehensive and as up‐to‐date as possible to identify published, unpublished, and ongoing trials. The search strategies that we created and used can be seen in <a href="./appendices#CD011906-sec-0188">Appendix 2</a>. </p> </section> <section id="CD011906-sec-0043"> <h4 class="title">Searching other resources</h4> <p>We screened reference lists of all included trials. In addition, we screened reference lists of recent systematic reviews, health technology assessment reports, and subject‐specific guidelines identified through <a href="http://www.guideline.gov/" target="_blank">www.guideline.gov</a>. The search was restricted to those guidelines meeting National Guideline Clearinghouse’s (NGC) 2013 inclusion criteria published in this year or later. </p> <p>We contacted experts in the field and companies marketing included interventions, in order to provide additional randomised trial reports that were not identified by the database search. </p> </section> </section> <section id="CD011906-sec-0044"> <h3 class="title" id="CD011906-sec-0044">Data collection and analysis</h3> <section id="CD011906-sec-0045"> <h4 class="title">Selection of studies</h4> <p>We used crowdsourcing to screen the search results. Details of this have been described here: <a href="http://www.medicine.ox.ac.uk/alois/content/modifiable-risk-factors" target="_blank">http://www.medicine.ox.ac.uk/alois/content/modifiable‐risk‐factors</a>. In brief, teams of volunteers performed a ‘first assessment’ on the search results. The volunteers were recruited through the author team’s institutions. They screened the results using an online tool developed for Cochrane Embase project but tailored for this programme of work. The crowd decided, based on a reading of title and abstract, whether the citation was describing a randomised or quasi‐randomised trial, irrespective of the citations topic. It is estimated that this removes 75% to 90% of results retrieved. The remaining titles and abstracts were then screened by the author team, followed by full text screening. Two clinicians in the author team screened independently (AA, DD, RA). In the event of disagreement that could not be resolved by discussion, a methodologist (LYC) and additional clinician (NT or JA) arbitrated on eligibility and reasons for exclusion. All consensus rulings and reasons for exclusion were subsequently verified by methodologists (AR and MdN or LYC). Citations and full text papers from the update searches conducted in 2017 and 2018 were screened independently by two clinicians (JM and GM), who reached consensus through discussion if necessary. </p> </section> <section id="CD011906-sec-0046"> <h4 class="title">Data extraction and management</h4> <p>Two review authors, working independently, extracted trial information using a structured data extraction form. Discrepancies were resolved by discussion, or by the involvement of a third reviewer. Where possible, we extracted (as a minimum) the following information related to characteristics of participants, intervention, and study design: </p> <p>Participant characteristics:</p> <p> <ul id="CD011906-list-0003"> <li> <p>gender;</p> </li> <li> <p>baseline age (range, median, mean);</p> </li> </ul> <ul id="CD011906-list-0004"> <li> <p>baseline cognitive function;</p> </li> <li> <p>cognitive diagnostic status.</p> </li> </ul> </p> <p>Intervention characteristics:</p> <p> <ul id="CD011906-list-0005"> <li> <p>nature of the intervention; generic and trade name of intervention;</p> </li> <li> <p>description of the control condition;</p> </li> <li> <p>duration of treatment;</p> </li> <li> <p>dosage and frequency;</p> </li> <li> <p>any concomitant treatments;</p> </li> <li> <p>treatment adherence.</p> </li> </ul> </p> <p>Methodological characteristics:</p> <p> <ul id="CD011906-list-0006"> <li> <p>trial design (individual or cluster randomisation; parallel group, factorial, or crossover design); </p> </li> <li> <p>number of participants;</p> </li> <li> <p>outcome measures used;</p> </li> <li> <p>duration of follow‐up as measured from randomisation;</p> </li> <li> <p>duration of follow‐up as measured from end of treatment;</p> </li> <li> <p>source of financial support;</p> </li> <li> <p>publication status.</p> </li> </ul> </p> <p>If eligible cognitive outcome data were available at multiple time points, we grouped outcomes into short‐term (12 weeks/three months to one year), medium‐term (&gt; one year to two years) and longer‐term results (&gt; two to five years, &gt; five to 10 years and &gt;10 years). For the secondary outcome all‐cause dementia, only outcome data after one or more years of follow‐up were considered. Within these time periods, the longest available data reported by the study were extracted (for example, if study reported data at six months, 9 months and one year, only the one‐year data were extracted and analysed for the short‐term time point. </p> <p>For dichotomous outcomes (such as incident dementia or mortality), we extracted from each trial the number of participants with each outcome. </p> <p>For continuous outcomes, we extracted the number of participants in whom the outcome was measured, and the mean and standard deviation of the change from baseline or of the mean value at each relevant time point. When necessary, means and measures of dispersion were approximated from figures in the reports. </p> <p>For crossover trials, we extracted data on the first treatment period only.</p> <p>Whenever possible, we extracted intention‐to‐treat data i.e. analysing all patients according to the group randomisation. If this was not available, then we extracted and reported data from available case analyses<i>.</i> If these data were also not available, we considered data from 'per protocol' analyses. We contacted the trialists if we could not obtain the necessary data from the trial report. </p> </section> <section id="CD011906-sec-0047"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two authors independently assessed the risk of bias in each of the included trials using Cochrane's 'Risk of bias' tool (<a href="./references#CD011906-bbs2-0107" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We resolved disagreements by consensus. We assessed the risk of bias potentially introduced by suboptimal design or conduct in the domains of sequence generation, concealment of allocation, blinding of participants and caregivers, blinding of outcome assessors, selective outcome reporting, and incomplete outcome data, including the type of statistical analyses used (true intention‐to‐treat versus other). The general definitions that were used are reported in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011906-bbs2-0107" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>); the review‐specific definitions described in <a href="./appendices#CD011906-sec-0189">Appendix 3</a> are in part derived from a previously published systematic review (<a href="./references#CD011906-bbs2-0150" title="RutjesAW , JuniP , DaCostaBR , TrelleS , NueschE , ReichenbachS . Viscosupplementation for osteoarthritis of the knee: a systematic review and meta‐analysis. Annals of Internal Medicine2012;157(3):180‐91. [PUBMED: 22868835] ">Rutjes 2012</a>). </p> </section> <section id="CD011906-sec-0048"> <h4 class="title">Measures of treatment effect</h4> <p>The measure of treatment effect for continuous outcomes was a mean difference (MD) if all studies measuring that outcome used the same scale and a standardised mean difference (SMD), defined as the between‐group difference in mean values divided by the pooled standard deviation (SD), if an outcome was measured with a variety of scales. The treatment effect for dichotomous outcomes was expressed as a relative risk (RR). </p> </section> <section id="CD011906-sec-0049"> <h4 class="title">Unit of analysis issues</h4> <p>We included no cluster‐randomised trials and identified no other unit of analysis issues. </p> </section> <section id="CD011906-sec-0050"> <h4 class="title">Dealing with missing data</h4> <p>Missing data in the individual trials may put the study estimates of effects at a high risk of bias, and may lower the overall certainty of the evidence according to GRADE (<a href="./references#CD011906-bbs2-0107" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We dealt with missing data in our 'Risk of bias' assessments and planned to evaluate attrition bias in stratified analyses of the primary outcomes (<a href="./appendices#CD011906-sec-0189">Appendix 3</a>). We thus analysed the available information and did not contact authors with a request to provide missing information. We did not impute missing data ourselves. </p> </section> <section id="CD011906-sec-0051"> <h4 class="title">Assessment of heterogeneity</h4> <p>We considered differences in trial populations, interventions (including duration of treatment), and outcomes when assessing clinical heterogeneity and deciding which data to pool. We used visual inspection of forest plots and the tau<sup>2</sup> and I<sup>2</sup> statistics when considering whether to downgrade our confidence in results for inconsistency between trials, see also <a href="#CD011906-sec-0053">Data synthesis</a>. </p> </section> <section id="CD011906-sec-0052"> <h4 class="title">Assessment of reporting biases</h4> <p>Due to the low number of studies included in meta‐analyses, we did not perform any funnel plot analyses to explore possible reporting biases. </p> </section> <section id="CD011906-sec-0053"> <h4 class="title">Data synthesis</h4> <p>We pooled interventions which have been postulated to share a main mechanism of action in preventing development of dementia. Specifically, we pooled data from trials of: </p> <p> <ul id="CD011906-list-0007"> <li> <p>the antioxidant vitamins C, E, and ß‐carotene, and</p> </li> <li> <p>B vitamins (thiamine (B1), pyridoxine (B6), folic acid (B9) and cobalamin (B12)) on the grounds that these are cofactors for key metabolic processes and are involved in reducing high homocysteine levels. </p> </li> </ul> </p> <p>Whenever possible, we used standard inverse‐variance random‐effects meta‐analysis to combine outcome data across the trials (<a href="./references#CD011906-bbs2-0099" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7(3):177‐88. [PUBMED: 3802833] ">DerSimonian 1986</a>) (see <a href="#CD011906-sec-0046">Data extraction and management</a> for definitions of time points). When indicated, we converted scales to a consistent direction of effect across all trials, so that negative estimates of effect referred to those favouring active supplementation, while positive estimates referred to those favouring control. We visually inspected forest plots for the presence of heterogeneity and calculated the variance estimate tau² as a measure of between‐trial heterogeneity (<a href="./references#CD011906-bbs2-0099" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7(3):177‐88. [PUBMED: 3802833] ">DerSimonian 1986</a>). We prespecified a tau² of 0.04 to represent low heterogeneity, 0.09 to represent moderate heterogeneity, and 0.16 to represent high heterogeneity between trials (<a href="./references#CD011906-bbs2-0157" title="SpiegelhalterDJ , AbramsKJ , MylesJP . Bayesian Approaches to Clinical Trials and Health‐Care Evaluation. Chichester, UK: J Wiley, 2004. ">Spiegelhalter 2004</a>). The I² statistic and the corresponding Chi² test were depicted in addition (<a href="./references#CD011906-bbs2-0106" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>) for the benefit of readers more familiar with this statistic. I² describes the percentage of variation across trials attributable to heterogeneity rather than chance, with values of 25%, 50%, and 75% typically being interpreted as low, moderate, and high between‐trial heterogeneity. Tau² was preferred over I² in the interpretation of between‐trial heterogeneity, as the interpretation of I² can be affected by the precision of trials included in the meta‐analysis (<a href="./references#CD011906-bbs2-0151" title="RückerG , SchwarzerG , CarpenterJR , SchumacherM . Undue reliance on I² in assessing heterogeneity may mislead. BMC Medical Research Methodology2008;8(1):79. ">Rücker 2008</a>). All P values were two‐sided. Statistical analysis was done in Review Manager 5 (<a href="./references#CD011906-bbs2-0146" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>); and in STATA, release 13 (StataCorp, College Station, Texas). </p> </section> <section id="CD011906-sec-0054"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where we identified substantial inconsistency between trials in a meta‐analysis, we inspected forest plots to look for obvious sources of inconsistency and reviewed the trials for clinical heterogeneity. Because of the small numbers of trials from which data could be pooled, we conducted no subgroup analyses. </p> </section> <section id="CD011906-sec-0055"> <h4 class="title">Sensitivity analysis</h4> <p>We did not conduct any sensitivity analyses.</p> <section id="CD011906-sec-0056"> <h5 class="title">GRADE and summary of findings table</h5> <p>We constructed 'Summary of Findings' (SoF) tables for comparisons of B vitamins, antioxidant vitamins, Vitamin D + calcium, Zinc + Copper and complex multivitamins with placebo. For each comparison, we included in the SoF tables results related to overall cognitive function and the incidence of dementia at each time point. If a study presented results for the same participants at different time points, and these could not be pooled with results from other studies, then we presented in the SoF table only the results from the longest period of follow‐up. </p> <p>We used GRADE to describe the certainty of the overall body of evidence for each outcome in the 'Summary of findings' table (<a href="./references#CD011906-bbs2-0107" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>; <a href="./references#CD011906-bbs2-0104" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. [PUBMED: 18436948] ">Guyatt 2008</a>). </p> <p>Certainty refers to the degree of confidence which can be placed in the estimates of treatment benefits and harms. There are four possible ratings: 'high', 'moderate', 'low' and 'very low'. The GRADE approach rates evidence from RCTs which do not have serious limitations as 'high‐certainty'. However, several factors can lead to the downgrading of the evidence to 'moderate', 'low' or 'very low'. The degree of downgrading is determined by the seriousness of these factors: study limitations (risk of bias); inconsistency; indirectness of evidence; imprecision; and publication bias (<a href="./references#CD011906-bbs2-0107" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>; <a href="./references#CD011906-bbs2-0104" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. [PUBMED: 18436948] ">Guyatt 2008</a>). Rating evidence 'high‐certainty' implies that we are confident in our estimate of the effect, and further research is very unlikely to change this. A rating of 'very low'‐certainty indicates that we are very uncertain about the obtained summary estimate of the effect. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011906-sec-0057" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011906-sec-0057"></div> <section id="CD011906-sec-0058"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD011906-sec-0199" title="">Characteristics of included studies</a> and <a href="./references#CD011906-sec-0200" title="">Characteristics of excluded studies</a>. </p> <section id="CD011906-sec-0059"> <h4 class="title">Results of the search</h4> <p>We conducted searches in December 2014, July 2015, March 2016, August 2016, March 2017, and January 2018. In total, we retrieved 7,257 records from the six searches. After de‐duplication, 5211 records remained. A Crowd and the CDCIG information specialist assessed these at title and abstract level. In total, 725 results remained after this assessment. The review team then screened these records. Of these, we assessed 74 full‐text articles for eligibility and included 28 studies. One study was placed in the section 'Awaiting classification'; although it was marked as 'completed' in the trial registry, we were unable to find any results or to get any response from the authors. This process is depicted in <a href="#CD011906-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD011906-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011906-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011906-sec-0060"> <h4 class="title">Included studies</h4> <p>We included 28 studies with a total of more than 83,000 participants in the review.</p> <section id="CD011906-sec-0061"> <h5 class="title">Studies of B vitamins</h5> <p>We included 14 studies with 27,882 participants in which the active intervention was folic acid, vitamin B12, vitamin B6, or a combination of these (<a href="./references#CD011906-bbs2-0002" title="AndreevaVA , Kesse‐GuyotE , Barberger‐GateauP , FezeuL , HercbergS , GalanP . Cognitive function after supplementation with B vitamins and long‐chain omega‐3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial. American Journal of Clinical Nutrition2011;94:278‐86. ">Andreeva 2011</a>; <a href="./references#CD011906-bbs2-0005" title="DangourAD , AllenE , ClarkeR , ElbourneD , FaseyN , FletcherAE , et al. A randomised controlled trial investigating the effect of vitamin B12 supplementation on neurological function in healthy older people: the Older People and Enhanced Neurological function (OPEN) study protocol. Nutrition Journal2011;10(22):1‐8. DangourAD , AllenE , ClarkeR , ElbourneD , FletcherAE , LetleyL , et al. Effects of vitamin B‐12 supplementation on neurologic and cognitive function in older people: a randomized controlled trial. American Journal of Clinical Nutrition2015;102(3):639‐47. ">Dangour 2015</a>; <a href="./references#CD011906-bbs2-0006" title="DurgaJ , VanBoxtelMP , SchoutenEG , KokFJ , JollesJ , KatanMB , et al. Effect of 3‐year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet2007;369:208‐16. MurffHJ . Folic acid supplementation improved cognitive function in older adults. Journal of Clinical Outcomes Management2007;14:134‐5. SchiepersOJ , VanBoxtelMP , DeGrootRH , JollesJ , deKortWL , SwinkelsDW , et al. Serum iron parameters, HFE C282Y genotype, and cognitive performance in older adults: results from the FACIT study. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences2010;65A:1312‐21. ">Durga 2007</a>; <a href="./references#CD011906-bbs2-0007" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98:960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84:361‐70. ">Eussen 2006</a>; <a href="./references#CD011906-bbs2-0008" title="FordAH , FlickerL , AlfonsoH , ThomasJ , ClarnetteR , MartinsR , et al. Vitamins B(12), B(6), and folic acid for cognition in older men. Neurology2010;75:1540‐7. FordAH , FlickerL , AlfonsoH , ThomasJ , ClarnetteR , MartinsR , et al. Vitamins B12, B6, and folic acid for cognition in older men: correction. Neurology2011;77:804. ">Ford 2010</a>; <a href="./references#CD011906-bbs2-0011" title="HankeyGJ , FordAH , QilongYi , EikelboomJW , LeesKR , ChenC , et al. Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack. Stroke2013;44:2232‐9. [DOI: 10.1161/STROKEAHA.113.001886] VITATOPS Trial Study Group. The VITATOPS (Vitamins to Prevent Stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13:120‐6. ">Hankey 2013</a>; <a href="./references#CD011906-bbs2-0013" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookN , MansonJ , BuringJE , AlbertCM , GrodsteinF . A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. American Journal of Clinical Nutrition2008;88:1602‐10. MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al. WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2008</a>; <a href="./references#CD011906-bbs2-0017" title="LewerinC , MatousekM , SteenG , JohanssonB , SteenB , Nilsson‐EhleH . Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short‐term vitamin therapy: a placebo‐controlled randomized study. American Journal of Clinical Nutrition2005;81:1155‐62. LewerinC , Nilsson‐EhleH , MatousekM , LindstedtG , SteenB . Reduction of plasma homocysteine and serum methylmalonate concentrations in apparently healthy elderly subjects after treatment with folic acid, vitamin B12 and vitamin B6: a randomised trial. European Journal of Clinical Nutrition2003;57(11):1426‐36. ">Lewerin 2005</a>; <a href="./references#CD011906-bbs2-0019" title="Anonymous . Homocysteine and cognitive function in healthy elderly people. Brown University Geriatric Psychopharmacology Update2006;10(11):4‐5. CacabelosR . Homocysteine and cognition: from Galenic dogmatism to genetic relativism. Aging Health2006;2:783–6. ClarkeR . Vitamin B12, folic acid, and the prevention of dementia. New England Journal of Medicine2006;354(26):2817‐9. McMahonJA , GreenTJ , SkeaffCM , KnightRG , MannJI , WilliamsSM . A controlled trial of homocysteine lowering and cognitive performance. New England Journal of Medicine2006;354:2764‐72. ">McMahon 2006</a>; <a href="./references#CD011906-bbs2-0022" title="ArmitageJ , BrowmanL , BulbuliaR , CollinsR , HaynesR , ParishS . SEARCH data analysis plan [SEARCH: Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine]. ctsu.ox.ac.uk/research/search (accessed 31 December 2017). ArmitageJ , BrowmanL , BulbuliaR , CollinsR , HaynesR , ParishS . SEARCH study protocol [SEARCH: study of the effectiveness of additional reductions in cholesterol and homocysteine]. ctsu.ox.ac.uk/research/search (accessed 31 December 2017). SEARCH Collaborative Group. Effects of homocysteine‐lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors. JAMA2010;303(24):2486‐94. SEARCH Study Collaborative Group. Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12,064 myocardial infarction survivors. American Heart Journal2007;154:815‐23. ">SEARCH 2010</a>; <a href="./references#CD011906-bbs2-0023" title="StottDJ , MacIntoshG , LoweGD , RumleyA , McMahonAD , LanghorneP , et al. Randomized controlled trial of homocysteine‐lowering vitamin treatment in elderly patients with vascular disease. American Journal of Clinical Nutrition2005;82(6):1320‐6. [PUBMED: 16332666] ">Stott 2005</a>; <a href="./references#CD011906-bbs2-0024" title="SpenceJD , HowardVJ , ChamblessLE , MalinowMR , PettigrewLC , StampferM , et al. Vitamin Intervention for stroke prevention (VISP) trial: rationale and design. Neuroepidemiology2001;20(1):16‐25. TooleJF , MalinowMR , ChamblessLE , SpenceJD , PettigrewLC , HowardVJ , et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death. JAMA2004;291:565‐75. ">Toole 2004</a>; <a href="./references#CD011906-bbs2-0025" title="VanWijngaardenJ , Dhonukshe‐RuttenR , VaesA , BrouwerE , EnnemanA , SwartK , et al. Vitamin B12 and folate intake, homocysteine levels and their association with cognitive functioning in Dutch elderly people. European Geriatric Medicine2011;2(Suppl 1):S5‐6. Van derZwaluwN , VanWijngaardenJ , Dhonukshe‐RuttenR , Brouwer‐BrolsmaE , In 't VeldP , KesselsR , et al. The impact of 2y b‐vitamin supplementation on cognitive performance: the b‐proof study. Alzheimer's &amp; Dementia2013;9(4 Suppl):P880‐1. [DOI: doi.org/10.1016/j.jalz.2013.08.228] Van derZwaluwNL , Dhonukshe‐RuttenRA , VanWijngaardenJP , Brouwer‐BrolsmaEM , Van deRestO , in 't veldPH , et al. Results of 2‐year vitamin B treatment on cognitive performance: secondary data from an RCT. Neurology2014;83:2158‐66. ">Van der Zwaluw 2014</a>; <a href="./references#CD011906-bbs2-0026" title="NCT00214682 . Beyond Ageing Project: a study for the prevention of depression [Beyond Ageing Project: a RCT to assess the benefit of improving mental health literacy as well as the effect of folate and B12, and physical activity, in preventing major depression and cognitive decline among older Australians]. clinicaltrials.gov/show/NCT00214682 (first received 22 September 2005). WalkerJG , BatterhamPJ , MackinnonAJ , JormAF , HickieI , FenechM , et al. Oral folic acid and vitamin B‐12 supplementation to prevent cognitive decline in community‐dwelling older adults with depressive symptoms ‐ the Beyond Ageing Project: a randomized controlled trial. American Journal of Clinical Nutrition2012;95(1):194‐203. [PUBMED: 22170358] WalkerJG , MackinnonAJ , BatterhamP , JormAF , HickieI , McCarthyA , et al. Mental health literacy, folic acid and vitamin B12, and physical activity for the prevention of depression in older adults: randomised controlled trial. British Journal of Psychiatry2010;197(1):45‐54. ">Walker 2012</a>). Seven of the 14 studies had been designed with cognition as a primary outcome. </p> <p> <ul id="CD011906-list-0008"> <li> <p><i>Study design</i>. Nine studies compared the B vitamin or B vitamin combination to placebo in a two‐arm, parallel group design. In one two‐arm, parallel group study (<a href="./references#CD011906-bbs2-0024" title="SpenceJD , HowardVJ , ChamblessLE , MalinowMR , PettigrewLC , StampferM , et al. Vitamin Intervention for stroke prevention (VISP) trial: rationale and design. Neuroepidemiology2001;20(1):16‐25. TooleJF , MalinowMR , ChamblessLE , SpenceJD , PettigrewLC , HowardVJ , et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death. JAMA2004;291:565‐75. ">Toole 2004</a>), the intervention was a multivitamin containing the United States' Food and Drug Administration (FDA) recommended daily allowances (RDA) of vitamins supplemented with high doses of folic acid, vitamin B6, and vitamin B12 while the comparator arm was a multivitamin containing the RDAs only. One study (<a href="./references#CD011906-bbs2-0007" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98:960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84:361‐70. ">Eussen 2006</a>) had a three‐arm, parallel group design with active intervention groups receiving B12 and (folic acid + B12); we combined these to make a single active intervention group. Four studies had factorial designs with placebo controls. <a href="./references#CD011906-bbs2-0022" title="ArmitageJ , BrowmanL , BulbuliaR , CollinsR , HaynesR , ParishS . SEARCH data analysis plan [SEARCH: Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine]. ctsu.ox.ac.uk/research/search (accessed 31 December 2017). ArmitageJ , BrowmanL , BulbuliaR , CollinsR , HaynesR , ParishS . SEARCH study protocol [SEARCH: study of the effectiveness of additional reductions in cholesterol and homocysteine]. ctsu.ox.ac.uk/research/search (accessed 31 December 2017). SEARCH Collaborative Group. Effects of homocysteine‐lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors. JAMA2010;303(24):2486‐94. SEARCH Study Collaborative Group. Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12,064 myocardial infarction survivors. American Heart Journal2007;154:815‐23. ">SEARCH 2010</a> had a 2 x 2 factorial design including (folic acid + B12) and simvastatin. <a href="./references#CD011906-bbs2-0002" title="AndreevaVA , Kesse‐GuyotE , Barberger‐GateauP , FezeuL , HercbergS , GalanP . Cognitive function after supplementation with B vitamins and long‐chain omega‐3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial. American Journal of Clinical Nutrition2011;94:278‐86. ">Andreeva 2011</a> had a 2 x 2 factorial design including (folic acid + B6 + B12) and omega fatty acids. <a href="./references#CD011906-bbs2-0023" title="StottDJ , MacIntoshG , LoweGD , RumleyA , McMahonAD , LanghorneP , et al. Randomized controlled trial of homocysteine‐lowering vitamin treatment in elderly patients with vascular disease. American Journal of Clinical Nutrition2005;82(6):1320‐6. [PUBMED: 16332666] ">Stott 2005</a> had a 2 x 2 x 2 factorial design including (folic acid + B12), B2, and B6 and reported results for all eight groups separately; for comparability with other studies, we included the (folic acid + B12) and the (folic acid + B12 + B6 groups), combining these to make a single active intervention group. <a href="./references#CD011906-bbs2-0013" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookN , MansonJ , BuringJE , AlbertCM , GrodsteinF . A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. American Journal of Clinical Nutrition2008;88:1602‐10. MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al. WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2008</a> had a 2 x 2 x 2 x 2 factorial design. It reported on a cognitive substudy of the Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS), which was established by adding a fourth arm ‐ (folic acid + B6 + B12) ‐ to the Women's Antioxidant Cardiovascular Study (WACS). The active interventions in WAFACS were therefore (folic acid + B6 + B12), vitamin E, vitamin C, and ß‐carotene. <a href="./references#CD011906-bbs2-0013" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookN , MansonJ , BuringJE , AlbertCM , GrodsteinF . A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. American Journal of Clinical Nutrition2008;88:1602‐10. MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al. WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2008</a> reported on the effects of the B vitamins. </p> </li> </ul> <ul id="CD011906-list-0009"> <li> <p><i>Interventions</i>. The active interventions varied in their constituents and dose. In one trial, the active intervention of interest was folic acid alone; in one trial, it was B12 alone. In five trials, the active intervention was (folic acid + B12) and in six trials (folic acid + B12 + B6), although in one of these trials the B12 dose was minimal. Daily doses of folic acid ranged from 0.4 mg to 2.5 mg, of B6 from 3 mg to 50 mg and of B12 from 0.02 mg to 1 mg. All studies had a placebo control, although for most of the factorial studies the comparison was 'B vitamin' versus 'no B vitamin' where the 'no B vitamin' group were taking a variety of other interventions. In one trial, all participants were also given 600 IU of vitamin D3 daily. </p> </li> </ul> <ul id="CD011906-list-0010"> <li> <p><i>Population</i>. The study populations varied. </p> <ul id="CD011906-list-0011"> <li> <p>Six studies recruited participants with a history of cardio‐ or cerebrovascular disease (<a href="./references#CD011906-bbs2-0002" title="AndreevaVA , Kesse‐GuyotE , Barberger‐GateauP , FezeuL , HercbergS , GalanP . Cognitive function after supplementation with B vitamins and long‐chain omega‐3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial. American Journal of Clinical Nutrition2011;94:278‐86. ">Andreeva 2011</a>, <a href="./references#CD011906-bbs2-0011" title="HankeyGJ , FordAH , QilongYi , EikelboomJW , LeesKR , ChenC , et al. Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack. Stroke2013;44:2232‐9. [DOI: 10.1161/STROKEAHA.113.001886] VITATOPS Trial Study Group. The VITATOPS (Vitamins to Prevent Stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13:120‐6. ">Hankey 2013</a>; <a href="./references#CD011906-bbs2-0020" title="Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high‐risk individuals: a randomised placebo‐controlled trial. Lancet2002;360(9326):23‐33. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol‐lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. European Heart Journal1999;20:725‐41. ">MRC/BHF 2002</a>, <a href="./references#CD011906-bbs2-0022" title="ArmitageJ , BrowmanL , BulbuliaR , CollinsR , HaynesR , ParishS . SEARCH data analysis plan [SEARCH: Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine]. ctsu.ox.ac.uk/research/search (accessed 31 December 2017). ArmitageJ , BrowmanL , BulbuliaR , CollinsR , HaynesR , ParishS . SEARCH study protocol [SEARCH: study of the effectiveness of additional reductions in cholesterol and homocysteine]. ctsu.ox.ac.uk/research/search (accessed 31 December 2017). SEARCH Collaborative Group. Effects of homocysteine‐lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors. JAMA2010;303(24):2486‐94. SEARCH Study Collaborative Group. Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12,064 myocardial infarction survivors. American Heart Journal2007;154:815‐23. ">SEARCH 2010</a>, <a href="./references#CD011906-bbs2-0023" title="StottDJ , MacIntoshG , LoweGD , RumleyA , McMahonAD , LanghorneP , et al. Randomized controlled trial of homocysteine‐lowering vitamin treatment in elderly patients with vascular disease. American Journal of Clinical Nutrition2005;82(6):1320‐6. [PUBMED: 16332666] ">Stott 2005</a>, <a href="./references#CD011906-bbs2-0024" title="SpenceJD , HowardVJ , ChamblessLE , MalinowMR , PettigrewLC , StampferM , et al. Vitamin Intervention for stroke prevention (VISP) trial: rationale and design. Neuroepidemiology2001;20(1):16‐25. TooleJF , MalinowMR , ChamblessLE , SpenceJD , PettigrewLC , HowardVJ , et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death. JAMA2004;291:565‐75. ">Toole 2004</a>) and one recruited men with hypertension (<a href="./references#CD011906-bbs2-0008" title="FordAH , FlickerL , AlfonsoH , ThomasJ , ClarnetteR , MartinsR , et al. Vitamins B(12), B(6), and folic acid for cognition in older men. Neurology2010;75:1540‐7. FordAH , FlickerL , AlfonsoH , ThomasJ , ClarnetteR , MartinsR , et al. Vitamins B12, B6, and folic acid for cognition in older men: correction. Neurology2011;77:804. ">Ford 2010</a>). Three studies included only participants with elevated serum homocysteine levels (&gt; 12 or 13 μmol/L) at baseline (<a href="./references#CD011906-bbs2-0006" title="DurgaJ , VanBoxtelMP , SchoutenEG , KokFJ , JollesJ , KatanMB , et al. Effect of 3‐year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet2007;369:208‐16. MurffHJ . Folic acid supplementation improved cognitive function in older adults. Journal of Clinical Outcomes Management2007;14:134‐5. SchiepersOJ , VanBoxtelMP , DeGrootRH , JollesJ , deKortWL , SwinkelsDW , et al. Serum iron parameters, HFE C282Y genotype, and cognitive performance in older adults: results from the FACIT study. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences2010;65A:1312‐21. ">Durga 2007</a>, <a href="./references#CD011906-bbs2-0019" title="Anonymous . Homocysteine and cognitive function in healthy elderly people. Brown University Geriatric Psychopharmacology Update2006;10(11):4‐5. CacabelosR . Homocysteine and cognition: from Galenic dogmatism to genetic relativism. Aging Health2006;2:783–6. ClarkeR . Vitamin B12, folic acid, and the prevention of dementia. New England Journal of Medicine2006;354(26):2817‐9. McMahonJA , GreenTJ , SkeaffCM , KnightRG , MannJI , WilliamsSM . A controlled trial of homocysteine lowering and cognitive performance. New England Journal of Medicine2006;354:2764‐72. ">McMahon 2006</a>, <a href="./references#CD011906-bbs2-0025" title="VanWijngaardenJ , Dhonukshe‐RuttenR , VaesA , BrouwerE , EnnemanA , SwartK , et al. Vitamin B12 and folate intake, homocysteine levels and their association with cognitive functioning in Dutch elderly people. European Geriatric Medicine2011;2(Suppl 1):S5‐6. Van derZwaluwN , VanWijngaardenJ , Dhonukshe‐RuttenR , Brouwer‐BrolsmaE , In 't VeldP , KesselsR , et al. The impact of 2y b‐vitamin supplementation on cognitive performance: the b‐proof study. Alzheimer's &amp; Dementia2013;9(4 Suppl):P880‐1. [DOI: doi.org/10.1016/j.jalz.2013.08.228] Van derZwaluwNL , Dhonukshe‐RuttenRA , VanWijngaardenJP , Brouwer‐BrolsmaEM , Van deRestO , in 't veldPH , et al. Results of 2‐year vitamin B treatment on cognitive performance: secondary data from an RCT. Neurology2014;83:2158‐66. ">Van der Zwaluw 2014</a>). Two studies included only participants with mild to moderate B12 deficiency (<a href="./references#CD011906-bbs2-0005" title="DangourAD , AllenE , ClarkeR , ElbourneD , FaseyN , FletcherAE , et al. A randomised controlled trial investigating the effect of vitamin B12 supplementation on neurological function in healthy older people: the Older People and Enhanced Neurological function (OPEN) study protocol. Nutrition Journal2011;10(22):1‐8. DangourAD , AllenE , ClarkeR , ElbourneD , FletcherAE , LetleyL , et al. Effects of vitamin B‐12 supplementation on neurologic and cognitive function in older people: a randomized controlled trial. American Journal of Clinical Nutrition2015;102(3):639‐47. ">Dangour 2015</a>; <a href="./references#CD011906-bbs2-0007" title="EussenS , UelandP , ClarkeR , BlomH , HoefnagelsW , VanStaverenW , et al. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. British Journal of Nutrition2007;98:960‐8. EussenSJ , DeGrootLC , JoostenLW , BlooRJ , ClarkeR , UelandPM , et al. Effect of oral vitamin B‐12 with or without folic acid on cognitive function in older people with mild vitamin B‐12 deficiency: a randomized, placebo‐controlled trial. American Journal of Clinical Nutrition2006;84:361‐70. ">Eussen 2006</a>). One study included only diabetic participants (<a href="./references#CD011906-bbs2-0001" title="AnandVPR , KumarBJ , VargheseJM , DasSK . Supplementation of vitamin E improves cognitive status and oxidative stress in type 2 diabetes mellitus. International Research Journal of Pharmacy2011;2:169‐72. ">Anand 2011</a>). In one study, participants were selected on the basis of elevated psychological distress (<a href="./references#CD011906-bbs2-0026" title="NCT00214682 . Beyond Ageing Project: a study for the prevention of depression [Beyond Ageing Project: a RCT to assess the benefit of improving mental health literacy as well as the effect of folate and B12, and physical activity, in preventing major depression and cognitive decline among older Australians]. clinicaltrials.gov/show/NCT00214682 (first received 22 September 2005). WalkerJG , BatterhamPJ , MackinnonAJ , JormAF , HickieI , FenechM , et al. Oral folic acid and vitamin B‐12 supplementation to prevent cognitive decline in community‐dwelling older adults with depressive symptoms ‐ the Beyond Ageing Project: a randomized controlled trial. American Journal of Clinical Nutrition2012;95(1):194‐203. [PUBMED: 22170358] WalkerJG , MackinnonAJ , BatterhamP , JormAF , HickieI , McCarthyA , et al. Mental health literacy, folic acid and vitamin B12, and physical activity for the prevention of depression in older adults: randomised controlled trial. British Journal of Psychiatry2010;197(1):45‐54. ">Walker 2012</a>). </p> </li> <li> <p>In all studies, there was evidence that most participants were cognitively healthy at baseline, but inclusion of small numbers of participants with cognitive impairment was possible. The inclusion decision was marginal for two studies. <a href="./references#CD011906-bbs2-0023" title="StottDJ , MacIntoshG , LoweGD , RumleyA , McMahonAD , LanghorneP , et al. Randomized controlled trial of homocysteine‐lowering vitamin treatment in elderly patients with vascular disease. American Journal of Clinical Nutrition2005;82(6):1320‐6. [PUBMED: 16332666] ">Stott 2005</a> reported median MMSE at baseline of 28 with an IQR of 26 to 29; hence 25% of participants in this UK study had an MMSE &lt; 26. In <a href="./references#CD011906-bbs2-0024" title="SpenceJD , HowardVJ , ChamblessLE , MalinowMR , PettigrewLC , StampferM , et al. Vitamin Intervention for stroke prevention (VISP) trial: rationale and design. Neuroepidemiology2001;20(1):16‐25. TooleJF , MalinowMR , ChamblessLE , SpenceJD , PettigrewLC , HowardVJ , et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death. JAMA2004;291:565‐75. ">Toole 2004</a>, all participants had had a 'non‐disabling' ischaemic stroke and baseline MMSE was 26.9 (SD 3.4) so it is likely that some participants had a degree of cognitive impairment at baseline. Only participants with 'severe cognitive impairment' were excluded. We decided to include both of these studies, but to consider the population as a possible source of heterogeneity. </p> </li> <li> <p>The age of participants also varied. In six studies, the mean age at the onset of supplementation was between 60 years and 70 years; in eight studies the mean age was between 70 years and 80 years. </p> </li> </ul> </li> </ul> </p> </section> <section id="CD011906-sec-0062"> <h5 class="title">Studies of antioxidant vitamins</h5> <p>We included eight studies with 47,840 participants in which the active intervention was one or more of the antioxidant vitamins: vitamin E, vitamin C, ß‐carotene (<a href="./references#CD011906-bbs2-0001" title="AnandVPR , KumarBJ , VargheseJM , DasSK . Supplementation of vitamin E improves cognitive status and oxidative stress in type 2 diabetes mellitus. International Research Journal of Pharmacy2011;2:169‐72. ">Anand 2011</a>; <a href="./references#CD011906-bbs2-0009" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , KangJH , GlynnRJ , CookNR , GazianoJM . A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Archives of Internal Medicine2007;167:2184‐90. ">Grodstein 2007</a>; <a href="./references#CD011906-bbs2-0012" title="KangJH , CookN , MansonJ , BuringJE , GrodsteinF . A randomized trial of vitamin E supplementation and cognitive function in women. Archives of Internal Medicine2006;166:2462‐8. RidkerPM , CookNR , LeeIM , GordonD , GazianoJM , MansonJE , et al. A randomized trial of low‐dose aspirin in the primary prevention of cardiovascular disease in women. New England Journal of Medicine2005;352(13):1293‐304. ">Kang 2006</a>; <a href="./references#CD011906-bbs2-0014" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookNR , MansonJE , BuringJE , AlbertCM , GrodsteinF . Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation2009;119(21):2772‐80. [PUBMED: 19451353] MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al: WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2009</a>; <a href="./references#CD011906-bbs2-0015" title="HercbergS , GalanP , PreziosiP , BertraisS , MennenL , MalvyD , et al. The SU.VI.MAX Study: a randomized, placebo‐controlled trial of the health effects of antioxidant vitamins and minerals. Archives of Internal Medicine2004;164(21):2335‐42. HercbergS , PreziosiP , BriançonS , GalanP , TriolI , MalvyD , et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study ‐ design, methods, and participant characteristics. Controlled Clinical Trials1998;19(4):336‐51. Kesse‐GuyotE , FezeuL , JeandelC , FerryM , AndreevaV , AmievaH , et al. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. American Journal of Clinical Nutrition2011;94:892‐9. ">Kesse‐Guyot 2011</a>; <a href="./references#CD011906-bbs2-0016" title="AbnerE , SchmittF , CabanAH , DennisB , MathewsM , CooperG , et al. Dual cognitive screening for dementia: preliminary case ascertainment in the antioxidant Alzheimer's prevention (PREADVISE) trial. Alzheimer's &amp; Dementia2012;8(4 suppl):P144. [DOI: 10.1016/j.jalz.2012.05.385] KryscioRJ , AbnerEL , Caban‐HoltA , LovellM , GoodmanP , DarkeAK , et al. Association of antioxidant supplement use and dementia in the prevention of Alzheimer's disease by vitamin E and selenium trial (PREADVISE). JAMA Neurology2017;74(5):567‐73. KryscioRJ , AbnerEL , SchmittFA , GoodmanPJ , MendiondoM , Caban‐HoltA , et al. A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE trial. Journal of Nutrition, Health &amp; Aging2013;17(1):72‐5. [PUBMED: 23299383] ">Kryscio 2017</a>; <a href="./references#CD011906-bbs2-0020" title="Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high‐risk individuals: a randomised placebo‐controlled trial. Lancet2002;360(9326):23‐33. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol‐lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. European Heart Journal1999;20:725‐41. ">MRC/BHF 2002</a>; <a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a>). Only one of these studies had been designed primarily to assess cognition. </p> <p> <ul id="CD011906-list-0012"> <li> <p><i>Study design</i>. One study (<a href="./references#CD011906-bbs2-0001" title="AnandVPR , KumarBJ , VargheseJM , DasSK . Supplementation of vitamin E improves cognitive status and oxidative stress in type 2 diabetes mellitus. International Research Journal of Pharmacy2011;2:169‐72. ">Anand 2011</a>) compared vitamin E to no vitamin E in a randomised, open‐label design. The remaining studies were placebo‐controlled. One (<a href="./references#CD011906-bbs2-0012" title="KangJH , CookN , MansonJ , BuringJE , GrodsteinF . A randomized trial of vitamin E supplementation and cognitive function in women. Archives of Internal Medicine2006;166:2462‐8. RidkerPM , CookNR , LeeIM , GordonD , GazianoJM , MansonJE , et al. A randomized trial of low‐dose aspirin in the primary prevention of cardiovascular disease in women. New England Journal of Medicine2005;352(13):1293‐304. ">Kang 2006</a>) was a 2 x 2 factorial comparison of vitamin E and low dose aspirin. One (<a href="./references#CD011906-bbs2-0016" title="AbnerE , SchmittF , CabanAH , DennisB , MathewsM , CooperG , et al. Dual cognitive screening for dementia: preliminary case ascertainment in the antioxidant Alzheimer's prevention (PREADVISE) trial. Alzheimer's &amp; Dementia2012;8(4 suppl):P144. [DOI: 10.1016/j.jalz.2012.05.385] KryscioRJ , AbnerEL , Caban‐HoltA , LovellM , GoodmanP , DarkeAK , et al. Association of antioxidant supplement use and dementia in the prevention of Alzheimer's disease by vitamin E and selenium trial (PREADVISE). JAMA Neurology2017;74(5):567‐73. KryscioRJ , AbnerEL , SchmittFA , GoodmanPJ , MendiondoM , Caban‐HoltA , et al. A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE trial. Journal of Nutrition, Health &amp; Aging2013;17(1):72‐5. [PUBMED: 23299383] ">Kryscio 2017</a>) was a 2 x 2 factorial comparison of vitamin E and selenium supplements (this trial was also included in a comparison of selenium with placebo, below). <a href="./references#CD011906-bbs2-0009" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , KangJH , GlynnRJ , CookNR , GazianoJM . A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Archives of Internal Medicine2007;167:2184‐90. ">Grodstein 2007</a> reported data on ß‐carotene. It started as a two‐arm parallel group study (ß‐carotene and placebo, the Physicians' Health Study I (PHS‐I)) which lasted for 13 years. After a gap of up to 18 months in some cases, approximately half the participants in PHS‐I and some new recruits entered the Physicians' Health Study II (PHS‐II) and a cognitive assessment was added. The original randomisation of participants in PHS‐I to ß‐carotene or placebo was retained in PHS‐II while vitamin C, vitamin E, and a complex multivitamin were added in a factorial design. The paper therefore reported data after both long‐term (mean 18 years, range 15 to 20 years) and shorter‐term (mean one year, range three months to three years) treatment with ß‐carotene. <a href="./references#CD011906-bbs2-0014" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookNR , MansonJE , BuringJE , AlbertCM , GrodsteinF . Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation2009;119(21):2772‐80. [PUBMED: 19451353] MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al: WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2009</a> studied vitamin E, vitamin C, and ß‐carotene in a 2 x 2 x 2 factorial design. In the remaining three studies, the active intervention was a combination of antioxidant vitamins. <a href="./references#CD011906-bbs2-0020" title="Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high‐risk individuals: a randomised placebo‐controlled trial. Lancet2002;360(9326):23‐33. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol‐lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. European Heart Journal1999;20:725‐41. ">MRC/BHF 2002</a> had a 2 x 2 factorial design comparing (vitamin E + vitamin C + ß‐carotene) and simvastatin. <a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a> was a four‐arm parallel group study; in this comparison, we included the (vitamin E + vitamin C + ß‐carotene) and placebo arms (<a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a> had two additional arms: one treated with zinc and cupric oxide, which we included in another comparison, and one treated with the antioxidant combination plus zinc and cupric oxide, which we excluded). Finally, <a href="./references#CD011906-bbs2-0015" title="HercbergS , GalanP , PreziosiP , BertraisS , MennenL , MalvyD , et al. The SU.VI.MAX Study: a randomized, placebo‐controlled trial of the health effects of antioxidant vitamins and minerals. Archives of Internal Medicine2004;164(21):2335‐42. HercbergS , PreziosiP , BriançonS , GalanP , TriolI , MalvyD , et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study ‐ design, methods, and participant characteristics. Controlled Clinical Trials1998;19(4):336‐51. Kesse‐GuyotE , FezeuL , JeandelC , FerryM , AndreevaV , AmievaH , et al. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. American Journal of Clinical Nutrition2011;94:892‐9. ">Kesse‐Guyot 2011</a> compared a combination of vitamin E, vitamin C, ß‐carotene, zinc, and selenium to placebo. In this case, it was not possible to separate the antioxidant vitamins from the minerals. This study also differed in the timing of the cognitive assessment which took place six years after the end of the eight‐year supplementation period. </p> </li> </ul> <ul id="CD011906-list-0013"> <li> <p><i>Interventions</i>. There were data on vitamin E from four trials, on vitamin C from one trial, and on ß‐carotene from two trials. Most of these data were from factorial trials in which the comparison group was receiving a variety of interventions. In two trials, the active intervention was the antioxidant combination (vitamin E + vitamin C + ß‐carotene), in one trial, it was the same combination with zinc and selenium and in one trial there were both vitamin E and (vitamin E + selenium) arms. All vitamin E was given as alpha‐tocopherol. Doses of vitamin C ranged from 120 mg to 500 mg daily, of vitamin E from 600 IU on alternate days to 660 IU daily (except in <a href="./references#CD011906-bbs2-0015" title="HercbergS , GalanP , PreziosiP , BertraisS , MennenL , MalvyD , et al. The SU.VI.MAX Study: a randomized, placebo‐controlled trial of the health effects of antioxidant vitamins and minerals. Archives of Internal Medicine2004;164(21):2335‐42. HercbergS , PreziosiP , BriançonS , GalanP , TriolI , MalvyD , et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study ‐ design, methods, and participant characteristics. Controlled Clinical Trials1998;19(4):336‐51. Kesse‐GuyotE , FezeuL , JeandelC , FerryM , AndreevaV , AmievaH , et al. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. American Journal of Clinical Nutrition2011;94:892‐9. ">Kesse‐Guyot 2011</a> in which the vitamin E dose in the combined antioxidant was only 45 IU daily) and of ß‐carotene from 6 mg to 50 mg daily. </p> </li> </ul> <ul id="CD011906-list-0014"> <li> <p><i>Population</i>. The study populations varied. </p> <ul id="CD011906-list-0015"> <li> <p>Two studies included women only (<a href="./references#CD011906-bbs2-0012" title="KangJH , CookN , MansonJ , BuringJE , GrodsteinF . A randomized trial of vitamin E supplementation and cognitive function in women. Archives of Internal Medicine2006;166:2462‐8. RidkerPM , CookNR , LeeIM , GordonD , GazianoJM , MansonJE , et al. A randomized trial of low‐dose aspirin in the primary prevention of cardiovascular disease in women. New England Journal of Medicine2005;352(13):1293‐304. ">Kang 2006</a>, <a href="./references#CD011906-bbs2-0014" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookNR , MansonJE , BuringJE , AlbertCM , GrodsteinF . Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation2009;119(21):2772‐80. [PUBMED: 19451353] MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al: WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2009</a>) and two studies included men only (<a href="./references#CD011906-bbs2-0009" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , KangJH , GlynnRJ , CookNR , GazianoJM . A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Archives of Internal Medicine2007;167:2184‐90. ">Grodstein 2007</a>; <a href="./references#CD011906-bbs2-0016" title="AbnerE , SchmittF , CabanAH , DennisB , MathewsM , CooperG , et al. Dual cognitive screening for dementia: preliminary case ascertainment in the antioxidant Alzheimer's prevention (PREADVISE) trial. Alzheimer's &amp; Dementia2012;8(4 suppl):P144. [DOI: 10.1016/j.jalz.2012.05.385] KryscioRJ , AbnerEL , Caban‐HoltA , LovellM , GoodmanP , DarkeAK , et al. Association of antioxidant supplement use and dementia in the prevention of Alzheimer's disease by vitamin E and selenium trial (PREADVISE). JAMA Neurology2017;74(5):567‐73. KryscioRJ , AbnerEL , SchmittFA , GoodmanPJ , MendiondoM , Caban‐HoltA , et al. A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE trial. Journal of Nutrition, Health &amp; Aging2013;17(1):72‐5. [PUBMED: 23299383] ">Kryscio 2017</a>). In <a href="./references#CD011906-bbs2-0001" title="AnandVPR , KumarBJ , VargheseJM , DasSK . Supplementation of vitamin E improves cognitive status and oxidative stress in type 2 diabetes mellitus. International Research Journal of Pharmacy2011;2:169‐72. ">Anand 2011,</a> all participants had type 2 diabetes and were taking oral hypoglycaemics. In <a href="./references#CD011906-bbs2-0014" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookNR , MansonJE , BuringJE , AlbertCM , GrodsteinF . Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation2009;119(21):2772‐80. [PUBMED: 19451353] MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al: WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2009</a>, all participants had cardiovascular disease or three or more coronary risk factors. In <a href="./references#CD011906-bbs2-0020" title="Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high‐risk individuals: a randomised placebo‐controlled trial. Lancet2002;360(9326):23‐33. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol‐lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. European Heart Journal1999;20:725‐41. ">MRC/BHF 2002</a>, participants were recruited on the basis of a high risk of coronary heart disease death over the next five years. In <a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a>, all participants had age‐related macular degeneration. </p> </li> <li> <p>Reflecting the fact that these studies were overwhelmingly cognitive 'add‐ons' to studies with other purposes, only one study (<a href="./references#CD011906-bbs2-0001" title="AnandVPR , KumarBJ , VargheseJM , DasSK . Supplementation of vitamin E improves cognitive status and oxidative stress in type 2 diabetes mellitus. International Research Journal of Pharmacy2011;2:169‐72. ">Anand 2011</a>) conducted any cognitive assessment at baseline. In this study, which was conducted in an economically‐deprived population in India, a score of 24 or more on the Tamil version of the MMSE was considered normal cognition. Although we could not be sure that the other studies did not include some participants with cognitive impairment, we considered it likely in all cases that the study populations were very largely free of dementia or significant cognitive impairment and that the data were informative for our review question. </p> </li> <li> <p>The age of participants included in this comparison was generally lower than in the B vitamin comparison. In three studies (<a href="./references#CD011906-bbs2-0001" title="AnandVPR , KumarBJ , VargheseJM , DasSK . Supplementation of vitamin E improves cognitive status and oxidative stress in type 2 diabetes mellitus. International Research Journal of Pharmacy2011;2:169‐72. ">Anand 2011</a>, the long‐term component of <a href="./references#CD011906-bbs2-0009" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , KangJH , GlynnRJ , CookNR , GazianoJM . A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Archives of Internal Medicine2007;167:2184‐90. ">Grodstein 2007</a> and <a href="./references#CD011906-bbs2-0015" title="HercbergS , GalanP , PreziosiP , BertraisS , MennenL , MalvyD , et al. The SU.VI.MAX Study: a randomized, placebo‐controlled trial of the health effects of antioxidant vitamins and minerals. Archives of Internal Medicine2004;164(21):2335‐42. HercbergS , PreziosiP , BriançonS , GalanP , TriolI , MalvyD , et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study ‐ design, methods, and participant characteristics. Controlled Clinical Trials1998;19(4):336‐51. Kesse‐GuyotE , FezeuL , JeandelC , FerryM , AndreevaV , AmievaH , et al. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. American Journal of Clinical Nutrition2011;94:892‐9. ">Kesse‐Guyot 2011</a>), the mean age at randomisation was between 50 and 60 years. In four studies, the mean or median age at randomisation was between 60 and 70 years. For the shorter‐term component of <a href="./references#CD011906-bbs2-0009" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , KangJH , GlynnRJ , CookNR , GazianoJM . A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Archives of Internal Medicine2007;167:2184‐90. ">Grodstein 2007</a>, the mean age at randomisation was 71 years. <a href="./references#CD011906-bbs2-0020" title="Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high‐risk individuals: a randomised placebo‐controlled trial. Lancet2002;360(9326):23‐33. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol‐lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. European Heart Journal1999;20:725‐41. ">MRC/BHF 2002</a> did not report a mean age of participants; the range at baseline was 40 years to 80 years. </p> </li> </ul> </li> </ul> </p> </section> <section id="CD011906-sec-0063"> <h5 class="title">Studies of vitamin D</h5> <p>We included one trial with 4143 participants which compared (vitamin D3 + calcium carbonate) with placebo (<a href="./references#CD011906-bbs2-0021" title="JacksonRD , LaCroixAZ , GassM , WallaceRB , RobbinsJ , LewisCE , et al. Calcium plus vitamin D supplementation and the risk of fractures. New England journal of medicine2006;354(7):669‐83. RossomRC , EspelandMA , MansonJE , DyskenMW , JohnsonKC , LaneDS , et al. Calcium and vitamin D supplementation and cognitive impairment in the Women's Health Initiative. Journal of the American Geriatrics Society2012;60:2197‐205. ">Rossom 2012</a>, the Women's Health Initiative Memory Study, or WHIMS) and a small pilot study with 60 participants comparing vitamin D3 and placebo (<a href="./references#CD011906-bbs2-0003" title="AspellN , HealyM , McPartlinJ , LawlorBA , O'SullivanM . Effects of vitamin D supplementation on cognitive function in healthy community dwelling older adults: results from a randomised double‐blind placebo‐controlled trial. Proceedings of the Nutrition Society2017;76 (OCE3):E59. ">Aspell 2017</a>). Cognition was a primary outcome in <a href="./references#CD011906-bbs2-0003" title="AspellN , HealyM , McPartlinJ , LawlorBA , O'SullivanM . Effects of vitamin D supplementation on cognitive function in healthy community dwelling older adults: results from a randomised double‐blind placebo‐controlled trial. Proceedings of the Nutrition Society2017;76 (OCE3):E59. ">Aspell 2017</a>. Although <a href="./references#CD011906-bbs2-0021" title="JacksonRD , LaCroixAZ , GassM , WallaceRB , RobbinsJ , LewisCE , et al. Calcium plus vitamin D supplementation and the risk of fractures. New England journal of medicine2006;354(7):669‐83. RossomRC , EspelandMA , MansonJE , DyskenMW , JohnsonKC , LaneDS , et al. Calcium and vitamin D supplementation and cognitive impairment in the Women's Health Initiative. Journal of the American Geriatrics Society2012;60:2197‐205. ">Rossom 2012</a> was an ancillary study to a larger study with different primary aims, participants did have a detailed assessment to exclude dementia or cognitive impairment prior to enrolment in WHIMS. </p> <p> <ul id="CD011906-list-0016"> <li> <p><i>Study design</i>. Both studies were two‐arm parallel group studies. The mean duration of treatment and follow‐up in <a href="./references#CD011906-bbs2-0021" title="JacksonRD , LaCroixAZ , GassM , WallaceRB , RobbinsJ , LewisCE , et al. Calcium plus vitamin D supplementation and the risk of fractures. New England journal of medicine2006;354(7):669‐83. RossomRC , EspelandMA , MansonJE , DyskenMW , JohnsonKC , LaneDS , et al. Calcium and vitamin D supplementation and cognitive impairment in the Women's Health Initiative. Journal of the American Geriatrics Society2012;60:2197‐205. ">Rossom 2012</a> was 7.8 years; in <a href="./references#CD011906-bbs2-0003" title="AspellN , HealyM , McPartlinJ , LawlorBA , O'SullivanM . Effects of vitamin D supplementation on cognitive function in healthy community dwelling older adults: results from a randomised double‐blind placebo‐controlled trial. Proceedings of the Nutrition Society2017;76 (OCE3):E59. ">Aspell 2017</a>, it was six months. </p> </li> <li> <p><i>Intervention</i>. The doses differed markedly in these two studies. In <a href="./references#CD011906-bbs2-0021" title="JacksonRD , LaCroixAZ , GassM , WallaceRB , RobbinsJ , LewisCE , et al. Calcium plus vitamin D supplementation and the risk of fractures. New England journal of medicine2006;354(7):669‐83. RossomRC , EspelandMA , MansonJE , DyskenMW , JohnsonKC , LaneDS , et al. Calcium and vitamin D supplementation and cognitive impairment in the Women's Health Initiative. Journal of the American Geriatrics Society2012;60:2197‐205. ">Rossom 2012</a>, the experimental intervention was 400 IU vitamin D3 and 1000 mg calcium carbonate daily. Use of personal supplemental vitamin D up to 600 IU (later 1000 IU) and of calcium up to 1000 mg was also permitted. All participants were also enrolled in WHI Hormone Therapy trials and may have been taking estrogen with or without progestin under those protocols. In <a href="./references#CD011906-bbs2-0003" title="AspellN , HealyM , McPartlinJ , LawlorBA , O'SullivanM . Effects of vitamin D supplementation on cognitive function in healthy community dwelling older adults: results from a randomised double‐blind placebo‐controlled trial. Proceedings of the Nutrition Society2017;76 (OCE3):E59. ">Aspell 2017</a>, the experimental intervention was 4000 IU of vitamin D3 on alternate days. </p> </li> <li> <p><i>Population</i>. The participants in <a href="./references#CD011906-bbs2-0021" title="JacksonRD , LaCroixAZ , GassM , WallaceRB , RobbinsJ , LewisCE , et al. Calcium plus vitamin D supplementation and the risk of fractures. New England journal of medicine2006;354(7):669‐83. RossomRC , EspelandMA , MansonJE , DyskenMW , JohnsonKC , LaneDS , et al. Calcium and vitamin D supplementation and cognitive impairment in the Women's Health Initiative. Journal of the American Geriatrics Society2012;60:2197‐205. ">Rossom 2012</a> were 4143 women with a mean age of 71 years (range 65 to 80 years). The participants in <a href="./references#CD011906-bbs2-0003" title="AspellN , HealyM , McPartlinJ , LawlorBA , O'SullivanM . Effects of vitamin D supplementation on cognitive function in healthy community dwelling older adults: results from a randomised double‐blind placebo‐controlled trial. Proceedings of the Nutrition Society2017;76 (OCE3):E59. ">Aspell 2017</a> were 60 community‐dwelling men and women with a mean age of 68.5 years. </p> </li> </ul> </p> </section> <section id="CD011906-sec-0064"> <h5 class="title">Studies of zinc and copper</h5> <p>We included two trials comparing zinc or zinc and copper supplements with placebo (<a href="./references#CD011906-bbs2-0018" title="Andriollo‐SanchezM , Hininger‐FavierI , MeunierN , TotiE , ZaccariaM , Brandolini‐BunlonM , et al. Zinc intake and status in middle‐aged and older European subjects: the ZENITH study. European Journal of Clinical Nutrition2005;59(Suppl 2):S37‐41. [DOI: 10.1038/sj.ejcn.1602296] CoudrayC , O'ConnorJM , MaianiG , CashmanKD , SimpsonEE , SeckerDL , et al. Introduction to the ZENITH study and summary of baseline results. European Journal of Clinical Nutrition2005;59(Suppl 2):S5‐7. MaylorEA , SimpsonEEA , SeckerDL , MeunierN , Andriollo‐SanchezM , PolitoA , et al. Effects of zinc supplementation on cognitive function in healthy middle‐aged and older adults: the ZENITH study. British Journal of Nutrition2006;96:752‐60. SimpsonEE , MaylorEA , McConvilleC , Stewart‐KnoxB , MeunierN , Andriollo‐SanchezM , et al. Mood and cognition in healthy older European adults: the Zenith study. BMC Psychology2014;2(1):11. SimpsonEE , MaylorEA , RaeG , MeunierN , Andriollo‐SanchezM , CatastaG , et al. Cognitive function in healthy older European adults: the ZENITH study. European Journal of Clinical Nutrition2005;59(2 Suppl 2):S26‐S30. ">Maylor 2006</a>, <a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a>), but only <a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a> with 1072 participants reported usable data. <a href="./references#CD011906-bbs2-0018" title="Andriollo‐SanchezM , Hininger‐FavierI , MeunierN , TotiE , ZaccariaM , Brandolini‐BunlonM , et al. Zinc intake and status in middle‐aged and older European subjects: the ZENITH study. European Journal of Clinical Nutrition2005;59(Suppl 2):S37‐41. [DOI: 10.1038/sj.ejcn.1602296] CoudrayC , O'ConnorJM , MaianiG , CashmanKD , SimpsonEE , SeckerDL , et al. Introduction to the ZENITH study and summary of baseline results. European Journal of Clinical Nutrition2005;59(Suppl 2):S5‐7. MaylorEA , SimpsonEEA , SeckerDL , MeunierN , Andriollo‐SanchezM , PolitoA , et al. Effects of zinc supplementation on cognitive function in healthy middle‐aged and older adults: the ZENITH study. British Journal of Nutrition2006;96:752‐60. SimpsonEE , MaylorEA , McConvilleC , Stewart‐KnoxB , MeunierN , Andriollo‐SanchezM , et al. Mood and cognition in healthy older European adults: the Zenith study. BMC Psychology2014;2(1):11. SimpsonEE , MaylorEA , RaeG , MeunierN , Andriollo‐SanchezM , CatastaG , et al. Cognitive function in healthy older European adults: the ZENITH study. European Journal of Clinical Nutrition2005;59(2 Suppl 2):S26‐S30. ">Maylor 2006</a> was designed to assess cognitive function, but <a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a> was part of a trial whose primary outcome was the effect of supplementation on age‐related macular degeneration. </p> <p> <ul id="CD011906-list-0017"> <li> <p><i>Study design and interventions</i>. <a href="./references#CD011906-bbs2-0018" title="Andriollo‐SanchezM , Hininger‐FavierI , MeunierN , TotiE , ZaccariaM , Brandolini‐BunlonM , et al. Zinc intake and status in middle‐aged and older European subjects: the ZENITH study. European Journal of Clinical Nutrition2005;59(Suppl 2):S37‐41. [DOI: 10.1038/sj.ejcn.1602296] CoudrayC , O'ConnorJM , MaianiG , CashmanKD , SimpsonEE , SeckerDL , et al. Introduction to the ZENITH study and summary of baseline results. European Journal of Clinical Nutrition2005;59(Suppl 2):S5‐7. MaylorEA , SimpsonEEA , SeckerDL , MeunierN , Andriollo‐SanchezM , PolitoA , et al. Effects of zinc supplementation on cognitive function in healthy middle‐aged and older adults: the ZENITH study. British Journal of Nutrition2006;96:752‐60. SimpsonEE , MaylorEA , McConvilleC , Stewart‐KnoxB , MeunierN , Andriollo‐SanchezM , et al. Mood and cognition in healthy older European adults: the Zenith study. BMC Psychology2014;2(1):11. SimpsonEE , MaylorEA , RaeG , MeunierN , Andriollo‐SanchezM , CatastaG , et al. Cognitive function in healthy older European adults: the ZENITH study. European Journal of Clinical Nutrition2005;59(2 Suppl 2):S26‐S30. ">Maylor 2006</a> was a three‐arm, parallel‐group trial with 232 participants which compared two doses of zinc gluconate (15 mg and 30 mg a day) with placebo over six months. This study was eligible for inclusion, but did not report data in sufficient detail for extraction and inclusion in analyses. <a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a> was a four‐arm, parallel group trial in which participants were treated for a median of 6.9 years. For this comparison, we used data from the active intervention arm in which participants were treated with 80 mg of zinc as zinc oxide and 2 mg of copper as cupric oxide. </p> </li> <li> <p><i>Population</i>. The participants in <a href="./references#CD011906-bbs2-0018" title="Andriollo‐SanchezM , Hininger‐FavierI , MeunierN , TotiE , ZaccariaM , Brandolini‐BunlonM , et al. Zinc intake and status in middle‐aged and older European subjects: the ZENITH study. European Journal of Clinical Nutrition2005;59(Suppl 2):S37‐41. [DOI: 10.1038/sj.ejcn.1602296] CoudrayC , O'ConnorJM , MaianiG , CashmanKD , SimpsonEE , SeckerDL , et al. Introduction to the ZENITH study and summary of baseline results. European Journal of Clinical Nutrition2005;59(Suppl 2):S5‐7. MaylorEA , SimpsonEEA , SeckerDL , MeunierN , Andriollo‐SanchezM , PolitoA , et al. Effects of zinc supplementation on cognitive function in healthy middle‐aged and older adults: the ZENITH study. British Journal of Nutrition2006;96:752‐60. SimpsonEE , MaylorEA , McConvilleC , Stewart‐KnoxB , MeunierN , Andriollo‐SanchezM , et al. Mood and cognition in healthy older European adults: the Zenith study. BMC Psychology2014;2(1):11. SimpsonEE , MaylorEA , RaeG , MeunierN , Andriollo‐SanchezM , CatastaG , et al. Cognitive function in healthy older European adults: the ZENITH study. European Journal of Clinical Nutrition2005;59(2 Suppl 2):S26‐S30. ">Maylor 2006</a> were 387 people aged 55 to 87 years. The cognitive inclusion criterion was MMSE &gt; 23, but in fact mean MMSE among participants was &gt; 28 with low variability.The participants in <a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a> were 2166 people with age‐related macular degeneration. Their median age at baseline was 69 years (range 55 to 80 years). There was no baseline cognitive assessment. </p> </li> </ul> </p> </section> <section id="CD011906-sec-0065"> <h5 class="title">Studies of selenium</h5> <p><a href="./references#CD011906-bbs2-0016" title="AbnerE , SchmittF , CabanAH , DennisB , MathewsM , CooperG , et al. Dual cognitive screening for dementia: preliminary case ascertainment in the antioxidant Alzheimer's prevention (PREADVISE) trial. Alzheimer's &amp; Dementia2012;8(4 suppl):P144. [DOI: 10.1016/j.jalz.2012.05.385] KryscioRJ , AbnerEL , Caban‐HoltA , LovellM , GoodmanP , DarkeAK , et al. Association of antioxidant supplement use and dementia in the prevention of Alzheimer's disease by vitamin E and selenium trial (PREADVISE). JAMA Neurology2017;74(5):567‐73. KryscioRJ , AbnerEL , SchmittFA , GoodmanPJ , MendiondoM , Caban‐HoltA , et al. A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE trial. Journal of Nutrition, Health &amp; Aging2013;17(1):72‐5. [PUBMED: 23299383] ">Kryscio 2017</a> (PREADVISE) was a 2 x 2 factorial study of vitamin E and selenium supplements. For this comparison (selenium versus placebo), we considered only the 3711 participants in the selenium only and placebo only groups. The participants who received vitamin E and (vitamin E + selenium) were considered in the antioxidant vitamins versus placebo comparison. This was an ancillary trial to SELECT, the primary aim of which was the prevention of prostate cancer. </p> </section> <section id="CD011906-sec-0066"> <h5 class="title">Studies of supplementation with B vitamin, antioxidant vitamin and mineral combinations ('complex multivitamins') </h5> <p>We included three studies with 6306 participants in which the interventions were supplements which included both B vitamins and antioxidant vitamins, with or without additional minerals (<a href="./references#CD011906-bbs2-0004" title="CockleSM , HallerJ , KimberS , DaweRA , HindmarchI . The influence of multivitamins on cognitive function and mood in the elderly. Aging &amp; Mental Health2000;4:339‐53. ">Cockle 2000</a>, <a href="./references#CD011906-bbs2-0010" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , O'BrienJ , KangJH , DushkesR , CookNR , OkerekeO , et al. Long‐term multivitamin supplementation and cognitive function in men: a randomized trial. Annals of Internal Medicine2013;159:806‐14. ">Grodstein 2013</a>, <a href="./references#CD011906-bbs2-0027" title="WoltersM , HicksteinM , FlintermannA , TewesU , HahnA . Cognitive performance in relation to vitamin status in healthy elderly German women ‐ the effect of 6‐month multivitamin supplementation. Preventive Medicine2005;41:253‐9. ">Wolters 2005</a>). For ease of reference, we called these 'complex multivitamins'. Only the two smaller trials (<a href="./references#CD011906-bbs2-0004" title="CockleSM , HallerJ , KimberS , DaweRA , HindmarchI . The influence of multivitamins on cognitive function and mood in the elderly. Aging &amp; Mental Health2000;4:339‐53. ">Cockle 2000</a>, <a href="./references#CD011906-bbs2-0027" title="WoltersM , HicksteinM , FlintermannA , TewesU , HahnA . Cognitive performance in relation to vitamin status in healthy elderly German women ‐ the effect of 6‐month multivitamin supplementation. Preventive Medicine2005;41:253‐9. ">Wolters 2005</a>, combined n = 359) were designed to assess cognition. </p> <p> <ul id="CD011906-list-0018"> <li> <p><i>Study design</i>. <a href="./references#CD011906-bbs2-0004" title="CockleSM , HallerJ , KimberS , DaweRA , HindmarchI . The influence of multivitamins on cognitive function and mood in the elderly. Aging &amp; Mental Health2000;4:339‐53. ">Cockle 2000</a> and <a href="./references#CD011906-bbs2-0027" title="WoltersM , HicksteinM , FlintermannA , TewesU , HahnA . Cognitive performance in relation to vitamin status in healthy elderly German women ‐ the effect of 6‐month multivitamin supplementation. Preventive Medicine2005;41:253‐9. ">Wolters 2005</a> were small, two‐arm, placebo‐controlled, parallel group studies lasting 24 weeks and six months respectively. <a href="./references#CD011906-bbs2-0010" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , O'BrienJ , KangJH , DushkesR , CookNR , OkerekeO , et al. Long‐term multivitamin supplementation and cognitive function in men: a randomized trial. Annals of Internal Medicine2013;159:806‐14. ">Grodstein 2013</a> reported the multivitamin data from a cognitive substudy (n = 5947) of the large Physicians' Health Study II (PHS‐II), which is described under 'antioxidant vitamins' above. It had a 2 x 2 x 2 x 2 factorial design. The mean time from randomisation to first cognitive assessment was 2.5 years (range 0.18 to 5.3 years) and to final cognitive assessment 8.5 years (range 0.3 to 14.2 years). </p> </li> </ul> <ul id="CD011906-list-0019"> <li> <p><i>Interventions</i>. </p> <ul id="CD011906-list-0020"> <li> <p>In <a href="./references#CD011906-bbs2-0004" title="CockleSM , HallerJ , KimberS , DaweRA , HindmarchI . The influence of multivitamins on cognitive function and mood in the elderly. Aging &amp; Mental Health2000;4:339‐53. ">Cockle 2000</a>, the daily dose of the experimental intervention contained: vitamin A palmitate 3334 IU, thiamine mononitrate (B1) 14 mg, riboflavin (B2) 16 mg, pyridoxine (B6) 22 mg, vitamin B12 0.03 mg, vitamin C 600 mg, dl‐alpha‐tocopherol acetate (vitamin E) 100 mg, folic acid 4 mg, d‐biotin 2 mg and nicotinamide 180 mg. The authors stated that "[t]he dosing was calculated to provide the equivalent of one US RDA (National Research Council, 1980) of vitamin A and ten US RDAs of the remaining vitamins." The study was planned to last for 48 weeks, but due to very high dropout after week 24, no data were reported after 24 weeks. </p> </li> <li> <p>In <a href="./references#CD011906-bbs2-0010" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , O'BrienJ , KangJH , DushkesR , CookNR , OkerekeO , et al. Long‐term multivitamin supplementation and cognitive function in men: a randomized trial. Annals of Internal Medicine2013;159:806‐14. ">Grodstein 2013</a>, the experimental intervention was Centrum Silver ® (Pfizer). Its composition is shown in <a href="./appendices#CD011906-sec-0190">Appendix 4</a>. </p> </li> <li> <p>In <a href="./references#CD011906-bbs2-0027" title="WoltersM , HicksteinM , FlintermannA , TewesU , HahnA . Cognitive performance in relation to vitamin status in healthy elderly German women ‐ the effect of 6‐month multivitamin supplementation. Preventive Medicine2005;41:253‐9. ">Wolters 2005</a>, the experimental intervention was Nobilin Q10 ® (Medicom Pharma) providing daily doses of 150 mg vitamin C (calcium ascorbate), 50 mg magnesium (magnesium carbonate), 36 mg vitamin E (D‐ alfa‐tocopherol acetate), 34 mg niacin (nicotinamide), 16 mg pantothenic acid, 9 mg ß‐carotene, 3.4 mg pyridoxine (pyridoxine hydrochloride), 3.2 mg riboflavin, 2.4 mg thiamine (thiamine mononitrate), 400 µg folic acid (pteroyl glutamic acid), 200 µg biotin, 60 µg selenium (selenium‐enriched yeast), and 9 µg cobalamin (cyanocobalamin). </p> </li> </ul> </li> </ul> <ul id="CD011906-list-0021"> <li> <p><i>Population</i>. </p> <ul id="CD011906-list-0022"> <li> <p><a href="./references#CD011906-bbs2-0004" title="CockleSM , HallerJ , KimberS , DaweRA , HindmarchI . The influence of multivitamins on cognitive function and mood in the elderly. Aging &amp; Mental Health2000;4:339‐53. ">Cockle 2000</a> randomised 139 participants, <a href="./references#CD011906-bbs2-0010" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , O'BrienJ , KangJH , DushkesR , CookNR , OkerekeO , et al. Long‐term multivitamin supplementation and cognitive function in men: a randomized trial. Annals of Internal Medicine2013;159:806‐14. ">Grodstein 2013</a> randomised 5947, and <a href="./references#CD011906-bbs2-0027" title="WoltersM , HicksteinM , FlintermannA , TewesU , HahnA . Cognitive performance in relation to vitamin status in healthy elderly German women ‐ the effect of 6‐month multivitamin supplementation. Preventive Medicine2005;41:253‐9. ">Wolters 2005</a> reported results for 220 (not clear how many were randomised). </p> </li> <li> <p><a href="./references#CD011906-bbs2-0027" title="WoltersM , HicksteinM , FlintermannA , TewesU , HahnA . Cognitive performance in relation to vitamin status in healthy elderly German women ‐ the effect of 6‐month multivitamin supplementation. Preventive Medicine2005;41:253‐9. ">Wolters 2005</a> included women only and <a href="./references#CD011906-bbs2-0010" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , O'BrienJ , KangJH , DushkesR , CookNR , OkerekeO , et al. Long‐term multivitamin supplementation and cognitive function in men: a randomized trial. Annals of Internal Medicine2013;159:806‐14. ">Grodstein 2013</a> included men only. </p> </li> <li> <p>The participants in <a href="./references#CD011906-bbs2-0004" title="CockleSM , HallerJ , KimberS , DaweRA , HindmarchI . The influence of multivitamins on cognitive function and mood in the elderly. Aging &amp; Mental Health2000;4:339‐53. ">Cockle 2000</a> had a mean MMSE at baseline of 28.8 ± 1.5 years. There was no baseline cognitive assessment in <a href="./references#CD011906-bbs2-0010" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , O'BrienJ , KangJH , DushkesR , CookNR , OkerekeO , et al. Long‐term multivitamin supplementation and cognitive function in men: a randomized trial. Annals of Internal Medicine2013;159:806‐14. ">Grodstein 2013</a>. In <a href="./references#CD011906-bbs2-0027" title="WoltersM , HicksteinM , FlintermannA , TewesU , HahnA . Cognitive performance in relation to vitamin status in healthy elderly German women ‐ the effect of 6‐month multivitamin supplementation. Preventive Medicine2005;41:253‐9. ">Wolters 2005</a>, baseline cognitive assessment supported the authors' assertion that subjects were cognitively healthy. </p> </li> <li> <p>The age of participants at baseline was median 63 years in <a href="./references#CD011906-bbs2-0027" title="WoltersM , HicksteinM , FlintermannA , TewesU , HahnA . Cognitive performance in relation to vitamin status in healthy elderly German women ‐ the effect of 6‐month multivitamin supplementation. Preventive Medicine2005;41:253‐9. ">Wolters 2005</a>, median 70 years in <a href="./references#CD011906-bbs2-0004" title="CockleSM , HallerJ , KimberS , DaweRA , HindmarchI . The influence of multivitamins on cognitive function and mood in the elderly. Aging &amp; Mental Health2000;4:339‐53. ">Cockle 2000</a> and mean 72 years in <a href="./references#CD011906-bbs2-0010" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , O'BrienJ , KangJH , DushkesR , CookNR , OkerekeO , et al. Long‐term multivitamin supplementation and cognitive function in men: a randomized trial. Annals of Internal Medicine2013;159:806‐14. ">Grodstein 2013</a>. </p> </li> </ul> </li> </ul> </p> </section> </section> <section id="CD011906-sec-0067"> <h4 class="title">Excluded studies</h4> <p>Forty‐five studies were excluded (See <a href="./references#CD011906-sec-0200" title="">Characteristics of excluded studies</a>). Studies were excluded if they did not meet the inclusion criteria relating to: population (<a href="./references#CD011906-bbs2-0030" title="ACTRN12607000321448 . Vitamin D and Cognition Trial [Vitamin D and Cognition Trial (VITA‐D). A randomised, placebo controlled trial of vitamin D in older adults with mild cognitive impairment and low vitamin D concentration to prevent cognitive decline and delay progression of cognitive decline]. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=82086 (first received 13 June 2007). ">ACTRN12607000321448</a>, <a href="./references#CD011906-bbs2-0031" title="AlaviN , ElmadfaI , DjazayeryA , BarekatainM , AghayeG , DjalaliM , et al. The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double‐blind, randomized, placebo‐controlled trial. European Journal of Nutrition2014;53:1255‐62. ">Alavi 2014</a>, <a href="./references#CD011906-bbs2-0033" title="Anonymous . Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. Journal of Internal Medicine2003;354:67‐75. ">Anonymous 2003</a>, <a href="./references#CD011906-bbs2-0035" title="BentonD , FordyJ , HallerJ . The impact of long‐term vitamin supplementation on cognitive functioning. Psychopharmacology1995;117:298‐305. ">Benton 1995</a>, <a href="./references#CD011906-bbs2-0040" title="CorlessD , EllisM , DawsonE , FraserF , EvansS , PerryJD , et al. Using activities of daily living assessments to measure the effectiveness of vitamin D supplements in elderly long‐stay patients. British Journal of Occupational Therapy1987;50:60‐2. ">Corless 1987</a>, <a href="./references#CD011906-bbs2-0041" title="DeJagerCA , OulhajA , JacobyR , RefsumH , SmithAD . Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry2012;27:592‐600. DouaudG , RefsumH , DeJagerCA , JacobyR , NicholsTE , SmithSM , et al. Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment. PNAS Proceedings of the National Academy of Sciences of the United States of America2013;110:9523‐8. SmithAD , SmithSM , DeJagerCA , WhitbreadP , JohnstonC , AgacinskiG , et al. Homocysteine‐lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLOS One2010;5:e12244. ">De Jager 2012</a>, <a href="./references#CD011906-bbs2-0043" title="FlickerL , GreenopK , AlmeidaO , BeerC , HillK , NowsonC , et al. Effect of vitamin d supplementation on cognitive function in older adults with mild cognitive impairment ‐ a randomized trial. Journal of bone and mineral research2011;26(1 suppl):S244. [DOI: 10.1111/j.1741‐6612.2010.00523a.x] ">Flicker 2011</a>, <a href="./references#CD011906-bbs2-0046" title="HvasAM , JuulS , LauritzenL , NexoE , EllegaardJ . No effect of vitamin B‐12 treatment on cognitive function and depression: a randomized placebo controlled study. Journal of Affective Disorders2004;81:269‐73. ">Hvas 2004</a>, <a href="./references#CD011906-bbs2-0047" title="ImaokaM , HiguchiY , TodoE , KitagwaT , UedaT . Low‐frequency exercise and vitamin D supplementation reduce falls among institutionalized frail elderly. International Journal of Gerontology2016;10:202‐6. ">Imaoka 2016</a>, <a href="./references#CD011906-bbs2-0048" title="KrikorianR , EliassenJC , BoespflugEL , NashTA , ShidlerMD . Improved cognitive‐cerebral function in older adults with chromium supplementation. Nutritional Neuroscience2010;13:116‐22. ">Krikorian 2010</a>, <a href="./references#CD011906-bbs2-0049" title="KwokT , LeeJ , MaR , WongS , KungK , LamA , et al. A randomized placebo controlled trial of vitamin B12 supplementation to prevent cognitive decline in older diabetic people with borderline low serum vitamin B12. Clinical Nutrition2017;36(6):1509‐15. [DOI: 10.1016/j.clnu.2016.10.018] ">Kwok 2017</a>, <a href="./references#CD011906-bbs2-0050" title="LiY , LiuS , ManY , LiN , ZhouY . Effects of vitamins E and C combined with beta‐carotene on cognitive function in the elderly. Experimental and Therapeutic Medicine2015;9(4):1489‐93. MaA , LiY , HanX , SunY . Effect of beta‐carotene, vitamin E and ascorbic acid supplementation on improving cognitive function in the old people. FASEB Journal2007;21(6):A1072. ">Li 2015</a>, <a href="./references#CD011906-bbs2-0053" title="MacphersonH , EllisKA , SaliA , PipingasA . Memory improvements in elderly women following 16 weeks treatment with a combined multivitamin, mineral and herbal supplement: a randomized controlled trial. Psychopharmacology2012;220:351‐65. MacphersonH , PipingasA , EllisK . Can taking a daily multivitamin improve cognitive performance in the elderly? Evidence from a steady state visually evoked potential investigation of memory in elderly women. International Journal of Psychophysiology2010;77:239‐87. ">Macpherson 2012</a>, <a href="./references#CD011906-bbs2-0057" title="Murray‐KolbLE , WengerMJ , VenkatramananS , MarquisGS , WesleyAS , HaasJD . Effects of double‐fortified salt on perceptual and cognitive performance in women. FASEB Journal2011;25(1 suppl):238.6. ">Murray‐Kolb 2011</a>, <a href="./references#CD011906-bbs2-0058" title="NCT00903695 . MemoryXL effects on mild cognitive impairment patients [Nutriceutical effects on cognitive status in mild cognitive impairment patients]. clinicaltrials.gov/show/NCT00903695 (first received 18 May 2009). ">NCT00903695</a>, <a href="./references#CD011906-bbs2-0061" title="NCT02185222 . Effect of vitamin D on cognitive decline of patients with memory complaint (D‐COG) [Effect of vitamin D on cognitive decline of patients with memory complaint]. clinicaltrials.gov/show/NCT02185222 (first received 9 July 2014). ">NCT02185222</a>, <a href="./references#CD011906-bbs2-0067" title="PetersenRC , ThomasRG , GrundmanM , BennettD , DoodyR , FerrisS , et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. New England Journal of Medicine2005;352:2379‐88, 2465. ">Petersen 2005</a>, <a href="./references#CD011906-bbs2-0072" title="SmithA , ClarkR , NuttD , HallerJ , HaywardS , PerryK . Anti‐oxidant vitamins and mental performance of the elderly. Human Psychopharmacology1999;14:459‐71. ">Smith 1999</a>, <a href="./references#CD011906-bbs2-0074" title="VanUffelenJG , ChinapawMJ , Hopman‐RockM , VanMechelenW . The effect of walking and vitamin B supplementation on quality of life in community‐dwelling adults with mild cognitive impairment: a randomized, controlled trial. Quality of Life Research2007;16:1137‐46. VanUffelenJG , ChinapawMJ , VanMechelenW , Hopman‐RockM . Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. British Journal of Sports Medicine2008;42(5):344‐51. ">Van Uffelen 2007</a>), outcomes (<a href="./references#CD011906-bbs2-0029" title="AbbasiB , KimiagarM , ShahidiS , ShiraziMM , SadeghniiatK , PayabM , et al. Effect of magnesium supplementation on mental health in elderly subjects with insomnia: a double‐blind randomized clinical trial. Iranian Journal of Psychiatry and Clinical Psychology2013;19:9‐19. ">Abbasi 2013</a>, <a href="./references#CD011906-bbs2-0044" title="FordAH , FlickerL , ThomasJ , NormanP , JamrozikK , AlmeidaOP . Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2‐year placebo‐controlled randomized trial. Journal of Clinical Psychiatry2008;69:1203‐9. ">Ford 2008</a>, <a href="./references#CD011906-bbs2-0056" title="MillerB , WhisnerC , JohnstonC . Vitamin D supplementation appears to increase plasma Aβ40 in vitamin D insufficient older adults: a pilot randomized controlled trial. Journal of Alzheimer's Disease2016;52:843‐7. ">Miller 2016</a>, <a href="./references#CD011906-bbs2-0062" title="NCT02467153 . Vitamin D and resistance exercise training; effects on musculoskeletal health in frail older men and women (EXVITD) [Influence of combined vitamin D supplementation and resistance exercise training on musculoskeletal health in frail older men and women (EXVITD)]. clinicaltrials.gov/show/NCT02467153 (first received 9 June 2015). ">NCT02467153</a>), intervention (<a href="./references#CD011906-bbs2-0034" title="ArwertLI , DeijenJB , DrentML . Effects of an oral mixture containing glycine, glutamine and niacin on memory, GH and IGF‐I secretion in middle‐aged and elderly subjects. Nutritional Neuroscience2003;6:269‐75. ">Arwert 2003</a>, <a href="./references#CD011906-bbs2-0036" title="BryanJ , CalvaresiE , HughesD . Short‐term folate, vitamin B‐12 or vitamin B‐6 supplementation slightly affects memory performance but not mood in women of various ages. Journal of Nutrition2002;132:1345‐56. ">Bryan 2002</a>, <a href="./references#CD011906-bbs2-0037" title="ChanA , RemingtonR , KotylaE , LeporeA , ZemianekJ , SheaTB . A vitamin/nutriceutical formulation improves memory and cognitive performance in community‐dwelling adults without dementia. Journal of Nutrition, Health &amp; Aging2010;14:224‐30. ">Chan 2010</a>, <a href="./references#CD011906-bbs2-0039" title="ChewEY , ClemonsTE , AgrónE , LaunerLJ , GrodsteinF , BernsteinPS , et al. Effect of Omega‐3 fatty acids, Lutein/Zeaxanthin, or other nutrient supplementation on cognitive function: the AREDS2 randomized clinical trial. JAMA2015;314(8):791‐801. [DOI: 10.1001/jama.2015.9677] ">Chew 2015</a>; <a href="./references#CD011906-bbs2-0042" title="DhesiJ , JacksonS , BearneL , MonizC , HurleyM , SwiftCG , et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age and Ageing2004;33(6):589‐95. ">Dhesi 2004</a>, <a href="./references#CD011906-bbs2-0045" title="HarrisE , MacphersonH , PipingasA . Improved blood biomarkers but no cognitive effects from 16 weeks of multivitamin supplementation in healthy older adults. Nutrients2015;7:3796‐812. ">Harris 2015</a>, <a href="./references#CD011906-bbs2-0059" title="NCT01095211 . B‐vitamins treatment for improvement of cognitive function [Effect of B‐vitamins on cognitive function in elderly people]. clinicaltrials.gov/show/NCT01095211 (first received 30 March 2010). ">NCT01095211</a>, <a href="./references#CD011906-bbs2-0060" title="NCT01708005 . Dietary supplements, executive functions and vitamin D (DIET‐D) [Dietary supplements, executive functions and vitamin D (DIET‐D): a double‐blind randomized controlled trial]. clinicaltrials.gov/show/NCT01708005 (first received 16 October 2012). ">NCT01708005</a>, <a href="./references#CD011906-bbs2-0063" title="NgT , NyuntM , FengL , FengL , NitiM , TanBY , et al. Multi‐domain lifestyle interventions reduces depressive symptoms among frail and pre‐frail older persons: randomized controlled trial. Journal of Nutrition, Health &amp; Aging2017;21(8):918‐26. [DOI: 10.1007/s12603‐016‐0867‐y] ">Ng 2017</a>, <a href="./references#CD011906-bbs2-0064" title="OngA , WeilerH , WallM , HaddadR , GorguiJ , DaskalopoulouSS , et al. Feasibility of a clinical trial to assess the effect of dietary calcium v. supplemental calcium on vascular and bone markers in healthy postmenopausal women. British Journal of Nutrition2016;116:104‐14. ">Ong 2016</a>, <a href="./references#CD011906-bbs2-0065" title="PaseMP , GrimaN , CockerellR , StoughC , ScholeyA , SaliA , et al. The effects of long‐chain Omega‐3 fish oils and multivitamins on cognitive and cardiovascular function: a randomized, controlled clinical trial. Journal of the American College of Nutrition2015;34:21‐31. ">Pase 2015</a>, <a href="./references#CD011906-bbs2-0066" title="PathansaliR , MangoniAA , Creagh‐BrownB , LanZC , NgowGL , YuanXF , et al. Effects of folic acid supplementation on psychomotor performance and hemorheology in healthy elderly subjects. Archives of Gerontology and Geriatrics2006;43:127‐37. ">Pathansali 2006</a>, <a href="./references#CD011906-bbs2-0068" title="PettersenJ . Does high dose vitamin D supplementation enhance cognition?: a randomized trial in healthy adults. Experimental Gerontology2017;90:90‐7. ">Pettersen 2017</a>, <a href="./references#CD011906-bbs2-0071" title="SchietzelS , BruggerP , FischerK , MeyerO , FreystaetterG , MeyerS , et al. Effect of high dose vitamin D on cognitive performance in healthy seniors ‐ a randomized controlled trial. European Geriatric Medicine2016;7(Suppl 1):71. ">Schietzel 2016</a>, <a href="./references#CD011906-bbs2-0073" title="SummersWK , MartinRL , CunninghamM , DeboyntonVL , MarshGM . Complex antioxidant blend improves memory in community‐dwelling seniors. Journal of Alzheimer's Disease2010;19:429‐39. ">Summers 2010</a>, <a href="./references#CD011906-bbs2-0075" title="Wouters‐WesselingW , WagenaarLW , RozendaalM , DeijenJB , DeGrootLC , BindelsJG , et al. Effect of an enriched drink on cognitive function in frail elderly persons. Journals of Gerontology2005;60A:265‐70. ">Wouters‐Wesseling 2005</a>), or study design (<a href="./references#CD011906-bbs2-0038" title="ChengD , KongH , PangW , YangH , LuH , HuangC , et al. B vitamin supplementation improves cognitive function in the middle aged and elderly with hyperhomocysteinaemia. Nutritional Neuroscience2016;19(10):461‐6. ">Cheng 2016</a>, <a href="./references#CD011906-bbs2-0069" title="QuickM , KieferD . Calcium plus vitamin D supplementation and cognitive decline in women. Integrative Medicine Alert2013;16:30‐4. ">Quick 2013</a>, <a href="./references#CD011906-bbs2-0070" title="RietsemaWJ . Unexpected recovery of moderate cognitive impairment on treatment with oral methylcobalamin. Journal of the American Geriatrics Society2014;62:1611‐2. ">Rietsema 2014</a>). One study was withdrawn prior to enrolment (<a href="./references#CD011906-bbs2-0051" title="LiuX , ShiM , XiaF , HanJ , LiuZ , WangB , et al. The China Stroke Secondary Prevention Trial (CSSPT) protocol: a double‐blinded, randomized, controlled trial of combined folic acid and B vitamins for secondary prevention of stroke. International Journal of Stroke2015;10:264‐8. ">Liu 2015</a>). <a href="./references#CD011906-bbs2-0054" title="ManiamJ , KrishnaswamyS , MohameJ . Randomized double blind placebo controlled human clinical trial investigating effect of 1200iu a‐tocopherol on lipid peroxidation, antioxidant status and cognitive function of elderly. Free Radical Biology &amp; Medicine2004;36:S146. ">Maniam 2004</a> was a potentially eligible RCT described in an abstract published in 2004, but we were unable to identify any related full report. Some of the studies were excluded in this review, but were included in the Cochrane review on vitamin and mineral supplementation in people with mild cognitive impairment (<a href="./references#CD011906-bbs2-0124" title="McCleeryJ , AbrahamRP , DentonDA , RutjesAW , ChongLY , Al‐AssafAS , et al. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. Cochrane Database of Systematic Reviews2018, Issue 11. [DOI: 10.1002/14651858.CD011905.pub2] ">McCleery 2018</a>). </p> </section> </section> <section id="CD011906-sec-0068"> <h3 class="title">Risk of bias in included studies</h3> <p>Our judgments about the risks of bias in the included studies are detailed in the <a href="./references#CD011906-sec-0199" title="">Characteristics of included studies</a> tables and shown graphically in <a href="#CD011906-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD011906-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011906-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011906-sec-0069"> <h4 class="title">Allocation</h4> <p>Overall, selection bias was not a major concern. We judged all studies to be at low or unclear risk of bias in this domain. In a number of papers, our judgment was 'unclear' because there was a lack of detail given about the allocation methods used, but in some cases these were large, multicentre studies in which the methods of random sequence generation and allocation concealment were likely to have been adequate. </p> </section> <section id="CD011906-sec-0070"> <h4 class="title">Blinding</h4> <p>One study (<a href="./references#CD011906-bbs2-0001" title="AnandVPR , KumarBJ , VargheseJM , DasSK . Supplementation of vitamin E improves cognitive status and oxidative stress in type 2 diabetes mellitus. International Research Journal of Pharmacy2011;2:169‐72. ">Anand 2011</a>) was explicitly an open‐label study and we therefore considered it to be at high risk of performance and detection bias. All other studies were described by their authors as being double‐blind, although again there was, in some cases, a lack of reporting of the methods used to ensure blinding, especially of outcome assessment. In most cases, the experimental intervention and placebo were described as being identical. We judged all studies other than Anand 2011 to be at either low or unclear risk of bias in these domains. </p> </section> <section id="CD011906-sec-0071"> <h4 class="title">Incomplete outcome data</h4> <p>Incomplete outcome data posed a significant risk of bias to the longer‐term results. For some studies (<a href="./references#CD011906-bbs2-0008" title="FordAH , FlickerL , AlfonsoH , ThomasJ , ClarnetteR , MartinsR , et al. Vitamins B(12), B(6), and folic acid for cognition in older men. Neurology2010;75:1540‐7. FordAH , FlickerL , AlfonsoH , ThomasJ , ClarnetteR , MartinsR , et al. Vitamins B12, B6, and folic acid for cognition in older men: correction. Neurology2011;77:804. ">Ford 2010</a>, <a href="./references#CD011906-bbs2-0010" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , O'BrienJ , KangJH , DushkesR , CookNR , OkerekeO , et al. Long‐term multivitamin supplementation and cognitive function in men: a randomized trial. Annals of Internal Medicine2013;159:806‐14. ">Grodstein 2013</a>, <a href="./references#CD011906-bbs2-0013" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookN , MansonJ , BuringJE , AlbertCM , GrodsteinF . A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. American Journal of Clinical Nutrition2008;88:1602‐10. MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al. WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2008</a>), we judged the risk to be low or unclear for shorter‐term outcomes, but high for longer‐term outcomes when there had been greater loss of participants to follow‐up. </p> </section> <section id="CD011906-sec-0072"> <h4 class="title">Selective reporting</h4> <p>The included studies had a variety of primary outcomes, In a number of large studies, cognitive outcomes were not specified in protocols, but were added at a later stage. However, in these cases, simple cognitive measures were generally used and were reported. We judged five studies to be at high risk of selective reporting bias. <a href="./references#CD011906-bbs2-0004" title="CockleSM , HallerJ , KimberS , DaweRA , HindmarchI . The influence of multivitamins on cognitive function and mood in the elderly. Aging &amp; Mental Health2000;4:339‐53. ">Cockle 2000</a> did not report all the relevant outcomes described in the Methods section of the paper. <a href="./references#CD011906-bbs2-0018" title="Andriollo‐SanchezM , Hininger‐FavierI , MeunierN , TotiE , ZaccariaM , Brandolini‐BunlonM , et al. Zinc intake and status in middle‐aged and older European subjects: the ZENITH study. European Journal of Clinical Nutrition2005;59(Suppl 2):S37‐41. [DOI: 10.1038/sj.ejcn.1602296] CoudrayC , O'ConnorJM , MaianiG , CashmanKD , SimpsonEE , SeckerDL , et al. Introduction to the ZENITH study and summary of baseline results. European Journal of Clinical Nutrition2005;59(Suppl 2):S5‐7. MaylorEA , SimpsonEEA , SeckerDL , MeunierN , Andriollo‐SanchezM , PolitoA , et al. Effects of zinc supplementation on cognitive function in healthy middle‐aged and older adults: the ZENITH study. British Journal of Nutrition2006;96:752‐60. SimpsonEE , MaylorEA , McConvilleC , Stewart‐KnoxB , MeunierN , Andriollo‐SanchezM , et al. Mood and cognition in healthy older European adults: the Zenith study. BMC Psychology2014;2(1):11. SimpsonEE , MaylorEA , RaeG , MeunierN , Andriollo‐SanchezM , CatastaG , et al. Cognitive function in healthy older European adults: the ZENITH study. European Journal of Clinical Nutrition2005;59(2 Suppl 2):S26‐S30. ">Maylor 2006</a> did not report results in sufficient detail for inclusion in analyses. <a href="./references#CD011906-bbs2-0023" title="StottDJ , MacIntoshG , LoweGD , RumleyA , McMahonAD , LanghorneP , et al. Randomized controlled trial of homocysteine‐lowering vitamin treatment in elderly patients with vascular disease. American Journal of Clinical Nutrition2005;82(6):1320‐6. [PUBMED: 16332666] ">Stott 2005</a> mentioned functional outcomes in the trial registry entry which were not reported in the paper. <a href="./references#CD011906-bbs2-0024" title="SpenceJD , HowardVJ , ChamblessLE , MalinowMR , PettigrewLC , StampferM , et al. Vitamin Intervention for stroke prevention (VISP) trial: rationale and design. Neuroepidemiology2001;20(1):16‐25. TooleJF , MalinowMR , ChamblessLE , SpenceJD , PettigrewLC , HowardVJ , et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death. JAMA2004;291:565‐75. ">Toole 2004</a> reported MMSE scores at 12 months but without the number of participants in each group, so we could not include the data in meta‐analysis, and did not report the MMSE data at 24 months. <a href="./references#CD011906-bbs2-0026" title="NCT00214682 . Beyond Ageing Project: a study for the prevention of depression [Beyond Ageing Project: a RCT to assess the benefit of improving mental health literacy as well as the effect of folate and B12, and physical activity, in preventing major depression and cognitive decline among older Australians]. clinicaltrials.gov/show/NCT00214682 (first received 22 September 2005). WalkerJG , BatterhamPJ , MackinnonAJ , JormAF , HickieI , FenechM , et al. Oral folic acid and vitamin B‐12 supplementation to prevent cognitive decline in community‐dwelling older adults with depressive symptoms ‐ the Beyond Ageing Project: a randomized controlled trial. American Journal of Clinical Nutrition2012;95(1):194‐203. [PUBMED: 22170358] WalkerJG , MackinnonAJ , BatterhamP , JormAF , HickieI , McCarthyA , et al. Mental health literacy, folic acid and vitamin B12, and physical activity for the prevention of depression in older adults: randomised controlled trial. British Journal of Psychiatry2010;197(1):45‐54. ">Walker 2012</a> did not report all outcomes in sufficient detail for inclusion. </p> </section> <section id="CD011906-sec-0073"> <h4 class="title">Other potential sources of bias</h4> <p>We identified no high risks of bias due to other factors.</p> </section> </section> <section id="CD011906-sec-0074"> <h3 class="title" id="CD011906-sec-0074">Effects of interventions</h3> <p>See: <a href="./full#CD011906-tbl-0001"><b>Summary of findings for the main comparison</b> B vitamins compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</a>; <a href="./full#CD011906-tbl-0002"><b>Summary of findings 2</b> Antioxidants compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</a>; <a href="./full#CD011906-tbl-0003"><b>Summary of findings 3</b> Vitamin D3 compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</a>; <a href="./full#CD011906-tbl-0004"><b>Summary of findings 4</b> Zinc + copper compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</a>; <a href="./full#CD011906-tbl-0005"><b>Summary of findings 5</b> Complex multivitamin compared to control for maintaining cognitive function in cognitively healthy people in mid and late life</a> </p> <p>The minimum clinically important difference on cognitive tests for healthy participants in prevention trials is unknown and is likely to vary with the age of participants and the duration of follow‐up. We are therefore unable to judge the likely clinical importance of differences detected on any cognitive test. When describing the results, we refer to a difference between groups when P &lt; 0.05. </p> <section id="CD011906-sec-0075"> <h4 class="title">B vitamins</h4> <p>We compared B vitamins to placebo at four time points: 3‐12 months of treatment, &gt; 1‐2 years, &gt; 2‐5 years and &gt; 5‐10 years. </p> <p>Some studies did not assess cognitive function at baseline and reported final measurement data. Some studies reported only change from baseline data. Because we were pooling outcomes measured with a variety of instruments, we used standardised mean differences and therefore pooled final measurement and change from baseline data separately. </p> <p>Negative SMDs favoured B vitamins; positive SMDs favoured placebo.</p> <section id="CD011906-sec-0076"> <h5 class="title">Overall cognitive function</h5> <p>See <a href="#CD011906-fig-0003">Figure 3</a>; <a href="./references#CD011906-fig-0006" title="">Analysis 1.1</a> </p> <div class="figure" id="CD011906-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 B vitamins versus control, outcome: 1.1 Overall cognitive functioning." data-id="CD011906-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 B vitamins versus control, outcome: 1.1 Overall cognitive functioning. </p> </div> </div> </div> <section id="CD011906-sec-0077"> <h6 class="title">3‐12 months of supplementation:</h6> <p>Three studies providing final measurement data showed that there is probably no effect of B vitamins on overall cognitive function (SMD 0.00, 95% CI ‐0.08 to 0.08, n = 2556; moderate‐certainty evidence). A fourth study (<a href="./references#CD011906-bbs2-0024" title="SpenceJD , HowardVJ , ChamblessLE , MalinowMR , PettigrewLC , StampferM , et al. Vitamin Intervention for stroke prevention (VISP) trial: rationale and design. Neuroepidemiology2001;20(1):16‐25. TooleJF , MalinowMR , ChamblessLE , SpenceJD , PettigrewLC , HowardVJ , et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death. JAMA2004;291:565‐75. ">Toole 2004</a>) also provided final measurement MMSE data on 3097 participants, but did not report the number of participants in each intervention group; it reported no significant difference between groups (P = 0.19). Two smaller studies providing change from baseline data confirmed that there may be no effect of B vitamins (SMD ‐0.03, 95% CI ‐0.26 to 0.19, n = 317; low‐certainty evidence). </p> </section> <section id="CD011906-sec-0078"> <h6 class="title">&gt; 1‐2 years of supplementation:</h6> <p>Five studies providing final measurement data showed that there is probably no effect of B vitamins (SMD ‐0.01, 95% CI ‐0.08 to 0.06, n = 6956; moderate‐certainty evidence). One study reporting only change from baseline data similarly showed that there may be no effect of B vitamins (SMD 0.06, 95% CI ‐0.20 to 0.31, n = 241; low‐certainty evidence). </p> </section> <section id="CD011906-sec-0079"> <h6 class="title">&gt; 2‐5 years of supplementation:</h6> <p>Four studies provided final measurement data and suggested that there is probably no effect of B vitamins (SMD ‐0.01, 95% CI ‐0.11 to 0.09, n = 3985; moderate‐certainty evidence). </p> </section> <section id="CD011906-sec-0080"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p>Three studies contributed data to this comparison; low‐certainty evidence indicated that there may be no effect of B vitamins (SMD ‐0.01, 95% CI ‐0.09 to 0.07, n = 10249). </p> </section> </section> <section id="CD011906-sec-0081"> <h5 class="title">Episodic memory</h5> <p>See <a href="./references#CD011906-fig-0007" title="">Analysis 1.2</a> </p> <section id="CD011906-sec-0082"> <h6 class="title">3‐12 months of supplementation:</h6> <p>Four studies providing final measurement data showed that B vitamins probably have no effect on episodic memory (SMD 0.02, ‐0.08 to 0.12, n = 1442; moderate‐certainty evidence). Two studies providing change from baseline data confirmed that there may be no effect (SMD 0.04, 95% CI ‐0.15 to 0.23, n = 430; low‐certainty evidence). </p> </section> <section id="CD011906-sec-0083"> <h6 class="title">&gt; 1‐2 years of supplementation:</h6> <p>Four studies providing final measurement data suggested there may be no effect of treatment (SMD 0.05, 95% CI ‐0.03 to 0.13, n = 5626; low‐certainty evidence). The one study providing only change from baseline data on this outcome confirmed an absence of effect (SMD 0.06, 95% CI ‐0.19 to 0.32, n = 241; low‐certainty evidence). </p> </section> <section id="CD011906-sec-0084"> <h6 class="title">&gt; 2‐5 years of supplementation:</h6> <p>Three studies providing final measurement data suggested there may be no effect of treatment (SMD ‐0.05, 95% CI ‐0.15 to 0.05, n = 3523; low‐certainty evidence). </p> </section> <section id="CD011906-sec-0085"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p>From one study, there was low‐certainty evidence that there may be little or no effect of treatment (SMD ‐0.10, 95% CI ‐0.22 to 0.02, n = 1053). </p> </section> </section> <section id="CD011906-sec-0086"> <h5 class="title">Executive function</h5> <p>See <a href="./references#CD011906-fig-0008" title="">Analysis 1.3</a> </p> <section id="CD011906-sec-0087"> <h6 class="title">3‐12 months of supplementation:</h6> <p>From three studies providing final measurement data, the effect estimate slightly favoured placebo, but there was uncertainty about the size and direction of the effect (SMD 0.14, 95% CI ‐0.18 to 0.46, n = 536). A single study providing change from baseline data also favoured placebo, but the certainty of this evidence was very low (SMD 0.39, 95% CI 0.07 to 0.71, n = 171). </p> </section> <section id="CD011906-sec-0088"> <h6 class="title">&gt; 1‐2 years of supplementation:</h6> <p>Very low‐certainty evidence from three studies providing final measurement data suggested no effect of treatment (SMD ‐0.01, 95% CI ‐0.15 to 0.13, n = 2976). There was inconsistency in this analysis in which one study (<a href="./references#CD011906-bbs2-0019" title="Anonymous . Homocysteine and cognitive function in healthy elderly people. Brown University Geriatric Psychopharmacology Update2006;10(11):4‐5. CacabelosR . Homocysteine and cognition: from Galenic dogmatism to genetic relativism. Aging Health2006;2:783–6. ClarkeR . Vitamin B12, folic acid, and the prevention of dementia. New England Journal of Medicine2006;354(26):2817‐9. McMahonJA , GreenTJ , SkeaffCM , KnightRG , MannJI , WilliamsSM . A controlled trial of homocysteine lowering and cognitive performance. New England Journal of Medicine2006;354:2764‐72. ">McMahon 2006</a>) tended to favour placebo. </p> </section> <section id="CD011906-sec-0089"> <h6 class="title">&gt; 2‐5 years of supplementation:</h6> <p>Two studies providing final measurement data showed that there may be no effect of treatment (SMD ‐0.06, 95% CI ‐0.13 to 0.02, n = 2648; low‐certainty evidence). </p> </section> <section id="CD011906-sec-0090"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p>From one study, there was low‐certainty evidence that there may be no effect of treatment (SMD 0.02, 95% ‐0.10 to 0.15, n = 1049). </p> </section> </section> <section id="CD011906-sec-0091"> <h5 class="title">Speed of processing</h5> <p>See <a href="./references#CD011906-fig-0009" title="">Analysis 1.4</a> </p> <section id="CD011906-sec-0092"> <h6 class="title">3‐12 months of supplementation:</h6> <p>Two studies provided final measurement data on this outcome and showed that there may be no effect of treatment (SMD ‐0.04, 95% CI ‐0.28 to 0.19, n = 289; low‐certainty evidence). Pooled data from three studies providing change from baseline data gave a similar result, but with very low‐certainty evidence (SMD 0.12, 95% CI ‐0.34 to 0.58, n = 487). </p> </section> <section id="CD011906-sec-0093"> <h6 class="title">&gt; 1‐2 years of supplementation:</h6> <p>Two studies provided final measurement data and showed that there is probably no effect of treatment (SMD 0.03, 95% CI ‐0.09 to 0.15, n = 1030; moderate‐certainty evidence). A further study providing change from baseline data confirmed this (SMD ‐0.04, ‐0.29 to 0.21, n = 241; low‐certainty evidence). </p> </section> <section id="CD011906-sec-0094"> <h6 class="title">&gt; 2‐5 years of supplementation:</h6> <p>One study provided final measurement data and showed no effect of treatment (SMD ‐0.08, 95% CI ‐0.22 to 0.06, n = 818; high‐certainty evidence). </p> </section> </section> <section id="CD011906-sec-0095"> <h5 class="title">Quality of life</h5> <section id="CD011906-sec-0096"> <h6 class="title">&gt; 1‐2 years of supplementation:</h6> <p><a href="./references#CD011906-bbs2-0008" title="FordAH , FlickerL , AlfonsoH , ThomasJ , ClarnetteR , MartinsR , et al. Vitamins B(12), B(6), and folic acid for cognition in older men. Neurology2010;75:1540‐7. FordAH , FlickerL , AlfonsoH , ThomasJ , ClarnetteR , MartinsR , et al. Vitamins B12, B6, and folic acid for cognition in older men: correction. Neurology2011;77:804. ">Ford 2010</a> reported that participants in the B vitamin and placebo groups did not differ significantly on any of the four mental summary scales of the SF‐36 after 24 months. </p> <p>No other included studies reported on quality of life.</p> </section> </section> <section id="CD011906-sec-0097"> <h5 class="title">Clinical global impression</h5> <p>No included studies reported on clinical global impression.</p> </section> <section id="CD011906-sec-0098"> <h5 class="title">Functional performance</h5> <p>No included studies reported on functional performance.</p> </section> <section id="CD011906-sec-0099"> <h5 class="title">Incidence of MCI or dementia</h5> <p>See <a href="./references#CD011906-fig-0010" title="">Analysis 1.5</a>. </p> <p><a href="./references#CD011906-bbs2-0011" title="HankeyGJ , FordAH , QilongYi , EikelboomJW , LeesKR , ChenC , et al. Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack. Stroke2013;44:2232‐9. [DOI: 10.1161/STROKEAHA.113.001886] VITATOPS Trial Study Group. The VITATOPS (Vitamins to Prevent Stroke) trial: rationale and design of an international, large, simple, randomized trial of homocysteine‐lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovascular Diseases2002;13:120‐6. ">Hankey 2013</a> (VITATOPS study) reported on the incidence of cognitive impairment (defined as MMSE score &lt; 24 during follow‐up on two or more occasions) after a median of 2.8 years of supplementation. Of those who had at least two MMSE measurements during follow‐up, 50/908 (5.51%) in the B vitamin group and 49/895 (5.47%) in the placebo group met this criterion for cognitive impairment (RR 1.01, 95% CI 0.69 to 1.48, n = 1803; moderate‐certainty evidence). </p> <p><a href="./references#CD011906-bbs2-0008" title="FordAH , FlickerL , AlfonsoH , ThomasJ , ClarnetteR , MartinsR , et al. Vitamins B(12), B(6), and folic acid for cognition in older men. Neurology2010;75:1540‐7. FordAH , FlickerL , AlfonsoH , ThomasJ , ClarnetteR , MartinsR , et al. Vitamins B12, B6, and folic acid for cognition in older men: correction. Neurology2011;77:804. ">Ford 2010</a> treated participants for two years, but also followed up the participants who were still alive approximately eight years after the baseline study assessment, assessing 73 of the 299 randomised participants with the Telephone Interview for Cognitive Status scale (TICS) and ascertaining dementia diagnoses from a population register for all 172 survivors. Defining cognitive impairment as TICS ≤ 27, they found an OR 0.72 (95% CI 0.25 to 2.09) favouring the B vitamin group. For either a dementia diagnosis or TICS ≤ 27, the OR was 0.76 (95% CI 0.37 to 1.56) also favouring B vitamins. Due to serious imprecision and risk of attrition bias, this was very low‐certainty evidence. </p> <p><a href="./references#CD011906-bbs2-0022" title="ArmitageJ , BrowmanL , BulbuliaR , CollinsR , HaynesR , ParishS . SEARCH data analysis plan [SEARCH: Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine]. ctsu.ox.ac.uk/research/search (accessed 31 December 2017). ArmitageJ , BrowmanL , BulbuliaR , CollinsR , HaynesR , ParishS . SEARCH study protocol [SEARCH: study of the effectiveness of additional reductions in cholesterol and homocysteine]. ctsu.ox.ac.uk/research/search (accessed 31 December 2017). SEARCH Collaborative Group. Effects of homocysteine‐lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors. JAMA2010;303(24):2486‐94. SEARCH Study Collaborative Group. Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12,064 myocardial infarction survivors. American Heart Journal2007;154:815‐23. ">SEARCH 2010</a> investigators recorded diagnoses of dementia at final follow‐up (after a mean of 6.7 person‐years) "based on reports from a participant/relative or doctor, there was no further confirmation or adjudication" (communication from author). The paper stated that "similar numbers of participants in each treatment group were reported to have developed dementia during follow‐up (vitamins, 43 (0.7%), vs placebo, 38 (0.6%))". </p> </section> <section id="CD011906-sec-0100"> <h5 class="title">Serious adverse events</h5> <p>Most papers made only general statements about an absence of serious adverse events in both treatment groups. </p> </section> <section id="CD011906-sec-0101"> <h5 class="title">All‐cause mortality</h5> <p>See <a href="./references#CD011906-fig-0011" title="">Analysis 1.6</a> </p> <section id="CD011906-sec-0102"> <h6 class="title">3‐12 months of supplementation:</h6> <p>In one study (<a href="./references#CD011906-bbs2-0005" title="DangourAD , AllenE , ClarkeR , ElbourneD , FaseyN , FletcherAE , et al. A randomised controlled trial investigating the effect of vitamin B12 supplementation on neurological function in healthy older people: the Older People and Enhanced Neurological function (OPEN) study protocol. Nutrition Journal2011;10(22):1‐8. DangourAD , AllenE , ClarkeR , ElbourneD , FletcherAE , LetleyL , et al. Effects of vitamin B‐12 supplementation on neurologic and cognitive function in older people: a randomized controlled trial. American Journal of Clinical Nutrition2015;102(3):639‐47. ">Dangour 2015</a>), one participant died in the placebo group and no participants in the B vitamin group. </p> </section> <section id="CD011906-sec-0103"> <h6 class="title">&gt; 1‐2 years of supplementation:</h6> <p>In <a href="./references#CD011906-bbs2-0024" title="SpenceJD , HowardVJ , ChamblessLE , MalinowMR , PettigrewLC , StampferM , et al. Vitamin Intervention for stroke prevention (VISP) trial: rationale and design. Neuroepidemiology2001;20(1):16‐25. TooleJF , MalinowMR , ChamblessLE , SpenceJD , PettigrewLC , HowardVJ , et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death. JAMA2004;291:565‐75. ">Toole 2004</a>, in which all participants had a history of recent ischaemic stroke, 99/1821 participants (5.4%) died in the B vitamin group compared to 117/1847 participants (6.3%) in the comparator group over 2 years of follow‐up (RR 0.9, 95% CI 0.7 to 1.1, n = 3668). </p> </section> <section id="CD011906-sec-0104"> <h6 class="title">&gt; 2‐5 years of supplementation:</h6> <p>In one study (<a href="./references#CD011906-bbs2-0002" title="AndreevaVA , Kesse‐GuyotE , Barberger‐GateauP , FezeuL , HercbergS , GalanP . Cognitive function after supplementation with B vitamins and long‐chain omega‐3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial. American Journal of Clinical Nutrition2011;94:278‐86. ">Andreeva 2011</a>), 24/585 participants (4.1%) died in the placebo group and 44/586 participants (7.5%) in the B vitamin group (RR 1.8 favouring placebo, 95% CI 1.17 to 3.08, n = 1171; very low‐certainty evidence). </p> </section> <section id="CD011906-sec-0105"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p>In <a href="./references#CD011906-bbs2-0022" title="ArmitageJ , BrowmanL , BulbuliaR , CollinsR , HaynesR , ParishS . SEARCH data analysis plan [SEARCH: Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine]. ctsu.ox.ac.uk/research/search (accessed 31 December 2017). ArmitageJ , BrowmanL , BulbuliaR , CollinsR , HaynesR , ParishS . SEARCH study protocol [SEARCH: study of the effectiveness of additional reductions in cholesterol and homocysteine]. ctsu.ox.ac.uk/research/search (accessed 31 December 2017). SEARCH Collaborative Group. Effects of homocysteine‐lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors. JAMA2010;303(24):2486‐94. SEARCH Study Collaborative Group. Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12,064 myocardial infarction survivors. American Heart Journal2007;154:815‐23. ">SEARCH 2010</a>, in which all participants had a history of myocardial infarction, 983/6033 participants (16.3%) died in the B vitamin group compared to 951/6031 participants (15.8%) in the placebo group over a mean of 6.7 years of follow‐up (RR 1.03, 95% CI 0.95 to 1.12, n = 12064; moderate‐certainty evidence). </p> <p>Mortality data was not clearly reported in any other study.</p> </section> </section> </section> <section id="CD011906-sec-0106"> <h4 class="title">Antioxidant vitamins</h4> <p>We compared antioxidants to placebo at four time points: 3‐12 months of treatment, &gt; 2‐5 years, &gt; 5‐10 years and &gt;10 years. (We had no data for the &gt; 1‐2 year time point). </p> <section id="CD011906-sec-0107"> <h5 class="title">Overall cognitive function</h5> <p>See <a href="./references#CD011906-fig-0012" title="">Analysis 2.1</a>; <a href="#CD011906-fig-0004">Figure 4</a> </p> <div class="figure" id="CD011906-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Antioxidants versus control, outcome: 2.1 Overall cognitive functioning." data-id="CD011906-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Antioxidants versus control, outcome: 2.1 Overall cognitive functioning. </p> </div> </div> </div> <p>Positive values favoured antioxidants; negative values favoured placebo.</p> <section id="CD011906-sec-0108"> <h6 class="title">3‐12 months of supplementation:</h6> <p>One study of vitamin E in middle‐aged adults with type 2 diabetes (<a href="./references#CD011906-bbs2-0001" title="AnandVPR , KumarBJ , VargheseJM , DasSK . Supplementation of vitamin E improves cognitive status and oxidative stress in type 2 diabetes mellitus. International Research Journal of Pharmacy2011;2:169‐72. ">Anand 2011</a>) found a higher MMSE in the intervention group, but this was the only open‐label study and the certainty of this evidence was very low due to risk of bias, imprecision and indirectness (MD 1.4, 95% CI 1.18 to 1.62, n = 74). </p> <p>One study of beta‐carotene (<a href="./references#CD011906-bbs2-0009" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , KangJH , GlynnRJ , CookNR , GazianoJM . A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Archives of Internal Medicine2007;167:2184‐90. ">Grodstein 2007</a>) included an older population (mean age 73 years) who were treated for a mean of 12 months, but a range of two months to three years. Among these participants, there was probably no effect of beta‐carotene on overall cognitive function measured with the TICS (MD ‐0.14, 95% CI ‐0.37 to 0.09, n = 1904; moderate‐certainty evidence). </p> </section> <section id="CD011906-sec-0109"> <h6 class="title">&gt; 2‐5 years of supplementation:</h6> <p>One study using a combination of vitamin C, E, and beta‐carotene (<a href="./references#CD011906-bbs2-0020" title="Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high‐risk individuals: a randomised placebo‐controlled trial. Lancet2002;360(9326):23‐33. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol‐lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. European Heart Journal1999;20:725‐41. ">MRC/BHF 2002</a>) found that there was probably no effect of the antioxidant treatment on the TICS after a mean five years of follow‐up (MD 0.09, 95% CI ‐0.05 to 0.23, n = 20536; moderate‐certainty evidence). </p> <p><a href="./references#CD011906-bbs2-0014" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookNR , MansonJE , BuringJE , AlbertCM , GrodsteinF . Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation2009;119(21):2772‐80. [PUBMED: 19451353] MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al: WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2009</a> was a factorial study which reported TICS results separately for vitamin C, E, and beta‐carotene after a mean of 3.5 years of treatment. It reported the mean difference (with 95% CI) between each vitamin group and placebo, but reported only the total number of participants (2824) and not the number in each treatment group. This study showed that there may be no effect of vitamin C (MD 0.16, 95% CI ‐0.08 to 0.40, n not reported; low‐certainty evidence), vitamin E (MD 0.01, 95% CI ‐0.23 to 0.25, n not reported; low‐certainty evidence) or beta‐carotene (MD ‐0.18, 95% CI ‐0.42 to 0.06; n not reported; low‐certainty evidence). </p> </section> <section id="CD011906-sec-0110"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p>One study using a combination of vitamins C and E and beta‐carotene for a median of 6.9 years (<a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a>) found that there may be no effect on the modified MMSE (3MS) (MD 0.6, 95% CI ‐0.2 to 1.40, n = 1100; moderate‐certainty evidence). </p> <p><a href="./references#CD011906-bbs2-0014" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookNR , MansonJE , BuringJE , AlbertCM , GrodsteinF . Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation2009;119(21):2772‐80. [PUBMED: 19451353] MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al: WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2009</a> also reported outcome data from a final assessment after a mean of 8.9 years. However, again it reported only the total number of participants (n = 1586) at this time point and not the number in each group. A second study (<a href="./references#CD011906-bbs2-0012" title="KangJH , CookN , MansonJ , BuringJE , GrodsteinF . A randomized trial of vitamin E supplementation and cognitive function in women. Archives of Internal Medicine2006;166:2462‐8. RidkerPM , CookNR , LeeIM , GordonD , GazianoJM , MansonJE , et al. A randomized trial of low‐dose aspirin in the primary prevention of cardiovascular disease in women. New England Journal of Medicine2005;352(13):1293‐304. ">Kang 2006</a>) reported TICS data after approximately 10 years of treatment with vitamin E. We were unable to pool data vitamin E data from these two studies because of the unknown number of relevant participants in <a href="./references#CD011906-bbs2-0014" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookNR , MansonJE , BuringJE , AlbertCM , GrodsteinF . Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation2009;119(21):2772‐80. [PUBMED: 19451353] MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al: WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2009</a>. In <a href="./references#CD011906-bbs2-0012" title="KangJH , CookN , MansonJ , BuringJE , GrodsteinF . A randomized trial of vitamin E supplementation and cognitive function in women. Archives of Internal Medicine2006;166:2462‐8. RidkerPM , CookNR , LeeIM , GordonD , GazianoJM , MansonJE , et al. A randomized trial of low‐dose aspirin in the primary prevention of cardiovascular disease in women. New England Journal of Medicine2005;352(13):1293‐304. ">Kang 2006</a>, the first cognitive assessment was conducted 5.6 years (range 4.4 to 6.8) after randomisation and the last 4.0 (range 2.6 to 5.7) years later. The mean difference in TICS scores between groups at final cognitive assessment was 0.04 points (95% CI ‐0.12 to 0.21, n = 5226). The mean difference in cognitive decline on the TICS between the vitamin E and placebo groups from first to last cognitive assessment was 0.02 points (95% CI ‐0.02 to 0.06; P = 0.31). In the vitamin E arm from <a href="./references#CD011906-bbs2-0014" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookNR , MansonJE , BuringJE , AlbertCM , GrodsteinF . Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation2009;119(21):2772‐80. [PUBMED: 19451353] MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al: WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2009</a>, there was also no evidence of an effect on final TICS score (MD ‐0.16, 95% CI ‐0.49 to 0.16; n not reported, P = 0.33). We considered the overall certainty of this evidence on vitamin E to be low. In the vitamin C arm from <a href="./references#CD011906-bbs2-0014" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookNR , MansonJE , BuringJE , AlbertCM , GrodsteinF . Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation2009;119(21):2772‐80. [PUBMED: 19451353] MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al: WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2009</a>, there may have been a small beneficial effect of vitamin C on final TICS score (MD 0.46, 95% CI 0.14 to 0.78, n not reported, P = 0.006; low‐certainty evidence). In the beta‐carotene arm from <a href="./references#CD011906-bbs2-0014" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookNR , MansonJE , BuringJE , AlbertCM , GrodsteinF . Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation2009;119(21):2772‐80. [PUBMED: 19451353] MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al: WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2009</a>, there was no evidence of an effect of treatment (MD ‐0.13, 95% CI ‐0.46 to 0.19, n not reported, P = 0.42; low‐certainty evidence). </p> </section> <section id="CD011906-sec-0111"> <h6 class="title">&gt; 10 years of supplementation:</h6> <p><a href="./references#CD011906-bbs2-0009" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , KangJH , GlynnRJ , CookNR , GazianoJM . A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Archives of Internal Medicine2007;167:2184‐90. ">Grodstein 2007</a> included 4052 participants who had been treated with beta‐carotene for a mean of 18 years (range 15 to 20 years), starting at a mean age of 56 years. There was moderate‐certainty evidence of a very small beneficial effect of beta‐carotene treatment on the TICS (MD 0.18, 95% CI 0.01 to 0.35, n = 4052). </p> </section> </section> <section id="CD011906-sec-0112"> <h5 class="title">Episodic memory</h5> <p>See <a href="./references#CD011906-fig-0013" title="">Analysis 2.2</a>; <a href="#CD011906-fig-0005">Figure 5</a> </p> <div class="figure" id="CD011906-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Antioxidants versus control, outcome: 2.2 Episodic memory." data-id="CD011906-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Antioxidants versus control, outcome: 2.2 Episodic memory.</p> </div> </div> </div> <section id="CD011906-sec-0113"> <h6 class="title">3‐12 months of supplementation:</h6> <p><a href="./references#CD011906-bbs2-0009" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , KangJH , GlynnRJ , CookNR , GazianoJM . A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Archives of Internal Medicine2007;167:2184‐90. ">Grodstein 2007</a> found that there was probably no effect of beta‐carotene (MD 0.01, 95% CI ‐0.05 to 0.08, n = 1904; moderate‐certainty evidence) on a composite verbal memory measure after a mean of 12 months (range two months to three years). </p> </section> <section id="CD011906-sec-0114"> <h6 class="title">&gt; 2‐5 years of supplementation:</h6> <p>From <a href="./references#CD011906-bbs2-0014" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookNR , MansonJE , BuringJE , AlbertCM , GrodsteinF . Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation2009;119(21):2772‐80. [PUBMED: 19451353] MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al: WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2009</a>, there was probably a very small beneficial effect of vitamin C on the TICS 10‐word recall test (MD ‐0.05, 95% CI ‐0.10 to 0; n = 2824; low‐certainty evidence), but probably no effect of vitamin E (MD ‐0.02, 95% CI ‐0.07 to 0.03, n = 2824; low‐certainty evidence) or beta‐carotene (MD 0.01, 95% CI ‐0.05 to 0.07, n = 2824; low‐certainty evidence). </p> </section> <section id="CD011906-sec-0115"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p><a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a>, using combined vitamin C and E and beta‐carotene, found no evidence of an effect on the delayed recall logical memory test (MD ‐0.30, 95% CI ‐1.30 to 0.70, n = 1100; low‐certainty evidence). </p> <p>A pooled analysis of two studies using vitamin E provided very low‐certainty evidence of no effect (MD 0.02, 95% CI ‐0.05 to 0.09, n = 6812, 2 studies). There was low‐certainty evidence from a single study (<a href="./references#CD011906-bbs2-0014" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookNR , MansonJE , BuringJE , AlbertCM , GrodsteinF . Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation2009;119(21):2772‐80. [PUBMED: 19451353] MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al: WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2009</a>) that there may be a small beneficial effect of vitamin C (MD ‐0.14, 95% CI ‐0.22 to ‐0.06, n = 1583) and no effect of beta‐carotene (MD 0.02, 95% CI ‐0.05 to 0.09, n = 1583). </p> <p><a href="./references#CD011906-bbs2-0015" title="HercbergS , GalanP , PreziosiP , BertraisS , MennenL , MalvyD , et al. The SU.VI.MAX Study: a randomized, placebo‐controlled trial of the health effects of antioxidant vitamins and minerals. Archives of Internal Medicine2004;164(21):2335‐42. HercbergS , PreziosiP , BriançonS , GalanP , TriolI , MalvyD , et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study ‐ design, methods, and participant characteristics. Controlled Clinical Trials1998;19(4):336‐51. Kesse‐GuyotE , FezeuL , JeandelC , FerryM , AndreevaV , AmievaH , et al. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. American Journal of Clinical Nutrition2011;94:892‐9. ">Kesse‐Guyot 2011</a> treated participants for eight years with a combination of vitamin C, vitamin E, beta‐carotene, zinc, and selenium and assessed cognition six years after the end of treatment. On a delayed cued‐recall test (the RI‐48), there was a small benefit for the vitamin group (MD 0.61, 95% CI 0.02‐1.20, n = 4447, moderate‐certainty evidence). </p> </section> <section id="CD011906-sec-0116"> <h6 class="title">&gt; 10 years of supplementation:</h6> <p><a href="./references#CD011906-bbs2-0009" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , KangJH , GlynnRJ , CookNR , GazianoJM . A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Archives of Internal Medicine2007;167:2184‐90. ">Grodstein 2007</a> found evidence of a small beneficial effect of beta‐carotene on a composite verbal memory measure after treatment for a mean of 18 years (range 15 to 20 years), starting at a mean age of 56 years (MD ‐0.06, 95% CI ‐0.11 to ‐0.02; n = 4052; moderate‐certainty evidence). </p> </section> </section> <section id="CD011906-sec-0117"> <h5 class="title">Executive function</h5> <p>See <a href="./references#CD011906-fig-0014" title="">Analysis 2.3</a> </p> <section id="CD011906-sec-0118"> <h6 class="title">3‐12 months of supplementation:</h6> <p>There was moderate‐certainty evidence from <a href="./references#CD011906-bbs2-0009" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , KangJH , GlynnRJ , CookNR , GazianoJM . A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Archives of Internal Medicine2007;167:2184‐90. ">Grodstein 2007</a> that beta‐carotene probably has no effect on executive function measured with a category fluency test after a mean of 12 months (range two months to three years) (MD 0.07, 95% CI ‐0.48 to 0.62, n = 1904). </p> </section> <section id="CD011906-sec-0119"> <h6 class="title">&gt; 2‐5 years of supplementation:</h6> <p>There was low‐certainty evidence from <a href="./references#CD011906-bbs2-0014" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookNR , MansonJE , BuringJE , AlbertCM , GrodsteinF . Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation2009;119(21):2772‐80. [PUBMED: 19451353] MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al: WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2009</a> of a small detrimental effect of vitamin E on category fluency (MD 0.42, 95% CI 0.06 to 0.78, n = 2819) and of no effect of vitamin C (MD ‐0.03, 95% CI ‐0.39 to 0.33, n = 2819) or beta‐carotene (MD 0.22, 95% CI ‐0.14 to 0.58, n = 2819). </p> </section> <section id="CD011906-sec-0120"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p><a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a> found no evidence of an effect of combined vitamin C and E and beta‐carotene on category fluency (MD ‐0.4, 95% CI ‐0.99 to 0.19, n = 1100; low‐certainty evidence) </p> <p>Pooled data on vitamin E from <a href="./references#CD011906-bbs2-0012" title="KangJH , CookN , MansonJ , BuringJE , GrodsteinF . A randomized trial of vitamin E supplementation and cognitive function in women. Archives of Internal Medicine2006;166:2462‐8. RidkerPM , CookNR , LeeIM , GordonD , GazianoJM , MansonJE , et al. A randomized trial of low‐dose aspirin in the primary prevention of cardiovascular disease in women. New England Journal of Medicine2005;352(13):1293‐304. ">Kang 2006</a> and <a href="./references#CD011906-bbs2-0014" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookNR , MansonJE , BuringJE , AlbertCM , GrodsteinF . Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation2009;119(21):2772‐80. [PUBMED: 19451353] MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al: WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2009</a> showed no evidence of an effect on category fluency (MD 0.11, 95% CI ‐0.26 to 0.48, n = 6808; low‐certainty evidence). <a href="./references#CD011906-bbs2-0014" title="AlbertCM , CookNR , GazianoJM , ZaharrisE , MacFadyenJ , DanielsonE , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA2008;299(17):2027‐36. BassukSS , AlbertCM , CookNR , ZaharrisE , MacFadyenJG , DanielsonE , et al. The Women’s Antioxidant Cardiovascular Study: design and baseline characteristics of participants. Journal of Women's Health2004;13:99–117. KangJH , CookNR , MansonJE , BuringJE , AlbertCM , GrodsteinF . Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: the Women's Antioxidant and Cardiovascular Study. Circulation2009;119(21):2772‐80. [PUBMED: 19451353] MansonJE , GazianoJM , SpelsbergA , RidkerPM , CookNR , BuringJE , et al: WACS Research Group. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. Annals of Epidemiology1995;5(4):261‐9. ">Kang 2009</a> also found no evidence of an effect of vitamin C (MD ‐0.25, 95% CI ‐0.7 to 0.2, n = 1583; low‐certainty evidence) or beta‐carotene (MD 0.01, 95% CI ‐0.44 to 0.46, n = 1583; low‐certainty evidence). </p> <p><a href="./references#CD011906-bbs2-0015" title="HercbergS , GalanP , PreziosiP , BertraisS , MennenL , MalvyD , et al. The SU.VI.MAX Study: a randomized, placebo‐controlled trial of the health effects of antioxidant vitamins and minerals. Archives of Internal Medicine2004;164(21):2335‐42. HercbergS , PreziosiP , BriançonS , GalanP , TriolI , MalvyD , et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study ‐ design, methods, and participant characteristics. Controlled Clinical Trials1998;19(4):336‐51. Kesse‐GuyotE , FezeuL , JeandelC , FerryM , AndreevaV , AmievaH , et al. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. American Journal of Clinical Nutrition2011;94:892‐9. ">Kesse‐Guyot 2011</a> treated participants for eight years with a combination of vitamin C, vitamin E, beta‐carotene, zinc, and selenium and assessed cognition six years after the end of treatment. There was no clear evidence of a difference between groups on category fluency (MD 0.50, 95% CI ‐0.09 to 1.09, n = 4447, moderate‐certainty evidence). </p> </section> <section id="CD011906-sec-0121"> <h6 class="title">&gt; 10 years of supplementation:</h6> <p><a href="./references#CD011906-bbs2-0009" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , KangJH , GlynnRJ , CookNR , GazianoJM . A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Archives of Internal Medicine2007;167:2184‐90. ">Grodstein 2007</a> found that beta‐carotene probably has no effect on executive function measured with a category fluency test after treatment for a mean of 18 years (range 15 to 20 years) (MD 0.01, 95% CI ‐0.36 to 0.38, n = 4052; moderate‐certainty evidence). </p> </section> </section> <section id="CD011906-sec-0122"> <h5 class="title">Speed of processing</h5> <section id="CD011906-sec-0123"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p><a href="./references#CD011906-bbs2-0015" title="HercbergS , GalanP , PreziosiP , BertraisS , MennenL , MalvyD , et al. The SU.VI.MAX Study: a randomized, placebo‐controlled trial of the health effects of antioxidant vitamins and minerals. Archives of Internal Medicine2004;164(21):2335‐42. HercbergS , PreziosiP , BriançonS , GalanP , TriolI , MalvyD , et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study ‐ design, methods, and participant characteristics. Controlled Clinical Trials1998;19(4):336‐51. Kesse‐GuyotE , FezeuL , JeandelC , FerryM , AndreevaV , AmievaH , et al. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial. American Journal of Clinical Nutrition2011;94:892‐9. ">Kesse‐Guyot 2011</a> treated participants for eight years with a combination of vitamin C, vitamin E, beta‐carotene, zinc, and selenium and assessed cognition six years after the end of treatment. There was no difference between groups on time taken to complete a trial‐making task (TMT) (MD 0.00, 95% CI ‐0.59 to 0.59, n = 4447, moderate‐certainty evidence). </p> </section> </section> <section id="CD011906-sec-0124"> <h5 class="title">Incidence of dementia</h5> <p>See <a href="./references#CD011906-fig-0015" title="">Analysis 2.4</a> </p> <section id="CD011906-sec-0125"> <h6 class="title">&gt; 2‐5 years of supplementation:</h6> <p>One study (<a href="./references#CD011906-bbs2-0020" title="Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high‐risk individuals: a randomised placebo‐controlled trial. Lancet2002;360(9326):23‐33. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol‐lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. European Heart Journal1999;20:725‐41. ">MRC/BHF 2002</a>) reported the number of participants who developed dementia during follow‐up. All participants were at high vascular risk. There were 62 events, 31 in each group (RR 1, 95% CI 0.61 to 1.64, n = 20536; low‐certainty evidence). </p> </section> <section id="CD011906-sec-0126"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p>The mean duration of supplement use in <a href="./references#CD011906-bbs2-0016" title="AbnerE , SchmittF , CabanAH , DennisB , MathewsM , CooperG , et al. Dual cognitive screening for dementia: preliminary case ascertainment in the antioxidant Alzheimer's prevention (PREADVISE) trial. Alzheimer's &amp; Dementia2012;8(4 suppl):P144. [DOI: 10.1016/j.jalz.2012.05.385] KryscioRJ , AbnerEL , Caban‐HoltA , LovellM , GoodmanP , DarkeAK , et al. Association of antioxidant supplement use and dementia in the prevention of Alzheimer's disease by vitamin E and selenium trial (PREADVISE). JAMA Neurology2017;74(5):567‐73. KryscioRJ , AbnerEL , SchmittFA , GoodmanPJ , MendiondoM , Caban‐HoltA , et al. A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE trial. Journal of Nutrition, Health &amp; Aging2013;17(1):72‐5. [PUBMED: 23299383] ">Kryscio 2017</a> was 5.4 ± 1.2 years although follow‐up continued for up to six years after supplement discontinuation. The unadjusted cumulative incidence of dementia was 3.95% in the vitamin E arm, 4.96% in the (vitamin E + selenium) arm and 4.62% in the placebo arm. A modified ITT analysis including all participants who had at least one follow‐up visit and adjusted for a variety of covariates showed that neither arm had an incidence significantly different from the placebo arm: vitamin E HR 0.88 (95% CI 0.64 to 1.20, P = 0.41); (vitamin E + selenium) HR 1.00 (95% CI 0.74 to 1.35, P = 0.98). We considered this to be low‐certainty evidence due to imprecision and indirectness. </p> </section> </section> <section id="CD011906-sec-0127"> <h5 class="title">All‐cause mortality</h5> <p>See <a href="./references#CD011906-fig-0016" title="">Analysis 2.5</a> </p> <section id="CD011906-sec-0128"> <h6 class="title">&gt; 2‐5 years of supplementation:</h6> <p>In one study (<a href="./references#CD011906-bbs2-0020" title="Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high‐risk individuals: a randomised placebo‐controlled trial. Lancet2002;360(9326):23‐33. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol‐lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. European Heart Journal1999;20:725‐41. ">MRC/BHF 2002</a>), 1389/10267 participants died in the placebo group and 1446/10269 participants in the antioxidant group (RR 1.04, 95% CI 0.97 to 1.11, n = 20536; moderate‐certainty evidence). </p> </section> </section> <section id="CD011906-sec-0129"> <h5 class="title">Serious adverse events</h5> <p><a href="./references#CD011906-bbs2-0016" title="AbnerE , SchmittF , CabanAH , DennisB , MathewsM , CooperG , et al. Dual cognitive screening for dementia: preliminary case ascertainment in the antioxidant Alzheimer's prevention (PREADVISE) trial. Alzheimer's &amp; Dementia2012;8(4 suppl):P144. [DOI: 10.1016/j.jalz.2012.05.385] KryscioRJ , AbnerEL , Caban‐HoltA , LovellM , GoodmanP , DarkeAK , et al. Association of antioxidant supplement use and dementia in the prevention of Alzheimer's disease by vitamin E and selenium trial (PREADVISE). JAMA Neurology2017;74(5):567‐73. KryscioRJ , AbnerEL , SchmittFA , GoodmanPJ , MendiondoM , Caban‐HoltA , et al. A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE trial. Journal of Nutrition, Health &amp; Aging2013;17(1):72‐5. [PUBMED: 23299383] ">Kryscio 2017</a> was an ancillary study to SELECT, in which the primary study was the incidence of prostate cancer. SELECT began recruitment in 2002. By 2011, there was a statistically significant 17% increase in the risk of prostate cancer in the men taking vitamin E only compared to those taking placebo only. After a mean of seven years of follow‐up (mean 5.5 years taking supplements) there were 65 prostate cancer cases per 1000 men taking placebo only and 76 prostate cancer cases per 1000 men taking vitamin E only. </p> </section> <section id="CD011906-sec-0130"> <h5 class="title">Other outcomes</h5> <p>Not reported.</p> </section> </section> <section id="CD011906-sec-0131"> <h4 class="title">Vitamin D</h4> <p>We considered data unsuitable for pooling because of the five‐fold difference in the daily dose of vitamin D3. </p> <section id="CD011906-sec-0132"> <h5 class="title">Overall cognitive function</h5> <p>See <a href="./references#CD011906-fig-0017" title="">Analysis 3.1</a> </p> <p>There was moderate‐certainty evidence from the small pilot study (<a href="./references#CD011906-bbs2-0003" title="AspellN , HealyM , McPartlinJ , LawlorBA , O'SullivanM . Effects of vitamin D supplementation on cognitive function in healthy community dwelling older adults: results from a randomised double‐blind placebo‐controlled trial. Proceedings of the Nutrition Society2017;76 (OCE3):E59. ">Aspell 2017</a>) that the change in Montreal Cognitive Assessment (MoCA) score over six months did not differ between the vitamin D3 group (4000 IU on alternate days) and the placebo group (MD 0.76 points, SD not reported, n = 60, P = 0.186). </p> <p>There was moderate‐certainty evidence from one study (<a href="./references#CD011906-bbs2-0021" title="JacksonRD , LaCroixAZ , GassM , WallaceRB , RobbinsJ , LewisCE , et al. Calcium plus vitamin D supplementation and the risk of fractures. New England journal of medicine2006;354(7):669‐83. RossomRC , EspelandMA , MansonJE , DyskenMW , JohnsonKC , LaneDS , et al. Calcium and vitamin D supplementation and cognitive impairment in the Women's Health Initiative. Journal of the American Geriatrics Society2012;60:2197‐205. ">Rossom 2012</a>) that there was probably no effect of treatment with a daily dose of 400 IU vitamin D3 + calcium carbonate on the modified MMSE (3MS) at any time point up to a mean follow‐up of 7.8 years. </p> <section id="CD011906-sec-0133"> <h6 class="title">3‐12 months of supplementation:</h6> <p>MD 0, 95% CI ‐0.24 to 0.24, n = 4122.</p> </section> <section id="CD011906-sec-0134"> <h6 class="title">&gt; 1‐2 years of supplementation:</h6> <p>MD 0, 95% CI ‐0.25 to 0.25, n = 3910.</p> </section> <section id="CD011906-sec-0135"> <h6 class="title">&gt; 2‐5 years of supplementation:</h6> <p>MD ‐0.2, 95% CI ‐0.53 to 0.13, n = 3515.</p> </section> <section id="CD011906-sec-0136"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p>MD ‐0.1, 95% CI ‐0.81 to 0.61, n = 918 (low‐certainty evidence, additional downgrade due to incomplete outcome data). </p> </section> </section> <section id="CD011906-sec-0137"> <h5 class="title">Episodic memory/executive function/speed of processing</h5> <p><a href="./references#CD011906-bbs2-0003" title="AspellN , HealyM , McPartlinJ , LawlorBA , O'SullivanM . Effects of vitamin D supplementation on cognitive function in healthy community dwelling older adults: results from a randomised double‐blind placebo‐controlled trial. Proceedings of the Nutrition Society2017;76 (OCE3):E59. ">Aspell 2017</a> reported results for executive function using the Trail Making Task but no results for episodic memory, although the trial registry entry indicated that it was to be measured with the Wechsler Memory Scale. For change in TMT scores over six months, there was probably little or no difference between the groups (TMTB‐A: MD 5.1, SD not reported, n = 60, P = 0.467). </p> <p>In annual domain‐specific cognitive assessments over approximately three to eight years, the authors of <a href="./references#CD011906-bbs2-0021" title="JacksonRD , LaCroixAZ , GassM , WallaceRB , RobbinsJ , LewisCE , et al. Calcium plus vitamin D supplementation and the risk of fractures. New England journal of medicine2006;354(7):669‐83. RossomRC , EspelandMA , MansonJE , DyskenMW , JohnsonKC , LaneDS , et al. Calcium and vitamin D supplementation and cognitive impairment in the Women's Health Initiative. Journal of the American Geriatrics Society2012;60:2197‐205. ">Rossom 2012</a> reported that there were "no significant differences in any domain‐specific cognitive scores between treatment groups either in unadjusted analyses or after adjustment for age, smoking, baseline 3MS, and treatment assignment in the hormone or diet modification trials." Results were not fully reported. They included the California Verbal Learning Test (episodic memory), letter and category fluency (executive function) and finger tapping (speed of processing). </p> </section> <section id="CD011906-sec-0138"> <h5 class="title">Incidence of MCI or dementia</h5> <p>In <a href="./references#CD011906-bbs2-0021" title="JacksonRD , LaCroixAZ , GassM , WallaceRB , RobbinsJ , LewisCE , et al. Calcium plus vitamin D supplementation and the risk of fractures. New England journal of medicine2006;354(7):669‐83. RossomRC , EspelandMA , MansonJE , DyskenMW , JohnsonKC , LaneDS , et al. Calcium and vitamin D supplementation and cognitive impairment in the Women's Health Initiative. Journal of the American Geriatrics Society2012;60:2197‐205. ">Rossom 2012</a>, "[t]he incidence of MCI or all‐cause dementia did not differ significantly between placebo and treatment groups, with 4.8% of calcium plus vitamin D subjects (62.2 per 10,000 person years) and 5.1% of placebo subjects (65.9 per 10,000 person years) developing cognitive impairment during a mean follow‐up time of 7.8 years (HR 0.94, 95% CI 0.72 to 1.24; P = 0.68)". The survival curve showed that the incidence did not differ over the course of follow‐up. We considered this to be low‐certainty evidence, downgraded due to imprecision and indirectness (women only). </p> </section> <section id="CD011906-sec-0139"> <h5 class="title">Other outcomes</h5> <p>Not reported.</p> </section> </section> <section id="CD011906-sec-0140"> <h4 class="title">Zinc and copper</h4> <p>For this comparison, the only data we were able to extract came from <a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a> which treated participants with 80 mg zinc and 2 mg copper daily for a median of 6.9 years. No usable data were available from <a href="./references#CD011906-bbs2-0018" title="Andriollo‐SanchezM , Hininger‐FavierI , MeunierN , TotiE , ZaccariaM , Brandolini‐BunlonM , et al. Zinc intake and status in middle‐aged and older European subjects: the ZENITH study. European Journal of Clinical Nutrition2005;59(Suppl 2):S37‐41. [DOI: 10.1038/sj.ejcn.1602296] CoudrayC , O'ConnorJM , MaianiG , CashmanKD , SimpsonEE , SeckerDL , et al. Introduction to the ZENITH study and summary of baseline results. European Journal of Clinical Nutrition2005;59(Suppl 2):S5‐7. MaylorEA , SimpsonEEA , SeckerDL , MeunierN , Andriollo‐SanchezM , PolitoA , et al. Effects of zinc supplementation on cognitive function in healthy middle‐aged and older adults: the ZENITH study. British Journal of Nutrition2006;96:752‐60. SimpsonEE , MaylorEA , McConvilleC , Stewart‐KnoxB , MeunierN , Andriollo‐SanchezM , et al. Mood and cognition in healthy older European adults: the Zenith study. BMC Psychology2014;2(1):11. SimpsonEE , MaylorEA , RaeG , MeunierN , Andriollo‐SanchezM , CatastaG , et al. Cognitive function in healthy older European adults: the ZENITH study. European Journal of Clinical Nutrition2005;59(2 Suppl 2):S26‐S30. ">Maylor 2006</a>, but the authors reported finding no cognitive effects of six months of supplementation with zinc gluconate. </p> <section id="CD011906-sec-0141"> <h5 class="title">Overall cognitive function</h5> <p>See <a href="./references#CD011906-fig-0023" title="">Analysis 4.1</a> </p> <section id="CD011906-sec-0142"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p>One study (<a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a>) found no evidence of an effect of treatment on the modified MMSE (MD 0.6, 95% CI ‐0.19 to 1.39, n = 1072; moderate‐certainty evidence). </p> </section> </section> <section id="CD011906-sec-0143"> <h5 class="title">Episodic memory</h5> <p>See <a href="./references#CD011906-fig-0024" title="">Analysis 4.2</a> </p> <section id="CD011906-sec-0144"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p>One study (<a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a>) found no evidence of an effect of treatment on a delayed recall test (MD ‐0.7 95% CI ‐1.74 to 0.34, n = 1072; moderate‐certainty evidence). </p> </section> </section> <section id="CD011906-sec-0145"> <h5 class="title">Executive function</h5> <p>See <a href="./references#CD011906-fig-0025" title="">Analysis 4.3</a> </p> <section id="CD011906-sec-0146"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p>One study (<a href="./references#CD011906-bbs2-0028" title="ClemonsTE , RankinMW , McBeeWL . Cognitive impairment in the Age‐Related Eye Disease Study: AREDS report no. 16. Archives of Ophthalmology2006;124(4):537‐43. YaffeK , ClemonsTE , McBeeWL , LindbladAS , BresslerSB . A randomized, controlled trial of antioxidants and zinc and the impact on cognition in the elderly: the AREDS ancillary trial. Annals of Neurology2003;54(Suppl 7):S28‐9. [DOI: doi.org/10.1002/ana.5051] YaffeK , ClemonsTE , McBeeWL , LindbladAS , Age‐Related Eye Disease Study Research Group. Impact of antioxidants, zinc, and copper on cognition in the elderly ‐ a randomized, controlled trial. Neurology2004;63:1705‐7. ">Yaffe 2004</a>) found no evidence of an effect of treatment on category fluency (MD ‐0.3, 95% CI ‐0.89 to 0.29, n = 1072; moderate‐certainty evidence). </p> </section> </section> <section id="CD011906-sec-0147"> <h5 class="title">Incidence of dementia or MCI</h5> <p>Yaffe 2004 reported that at the time of administration of the cognitive test battery, 4.5% of participants had a 3MS score &lt; 80, which was the authors' definition of cognitive impairment, and that "there was no significant effect of treatment group on likelihood of having cognitive impairment." We considered this to be low‐certainty evidence. </p> </section> <section id="CD011906-sec-0148"> <h5 class="title">Other outcomes</h5> <p>Not reported.</p> </section> </section> <section id="CD011906-sec-0149"> <h4 class="title">Selenium</h4> <p>For this comparison, the only data came from the selenium arm of <a href="./references#CD011906-bbs2-0016" title="AbnerE , SchmittF , CabanAH , DennisB , MathewsM , CooperG , et al. Dual cognitive screening for dementia: preliminary case ascertainment in the antioxidant Alzheimer's prevention (PREADVISE) trial. Alzheimer's &amp; Dementia2012;8(4 suppl):P144. [DOI: 10.1016/j.jalz.2012.05.385] KryscioRJ , AbnerEL , Caban‐HoltA , LovellM , GoodmanP , DarkeAK , et al. Association of antioxidant supplement use and dementia in the prevention of Alzheimer's disease by vitamin E and selenium trial (PREADVISE). JAMA Neurology2017;74(5):567‐73. KryscioRJ , AbnerEL , SchmittFA , GoodmanPJ , MendiondoM , Caban‐HoltA , et al. A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE trial. Journal of Nutrition, Health &amp; Aging2013;17(1):72‐5. [PUBMED: 23299383] ">Kryscio 2017</a>. The only outcome reported was incidence of dementia. Supplements ‐ in this case, selenium 200 mcg per day ‐ were taken for a mean of 5.4 ± 1.2 years although follow‐up continued for up to six years after supplement discontinuation. The unadjusted cumulative incidence of dementia was 4.15% in the selenium arm and 4.62% in the placebo arm. A modified ITT analysis including all participants who had at least one follow‐up visit and adjusted for a variety of covariates showed no significant difference in incidence between the selenium and placebo arms (HR 0.83, 95% CI 0.61 to 1.13, P = 0.23, n = 7388). We considered this to be low‐certainty evidence due to imprecision and indirectness. </p> </section> <section id="CD011906-sec-0150"> <h4 class="title">Complex multivitamins (containing B vitamins and antioxidants +/‐ minerals)</h4> <section id="CD011906-sec-0151"> <h5 class="title">Overall cognitive function</h5> <p>See <a href="./references#CD011906-fig-0026" title="">Analysis 5.1</a> </p> <section id="CD011906-sec-0152"> <h6 class="title">&gt; 2‐5 years of supplementation:</h6> <p>One study (<a href="./references#CD011906-bbs2-0010" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , O'BrienJ , KangJH , DushkesR , CookNR , OkerekeO , et al. Long‐term multivitamin supplementation and cognitive function in men: a randomized trial. Annals of Internal Medicine2013;159:806‐14. ">Grodstein 2013</a>) found no effect of a complex multivitamin on the TICS over a mean of 2.5 years of treatment (range 0.18 to 5.3 years) (MD 0.04, 95% CI ‐0.09 to 0.18; n = 5947; low‐certainty evidence). </p> </section> <section id="CD011906-sec-0153"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p>The same study found no effect of the complex multivitamin on the TICS over a mean of 8.5 years (range 0.3 to 14.2 years) (MD 0.12, 95% CI ‐0.14 to 0.38; n = 2324; low‐certainty evidence). </p> </section> </section> <section id="CD011906-sec-0154"> <h5 class="title">Episodic memory</h5> <p>See <a href="./references#CD011906-fig-0027" title="">Analysis 5.2</a> </p> <section id="CD011906-sec-0155"> <h6 class="title">3‐12 months of supplementation:</h6> <p>One study (<a href="./references#CD011906-bbs2-0004" title="CockleSM , HallerJ , KimberS , DaweRA , HindmarchI . The influence of multivitamins on cognitive function and mood in the elderly. Aging &amp; Mental Health2000;4:339‐53. ">Cockle 2000</a>) found no evidence of an effect of treatment on a word scan (recognition) test (MD 33.17, 95% CI ‐28.12 to 94.46; n = 124; low‐certainty evidence). Another study (<a href="./references#CD011906-bbs2-0027" title="WoltersM , HicksteinM , FlintermannA , TewesU , HahnA . Cognitive performance in relation to vitamin status in healthy elderly German women ‐ the effect of 6‐month multivitamin supplementation. Preventive Medicine2005;41:253‐9. ">Wolters 2005</a>) used a pattern recognition subtest of the Berliner Amnesie test (BAT) and reported the results as medians with 5th to 95th percentiles; the difference between groups was 'not significant' (no P value given). </p> </section> <section id="CD011906-sec-0156"> <h6 class="title">&gt; 2‐5 years of supplementation:</h6> <p>One study (<a href="./references#CD011906-bbs2-0010" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , O'BrienJ , KangJH , DushkesR , CookNR , OkerekeO , et al. Long‐term multivitamin supplementation and cognitive function in men: a randomized trial. Annals of Internal Medicine2013;159:806‐14. ">Grodstein 2013</a>) found no evidence of an effect of treatment on a composite verbal memory score after a mean of 2.5 years (range 0.18 to 5.3 years) (MD ‐0.01, 95% CI ‐0.05 to 0.03; n = 5942; low‐certainty evidence). </p> </section> <section id="CD011906-sec-0157"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p>One study (<a href="./references#CD011906-bbs2-0010" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , O'BrienJ , KangJH , DushkesR , CookNR , OkerekeO , et al. Long‐term multivitamin supplementation and cognitive function in men: a randomized trial. Annals of Internal Medicine2013;159:806‐14. ">Grodstein 2013</a>) found no evidence of an effect of treatment on a composite verbal memory score after a mean of 8.5 years (range 0.3 to 14.2 years) (MD ‐0.01, 95% CI ‐0.07 to 0.05; n = 2324; low‐certainty evidence). </p> </section> </section> <section id="CD011906-sec-0158"> <h5 class="title">Executive function</h5> <p>See <a href="./references#CD011906-fig-0028" title="">Analysis 5.3</a> </p> <section id="CD011906-sec-0159"> <h6 class="title">&gt; 2‐5 years of supplementation:</h6> <p>One study (<a href="./references#CD011906-bbs2-0010" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , O'BrienJ , KangJH , DushkesR , CookNR , OkerekeO , et al. Long‐term multivitamin supplementation and cognitive function in men: a randomized trial. Annals of Internal Medicine2013;159:806‐14. ">Grodstein 2013</a>) found no evidence of an effect of treatment on verbal fluency after a mean of 2.5 years (range 0.18 to 5.3 years) (MD ‐0.02, 95% CI ‐0.33 to 0.29; n = 5942; low‐certainty evidence). </p> </section> <section id="CD011906-sec-0160"> <h6 class="title">&gt; 5‐10 years of supplementation:</h6> <p>One study (<a href="./references#CD011906-bbs2-0010" title="ChristenWG , GazianoJM , HennekensCH . Design of Physicians’ Health Study II — a randomized trial of beta‐carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Annals of Epidemiology2000;10:125‐34. GrodsteinF , O'BrienJ , KangJH , DushkesR , CookNR , OkerekeO , et al. Long‐term multivitamin supplementation and cognitive function in men: a randomized trial. Annals of Internal Medicine2013;159:806‐14. ">Grodstein 2013</a>) found no evidence of an effect of treatment on verbal fluency after a mean of 8.5 years (range 0.3 to 14.2 years) (MD ‐0.22, 95% CI ‐0.65 to 0.21; n = 2324; low‐certainty evidence). </p> </section> </section> <section id="CD011906-sec-0161"> <h5 class="title">Speed of processing</h5> <p>See <a href="./references#CD011906-fig-0029" title="">Analysis 5.4</a> </p> <section id="CD011906-sec-0162"> <h6 class="title">3‐12 months of supplementation:</h6> <p>One study (<a href="./references#CD011906-bbs2-0004" title="CockleSM , HallerJ , KimberS , DaweRA , HindmarchI . The influence of multivitamins on cognitive function and mood in the elderly. Aging &amp; Mental Health2000;4:339‐53. ">Cockle 2000</a>) found no evidence of an effect of treatment on a total reaction time (TRT) (MD ‐14.71, 95% CI ‐57.22 to 27.80; n = 127; low‐certainty evidence). Another study (<a href="./references#CD011906-bbs2-0027" title="WoltersM , HicksteinM , FlintermannA , TewesU , HahnA . Cognitive performance in relation to vitamin status in healthy elderly German women ‐ the effect of 6‐month multivitamin supplementation. Preventive Medicine2005;41:253‐9. ">Wolters 2005</a>) used the symbol search subtest from the WAIS‐III and reported the results as medians with 5th to 95th percentiles. The vitamin group was significantly faster than the placebo group (P = 0.015) at baseline and this difference persisted at the end of the intervention (P = 0.01). </p> </section> </section> <section id="CD011906-sec-0163"> <h5 class="title">Other outcomes</h5> <p>Not reported.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011906-sec-0164" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011906-sec-0164"></div> <section id="CD011906-sec-0165"> <h3 class="title" id="CD011906-sec-0165">Summary of main results</h3> <section id="CD011906-sec-0166"> <h4 class="title">B vitamins</h4> <p>Fourteen studies with 27,882 participants contributed data. Only two studies lasted for longer than five years, although between them these included more than 10,000 participants. We found no evidence that giving B vitamin supplements to cognitively healthy adults, mainly in their 60s and 70s, had any effect on global cognitive function or on episodic memory, executive function, or speed of processing. There were very sparse data on adverse effects or on incidence of cognitive impairment or dementia, quality of life, functional performance, or clinical global impression. </p> </section> <section id="CD011906-sec-0167"> <h4 class="title">Antioxidant vitamins (vitamins C and E, and beta‐carotene)</h4> <p>Eight studies with 47,840 participants contributed data. Six studies had a mean treatment duration longer than five years. Two studies followed participants up for more than 10 years. The results of these trials were more mixed than for B vitamins. There was low‐certainty evidence that vitamin C supplements may have a small beneficial effect on episodic memory after 2 to 5 years of treatment and on overall cognitive function after 5 to 10 years, although effects were not seen at other time points. There were no longer‐term data on vitamin C. For vitamin E, there was low‐certainty evidence of a small detrimental effect on executive function after 2 to 5 years and no data beyond 10 years. For beta‐carotene, there was no evidence of any effects up to 10 years, but moderate‐certainty evidence from one large study with a duration of 15 to 20 years of small benefits on overall cognitive function and episodic memory after a mean of 18 years of treatment. There were very few cognitive data from trials using combinations of antioxidant vitamins. There was no evidence of an effect of 5 to 10 years of antioxidant combination treatment in two trials, but one trial which assessed participants six years after the end of an 8‐year treatment period (using vitamins C, E, beta‐carotene plus zinc and selenium) reported a small benefit on episodic memory. Two studies found no effect of antioxidant vitamins on the incidence of dementia. Other review outcomes were not reported in these trials. </p> </section> <section id="CD011906-sec-0168"> <h4 class="title">Vitamin D</h4> <p>One large trial in this comparison provided low to moderate‐certainty evidence of no effect on cognitive outcomes or the incidence of MCI or dementia of a relatively low dose of vitamin D3 with calcium carbonate in any time period up to 10 years. It provided no evidence on other review outcomes. There was also a small pilot trial which used a much higher dose of vitamin D3 and found no evidence of cognitive effects over six months. </p> </section> <section id="CD011906-sec-0169"> <h4 class="title">Zinc and copper</h4> <p>One study contributed usable data, providing low‐certainty evidence of no effect on cognitive outcomes or the incidence of cognitive impairment after 5 to 10 years, but no evidence on other outcomes. </p> </section> <section id="CD011906-sec-0170"> <h4 class="title">Selenium</h4> <p>One study found no evidence of an effect of approximately five years of selenium supplementation on the incidence of dementia, but there was no information on other outcomes. </p> </section> <section id="CD011906-sec-0171"> <h4 class="title">Complex multivitamins (B vitamins and antioxidants +/‐ minerals)</h4> <p>Two small, short‐term studies and one large study with a mean duration of treatment of 8.5 years at final follow‐up found no effects of complex multivitamins on cognitive outcomes. There was no evidence on other review outcomes. </p> </section> </section> <section id="CD011906-sec-0172"> <h3 class="title" id="CD011906-sec-0172">Overall completeness and applicability of evidence</h3> <p>Our principal interest was in whether or not vitamin supplementation could be of benefit to the general middle‐aged or older population in terms of maintaining cognitive function or preventing dementia in late life. Some general points can be made about the evidence across all the interventions. </p> <p>Many of the included studies, especially the larger and longer ones, were not designed primarily with cognitive outcomes in mind and did not assess cognition at baseline. It is therefore possible that some participants may not have been cognitively healthy at baseline, although we considered it unlikely that people with known dementia would have been recruited. In some cases, limited cognitive assessments, using measures which lack sensitivity to detect change in cognitively healthy people, were added to existing studies some years after onset. Participation in these studies was often restricted in ways which reflected the original aims, e.g. recruitment limited to one gender, or to people with particular comorbidities or risk factors, so the evidence was often not directly applicable to the older population in general. Only three studies specifically assessed the incidence of dementia. Studies which were designed to assess cognition tended to be shorter (less than two years), which may not be long enough to detect effects. If cognitive effects are detected on this timescale, it is not clear what implications this has for the incidence of dementia. There are problems inherent in combining short‐term studies, in which separation of groups may only be seen if the intervention leads to cognitive improvement (or harm), and studies which are long enough to detect a change in the trajectory of age‐ or pathology‐related decline. We considered it important to separate studies into groups of different durations, but our time divisions were inevitably somewhat arbitrary and this decision greatly limited the numbers of studies which could be combined. </p> <p>There is no well developed understanding of the mechanisms by which any of these interventions might affect cognition, which may be the reason that studies used a wide variety of doses and treatment combinations. This makes it difficult to compare studies and leaves open the possibility that different doses or combinations could have different effects. </p> <section id="CD011906-sec-0173"> <h4 class="title">B vitamins</h4> <p>The body of evidence on vitamin B supplements addresses our review question only indirectly. Many studies restricted participation to those with particular comorbidities or who had some evidence of low vitamin B levels or exposure at baseline. Four of the 13 studies allowed inclusion of participants younger than 60 years, but in all cases, the mean age of participants was &gt; 60 years so the data do not adequately address the effects of supplementation in midlife. We excluded very short‐term studies (&lt; 3 months), but the majority of included studies treated participants for 2 years or less, which may not be long enough to detect any effect. The particular vitamin B subtypes and their doses differed between studies and in several studies, particularly those with factorial designs, some participants receiving B vitamins also received other potentially active interventions. The studies were too heterogeneous to allow these various characteristics to be explored in subgroup analyses. </p> </section> <section id="CD011906-sec-0174"> <h4 class="title">Antioxidant vitamins</h4> <p>We considered vitamin C, vitamin E, and beta‐carotene in this group. The evidence on cognitive effects of antioxidant vitamins is very largely from studies which had other primary aims and to which very limited cognitive assessment was added after the studies were underway. In two of the large trials, all participants were at high vascular risk. However, the age of participants at recruitment was generally lower and the duration of the trials was generally longer than the B vitamin trials, so this body of evidence may be more informative about the potential of prolonged treatment to protect cognitive function against decline. Only two of these studies assessed incidence of dementia so most of the results have no more than indirect implications for dementia prevention.There was substantial variation in the doses of vitamins used. Again, the use of factorial designs in some studies meant the comparator groups included participants exposed to a variety of treatments. </p> </section> <section id="CD011906-sec-0175"> <h4 class="title">Vitamin D</h4> <p>One study used a combination of vitamin D and calcium carbonate. Mean follow‐up was 7.8 years. All participants were postmenopausal women, but inclusion criteria were otherwise broad. The dose of vitamin D was relatively low (400 IU/day). This was one of very few studies that used a rigorous method to assess for incident MCI or dementia. The other study used a higher dose of vitamin D3 (4000 IU on alternate days), but was small and provided only preliminary evidence on supplementation with this dose. </p> </section> <section id="CD011906-sec-0176"> <h4 class="title">Minerals (zinc and copper, selenium)</h4> <p>We found limited data from two studies of mineral supplements. One used a combination of zinc and copper oxides. It was designed to look for an effect on age‐related macular degeneration, but there is no reason to think that this limits generalisibility of the cognitive results. Cognitive assessment was after a median of 6.9 years. Dementia incidence was not an outcome. The other was a selenium‐only arm of a factorial study in which dementia incidence was the only relevant outcome reported. It found no evidence of an effect of selenium. </p> </section> <section id="CD011906-sec-0177"> <h4 class="title">Complex multivitamins with or without minerals</h4> <p>There were three included studies in this category. One used a combination of B vitamins and antioxidant vitamins. Two used commercially available multivitamin and mineral combinations. Two studies were very small and lasted less than a year. In the large study, all participants were men, treated for a mean of 8.5 years. Dementia incidence was not an outcome. </p> </section> </section> <section id="CD011906-sec-0178"> <h3 class="title" id="CD011906-sec-0178">Quality of the evidence</h3> <p>The large studies were generally well‐conducted and we did not consider that risk of bias was a major threat to the results, although there were some gaps in reporting in all domains. Uncertainty about the risk of selection bias and concerns about attrition bias led us to downgrade the certainty of some results due to possible study limitations. We considered much of the evidence to be indirect with respect to our review question because participation in many studies was restricted, e.g. by comorbidities, baseline biochemistry, or gender. Overall, we considered the certainty of the evidence behind almost all effect estimates to be moderate or low with respect to our review question. </p> </section> <section id="CD011906-sec-0179"> <h3 class="title" id="CD011906-sec-0179">Potential biases in the review process</h3> <p>Particularly for B vitamins, bias may arise from pooling studies which differed in participants (e.g. with or without elevated homocysteine at baseline) and interventions (various constituents and doses). This 'broad brush' approach may disguise effects. </p> </section> <section id="CD011906-sec-0180"> <h3 class="title" id="CD011906-sec-0180">Agreements and disagreements with other studies or reviews</h3> <p>A comprehensive systematic review and meta‐analysis of the cognitive effects of several years of treatment with B vitamins was published by the B‐Vitamin Treatment Trialists' Collaboration in 2014 (<a href="./references#CD011906-bbs2-0092" title="ClarkeR , BennettD , ParishS , LewingtonS , SkeaffM , EussenSJ , et al. Effects of homocysteine lowering with B vitamins on cognitive aging: meta‐analysis of 11 trials with cognitive data on 22,000 individuals. American Journal of Clinical Nutrition2014;100:657‐66. ">Clarke 2014</a>). It included 11 trials for which data were available by September 2010. All the included trials were also included in this review. The authors investigated the effect of the interventions on homocysteine levels as well as on cognition. Although they found that the treatments effectively lowered homocysteine levels (by slightly more than 25%), they also found no evidence of significant effects on global ('MMSE‐type') cognitive function, domain‐specific cognitive function, or cognitive aging. We are not aware of similar systematic reviews of the effects of treatment with non‐B vitamins or minerals. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011906-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011906-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011906-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 B vitamins versus control, outcome: 1.1 Overall cognitive functioning." data-id="CD011906-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 B vitamins versus control, outcome: 1.1 Overall cognitive functioning. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Antioxidants versus control, outcome: 2.1 Overall cognitive functioning." data-id="CD011906-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Antioxidants versus control, outcome: 2.1 Overall cognitive functioning. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Antioxidants versus control, outcome: 2.2 Episodic memory." data-id="CD011906-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Antioxidants versus control, outcome: 2.2 Episodic memory.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 B vitamins versus control, Outcome 1 Overall cognitive functioning." data-id="CD011906-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 B vitamins versus control, Outcome 1 Overall cognitive functioning.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 B vitamins versus control, Outcome 2 Episodic memory." data-id="CD011906-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 B vitamins versus control, Outcome 2 Episodic memory.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 B vitamins versus control, Outcome 3 Executive function." data-id="CD011906-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 B vitamins versus control, Outcome 3 Executive function.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 B vitamins versus control, Outcome 4 Speed of processing." data-id="CD011906-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 B vitamins versus control, Outcome 4 Speed of processing.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 B vitamins versus control, Outcome 5 Incidence of MCI or dementia." data-id="CD011906-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 B vitamins versus control, Outcome 5 Incidence of MCI or dementia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 B vitamins versus control, Outcome 6 All‐cause mortality." data-id="CD011906-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 B vitamins versus control, Outcome 6 All‐cause mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antioxidants versus control, Outcome 1 Overall cognitive functioning." data-id="CD011906-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Antioxidants versus control, Outcome 1 Overall cognitive functioning.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-002-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antioxidants versus control, Outcome 2 Episodic memory." data-id="CD011906-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Antioxidants versus control, Outcome 2 Episodic memory.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antioxidants versus control, Outcome 3 Executive function." data-id="CD011906-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Antioxidants versus control, Outcome 3 Executive function.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antioxidants versus control, Outcome 4 Incidence of dementia." data-id="CD011906-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Antioxidants versus control, Outcome 4 Incidence of dementia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antioxidants versus control, Outcome 5 All‐cause mortality." data-id="CD011906-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Antioxidants versus control, Outcome 5 All‐cause mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamin D3 versus placebo, Outcome 1 Overall cognitive functioning." data-id="CD011906-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Vitamin D3 versus placebo, Outcome 1 Overall cognitive functioning.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamin D3 versus placebo, Outcome 2 Episodic memory." data-id="CD011906-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Vitamin D3 versus placebo, Outcome 2 Episodic memory.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamin D3 versus placebo, Outcome 3 Executive function." data-id="CD011906-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Vitamin D3 versus placebo, Outcome 3 Executive function.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamin D3 versus placebo, Outcome 4 Speed of processing." data-id="CD011906-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Vitamin D3 versus placebo, Outcome 4 Speed of processing.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamin D3 versus placebo, Outcome 5 Incident MCI." data-id="CD011906-fig-0021" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Vitamin D3 versus placebo, Outcome 5 Incident MCI.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamin D3 versus placebo, Outcome 6 Incident all‐cause dementia." data-id="CD011906-fig-0022" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Vitamin D3 versus placebo, Outcome 6 Incident all‐cause dementia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Zinc + copper versus placebo, Outcome 1 Overall cognitive functioning." data-id="CD011906-fig-0023" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Zinc + copper versus placebo, Outcome 1 Overall cognitive functioning.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Zinc + copper versus placebo, Outcome 2 Episodic memory." data-id="CD011906-fig-0024" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Zinc + copper versus placebo, Outcome 2 Episodic memory.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Zinc + copper versus placebo, Outcome 3 Executive function." data-id="CD011906-fig-0025" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Zinc + copper versus placebo, Outcome 3 Executive function.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Complex multivitamin versus control, Outcome 1 Overall cognitive functioning." data-id="CD011906-fig-0026" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Complex multivitamin versus control, Outcome 1 Overall cognitive functioning.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Complex multivitamin versus control, Outcome 2 Episodic memory." data-id="CD011906-fig-0027" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Complex multivitamin versus control, Outcome 2 Episodic memory.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Complex multivitamin versus control, Outcome 3 Executive function." data-id="CD011906-fig-0028" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Complex multivitamin versus control, Outcome 3 Executive function.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011906-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/urn:x-wiley:14651858:media:CD011906:CD011906-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_t/tCD011906-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Complex multivitamin versus control, Outcome 4 Speed of processing." data-id="CD011906-fig-0029" src="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Complex multivitamin versus control, Outcome 4 Speed of processing.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/media/CDSR/CD011906/image_n/nCD011906-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011906-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">B vitamins compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>B Vitamins compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> cognitively healthy people in mid and late life<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> B Vitamins (folic acid, vitamins B6 and vitamin B12, alone or in combination)<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with B Vitamins</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning 3 to 12 months of supplementation (final measurement data) </p> <p>assessed with: MMSE or TICSm</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>SMD 0<br/> (0.08 lower to 0.08 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2556<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning 3 to 12 months of supplementation (change from baseline data) </p> <p>assessed with: MMSE or TICSm</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.03 lower<br/> (0.26 lower to 0.19 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning &gt; 1 to 2 years of supplementation (final measurement data) </p> <p>assessed with: MMSE, TICS, or TICSm</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.15 higher<br/> (0.17 lower to 0.47 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6956<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning &gt; 1 to 2 years of supplementation (change from baseline data) </p> <p>assessed with MMSE</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.06 higher<br/> (0.2 lower to 0.31 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>241<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning &gt; 2 to 5 years of supplementation (final measurement data) </p> <p>assessed with MMSE, TICS, F‐TICSm or a composite score</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.01 lower<br/> (0.11 lower to 0.09 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3985<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning ‐ &gt; 5‐10 years of supplementation (final measurement data) </p> <p>assessed with MMSE, TICS or TICSm</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.01 lower<br/> (0.09 lower to 0.07 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10249<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incidence of MCI or dementia &gt; 2 to 5 years of supplementation<br/> assessed with: MMSE &lt; 24 on 2 or more occasions<br/> follow‐up: median 2.8 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.89<br/> (0.67 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1803<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>103 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>91 per 1.000<br/> (69 to 121) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded for indirectness due to restricted inclusion criteria for participants in included studies </p> <p><sup>2</sup> Downgraded for imprecision due to small sample size and wide confidence intervals </p> <p><sup>3</sup> Downgraded for study limitations due to missing data from 26% of participants in SEARCH 2010 </p> <p><sup>MMSE: Mini Mental State Examination</sup><br/> <sup>TICS: Telephone Interview for Cognitive Status</sup><br/> <sup>TICSm: modified Telephone Interview for Cognitive Status</sup><br/> <sup>F‐TICSm: modified Telephone Interveiw for Cognitive Status (French version)</sup> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">B vitamins compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011906-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antioxidants compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Antioxidants compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> cognitively healthy people in mid and late life<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> antioxidant vitamins (vitamins C, E, and beta‐carotene, alone or in combination)<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Antioxidants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Vitamin E supplementation</b><br/> Overall cognitive functioning </p> <p>assessed with: MMSE<br/> Scale from: 0 to 30<br/> follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean MMSE score was 26.6</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1.4 higher<br/> (1.18 higher to 1.62 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicates better cognitive function.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Vitamin E supplementation</b><br/> Overall cognitive functioning assessed with: TICS </p> <p>Scale from: 0 to 41<br/> follow‐up: range 6 years to 10 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Two studies found no evidence of an effect of vitamin E</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(2 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> LOW <sup>4 5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Range of follow‐up durations was approximate. Mean in one study was 9.6 years and in the other study was 8.9 years. There were 5226 participants in one study. The number in the other study was not reported for this time point (approximately 800). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Beta‐carotene supplementation</b> </p> <p>Overall cognitive functioning<br/> assessed with: TICS<br/> Scale from: 0 to 41<br/> follow‐up: mean 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TICS score was 34.29</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.14 lower<br/> (0.37 lower to 0.09 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1904<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicates better cognitive function.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Beta‐carotene supplementation</b> </p> <p>Overall cognitive functioning<br/> assessed with: TICS<br/> follow‐up: mean 8.9 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>MD 0.13 lower<br/> (0.46 lower to 0.19 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> LOW <sup>4 7</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference with 95% CI reported in paper. Absolute values in each treatment group not reported. Number in each treatment group at final follow‐up not reported. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Beta‐carotene supplementation</b> </p> <p>Overall cognitive functioning<br/> assessed with: TICS<br/> Scale from: 0 to 41<br/> follow‐up: mean 18 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean TICS score was 34.23</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>MD 0.18 higher<br/> (0.01 higher to 0.35 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4052<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> MODERATE <sup>6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Vitamin C supplementation</b> </p> <p>Overall cognitive functioning<br/> assessed with: TICS<br/> follow‐up: mean 8.9 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>MD 0.46 higher<br/> (0.14 higher to 0.78 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> LOW <sup>4 7</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference with 95% CI reported in paper. Absolute values in each group not reported. Number in each treatment group at final follow‐up not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplementation with beta‐carotene + vit C + vit E</b> </p> <p>Overall cognitive functioning<br/> assessed with: TICSm<br/> Scale from: 0 to 39<br/> follow‐up: mean 5 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TICSm score was 24.02</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.09 higher<br/> (0.05 lower to 0.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20536<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Supplementation with beta‐carotene + vit C + vit E</b> </p> <p>Overall cognitive functioning<br/> assessed with: 3MS (modified MMSE)<br/> Scale from: 0 to 100<br/> follow‐up: median 6.9 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean 3MS score was 92.1</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.6 higher<br/> (0.2 lower to 1.4 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1100<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Higher score indicates better cognitive function.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incidence of all‐cause dementia<br/> follow‐up: mean approximately 5 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Two studies, one using a combination of beta‐carotene, vit C and vit E and one using vit E ± selenium, found no significant difference in the incidence of dementia. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 993<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>8 9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded for risk of bias due to lack of blinding (open‐label study) </p> <p><sup>2</sup> Downgraded for indirectness (diabetic participants only) </p> <p><sup>3</sup> Downgraded for imprecision due to small sample size </p> <p><sup>4</sup> Downgraded for risk of bias due to incomplete outcome data </p> <p><sup>5</sup> Downgraded for indirectness (both studies included only women and in one study all participants also had cardiovascular disease or 3 or more coronary risk factors) </p> <p><sup>6</sup> Downgraded for indirectness (included men only) </p> <p><sup>7</sup> Downgraded for indirectness (included only women with cardiovascular disease or ≥ 3 coronary risk factors) </p> <p><sup>8</sup> Downgraded for indirectness (all participants had high risk of coronary heart disease death over the next 5 years) </p> <p><sup>9</sup> Downgraded for imprecision due to wide confidence interval </p> <p><sup>MMSE: Mini Mental State Examination</sup><br/> <sup>TICS: Telephone Interview for Cognitive Status</sup><br/> <sup>TICSm: Modified Telephone Interview for Cognitive Status</sup><br/> <sup>3MS: The Modified Mini‐Mental State Examination</sup> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antioxidants compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011906-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Vitamin D3 compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vitamin D3 compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> cognitively healthy people in mid and late life<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> vitamin D3 +/‐ calcium carbonate<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Vitamin D3</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall cognitive functioning</p> <p>assessed with: MoCA change from baseline</p> <p>Scale from: 0 to 30</p> <p>follow‐up: 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>There was no significant difference between groups in the change in MoCA score (P=0.186).</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Experimental intervention was vitamin D3 4000 IU on alternate days.</p> <p>Data not fully reported (conference abstract only).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning<br/> assessed with: 3MS<br/> Scale from: 0 to 100<br/> follow‐up: mean 7.8 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean 3MS score was 96.6</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.1 lower<br/> (0.81 lower to 0.61 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>918<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Experimental intervention was vitamin D3 400 IU/day and calcium carbonate 1000 mg/day.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incidence of probable dementia or MCI<br/> follow‐up: mean 7.8 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No significant difference in incidence between treatment groups. In an intention‐to‐treat analysis, incidence was 62.2/10 000 person‐years in the vit D + Ca group and 65.9/10 000 person‐years in the placebo group (HR 0.94, 95% CI 0.72 to 1.24, P = 0.68). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4143<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Experimental intervention was vitamin D3 400 IU/day and calcium carbonate 1000 mg/day.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded for imprecision (small sample size) </p> <p><sup>2</sup> Downgraded for risk of bias due to incomplete outcome data </p> <p><sup>3</sup> Downgraded for indirectness (study included women only) </p> <p><sup>4</sup> Downgraded for imprecision due to wide confidence interval </p> <p><sup>MCI: Mild Cognitive Impairment<br/> MOCA: Montreal cognitive assessment<br/> 3MS: The Modified Mini‐Mental State Examination</sup> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Vitamin D3 compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011906-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Zinc + copper compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Zinc + copper compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> cognitively healthy people in mid and late life<br/> <b>Setting:</b> Community<br/> <b>Intervention:</b> Zinc + copper oxides<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Zinc + copper</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning<br/> assessed with: 3MS<br/> Scale from: 0 to 100<br/> follow‐up: median 6.9 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean 3MS score was 92.1</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.6 higher<br/> (0.19 lower to 1.39 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1072<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incidence of dementia or MCI<br/> assessed with: 3MS score &lt; 80<br/> follow‐up: median 6.9 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>4.5% of participants met the authors' definition of cognitive impairment (3MS &lt; 80) and "there was no significant effect of treatment group on likelihood of having cognitive impairment." </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1072<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded for risk of bias due to unclear selective reporting and high risk of bias due to incomplete outcome data </p> <p><sup>2</sup> Downgraded for indirectness (Yaffe 2004 included participants with age‐related macular degeneration) </p> <p><sup>3</sup> Downgraded two levels for study limitations due to incomplete outcome data and selective reporting </p> <p><sup>3MS: The Modified Mini‐Mental State Examination</sup><br/> <sup>MCI: Mild cognitive impairment</sup> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Zinc + copper compared to placebo for maintaining cognitive function in cognitively healthy people in mid and late life</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011906-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Complex multivitamin compared to control for maintaining cognitive function in cognitively healthy people in mid and late life</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Complex multivitamin compared to control for maintaining cognitive function in cognitively healthy people in mid and late life</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> cognitively healthy people in mid and late life<br/> <b>Setting:</b> community<br/> <b>Intervention:</b> complex multivitamins (combinations of B vitamins and antioxidant vitamins +/‐ minerals)<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Complex multivitamin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning</p> <p>assessed with: TICS</p> <p>Scale from: 0 to 41</p> <p>follow‐up: mean 2.5 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TICS score was 34.3</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.04 higher<br/> (0.09 lower to 0.18 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5947<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Follow‐up ranged from 0.18 to 5.3 years.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall cognitive functioning<br/> assessed with: TICS<br/> Scale from: 0 to 41<br/> follow‐up: mean 8.5 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TICS score was 33.1</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.12 higher<br/> (0.14 lower to 0.38 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2324<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Follow‐up ranged from 0.3 to 14.2 years.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incidence of MCI or all‐cause dementia ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded for study limitations due to incomplete outcome data and wide range of follow‐up durations </p> <p><sup>2</sup> Downgraded for indirectness (study included only men) </p> <p><sup>TICS: Telephone Interview for Cognitive Status<br/> MCI: mild cognitive impairment</sup> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Complex multivitamin compared to control for maintaining cognitive function in cognitively healthy people in mid and late life</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/full#CD011906-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011906-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">B vitamins versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall cognitive functioning <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 3‐12 months of supplementation (final measurement data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2556</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.08, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 3‐12 months of supplementation (change from baseline data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.26, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 &gt; 1‐2 years of supplementation (final measurement data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6956</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.08, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 &gt; 1‐2 years of supplementation (change from baseline data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.20, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 &gt; 2‐5 years of supplementation (final measurement data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.11, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 &gt; 5‐10 years of supplementation (final measurement data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.09, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Episodic memory <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 3‐12 months of supplementation (final measurement data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1442</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.08, 0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 3‐12 months of supplementation (change from baseline data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>430</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.15, 0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 &gt; 1‐2 years of supplementation (final measurement data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5625</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.03, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 &gt; 1‐2 years of supplementation (change from baseline data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.19, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 &gt; 2‐5 years of supplementation (final measurement data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.15, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 &gt; 5‐10 years of supplementation (final measurement data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1053</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.22, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Executive function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 3‐12 months of supplementation (final measurement data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>536</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [‐0.18, 0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 3‐12 months of supplementation (change from baseline data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.07, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 &gt; 1‐2 years of supplementation (final measurement data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2976</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.15, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 &gt; 2‐5 years of supplementation (final measurement data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2648</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.13, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 &gt; 5‐10 years of supplementation (final measurement data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1049</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.10, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Speed of processing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 3‐12 months of supplementation (final measurement data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>289</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.28, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 3‐12 months of supplementation (change from baseline data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>487</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.34, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 &gt; 1‐2 years of supplementation (final measurement data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1030</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.09, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 &gt; 1‐2 years of supplementation (change from baseline data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.29, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5 &gt; 2‐5 years of supplementation (final measurement data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>818</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.22, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Incidence of MCI or dementia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 &gt; 2‐5 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1803</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.69, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 3‐12 months of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 &gt;1 to 2 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3680</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.66, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 &gt;2‐5 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.98 [1.22, 3.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 &gt;5‐10 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12064</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.95, 1.12]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">B vitamins versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011906-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Antioxidants versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall cognitive functioning <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 3‐12 months Vitamin E supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.4 [1.18, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 3‐12 months Beta Carotene supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.37, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 &gt; 2‐5 years antioxidants (Vitamin E + Vitamin C + Beta Carotene) supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.05, 0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 &gt; 2‐5 years Vitamin E supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.23, 0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 &gt; 2‐5 years Vitamin C supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐0.08, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 &gt; 2‐5 years Beta Carotene supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.42, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 &gt; 5‐10 years antioxidants (Vitamin E + Vitamin C + Beta carotene) supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.6 [‐0.20, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8 &gt; 5‐10 years Vitamin C supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.14, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9 &gt; 5‐10 years Beta Carotene supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.46, 0.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10 &gt; 10 years Beta Carotene supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.01, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Episodic memory <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 3‐12 months Beta Carotene supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.05, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 &gt; 2‐5 years Vitamin E supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.07, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 &gt; 2‐5 years Vitamin C supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.10, ‐0.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 &gt; 2‐5 years Beta Carotene supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.05, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 &gt; 5‐10 years antioxidants (Vitamin E + Vitamin C + Beta Carotene) supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.3 [‐1.30, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 &gt; 5‐10 years Vitamin E supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.05, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7 &gt; 5‐10 years Vitamin C supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.22, ‐0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8 &gt; 5‐10 years Beta Carotene supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.05, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9 &gt; 10 years Beta Carotene supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.11, ‐0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Executive function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 3‐12 months Beta Carotene supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.48, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 &gt; 2‐5 years Vitamin E supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.06, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 &gt; 2‐5 years Vitamin C supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.39, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 &gt; 2‐5 years Beta Carotene supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [‐0.14, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 &gt; 5‐10 years antioxidants (Vitamin E + Vitamin C + Beta Carotene) supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.4 [‐0.99, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6 &gt; 5‐10 years Vitamin E supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.26, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7 &gt; 5‐10 years Vitamin C supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.70, 0.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8 &gt; 5‐10 years Beta Carotene supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.44, 0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.9 &gt; 10 years Beta Carotene supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.36, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Incidence of dementia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 &gt; 2‐5 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20536</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.61, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 &gt; 2‐5 years antioxidants (Vitamin E + Vitamin C + + Beta Carotene) supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20536</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.97, 1.11]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Antioxidants versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011906-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Vitamin D3 versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall cognitive functioning <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 3‐12 months of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.24, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 &gt; 1‐2 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3910</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.25, 0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 &gt; 2‐5 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3515</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.2 [‐0.53, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 &gt; 5‐10 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>918</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.1 [‐0.81, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Episodic memory <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 &gt; 5‐10 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.03, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Executive function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 &gt; 5‐10 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.08, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Speed of processing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 &gt; 5‐10 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.05, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Incident MCI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 &gt; 5‐10 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.72, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Incident all‐cause dementia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 &gt; 5‐10 years supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.70, 1.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Vitamin D3 versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011906-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Zinc + copper versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall cognitive functioning <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 &gt; 5‐10 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1072</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.6 [‐0.19, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Episodic memory <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 &gt; 5‐10 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1072</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.7 [‐1.74, 0.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Executive function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 &gt; 5‐10 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1072</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.3 [‐0.89, 0.29]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Zinc + copper versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011906-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Complex multivitamin versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall cognitive functioning <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 &gt; 2‐5 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5947</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.09, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 &gt; 5‐10 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.14, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Episodic memory <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 3‐12 months of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>33.17 [‐28.12, 94.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 &gt; 2‐5 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5942</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.05, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 &gt; 5‐10 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.07, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Executive function <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 &gt; 2‐5 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5942</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.33, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 &gt; 5‐10 years of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.22 [‐0.65, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Speed of processing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 3‐12 months of supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐14.71 [‐57.22, 27.80]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Complex multivitamin versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011906.pub2/references#CD011906-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011906.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011906-note-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011906-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011906-note-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="ja#CD011906-note-0005">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD011906-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD011906-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011906-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011906\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011906\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011906\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011906\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011906\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9nGOjNGw&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011906.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011906.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011906.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011906.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011906.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724911733"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011906.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724911739"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011906.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e6e5f4b8bf4ca',t:'MTc0MDcyNDkxMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 